Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1039997-1065572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;pituitary gland: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;HMC-1: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	4.4	3.0	3.4	5.5	3.9	27.4	3.3	4.0	6.1	3.2	11.5	3.8	2.3	1.2	0.2	7.6	2.1	2.1	3.1	3.6	3.7	6.4	4.2	9.5	8.5	5.8	4.5	0.5	7.7	2.7	28.7	1.2	5.3	5.3	1.2	25.5	8.6	1.1	3.8	5.9	10.1	0.5	3.0	26.6	3.8	1.7	4.1	10.0	5.7	0.3	3.2	2.3	2.8	3.2	4.7	6.4	0.5	4.4	7.2	2.2	7.3	0.8	1.0	0.4	0.6	5.2	2.8	13.9	5.6	1.3	0.6	8.0	1.3	6.2	0.4	10.2	2.5	6.7	20.4	5.6	1.8	3.9	40.3	3.8	1.8	0.9	1.2	4.4	1.4	7.7	10.2	6.9	1.3	2.2	4.3	2.2	0.9	3.3	2.5	3.1	0.8	11.6	3.8	6.0	0.3	1.3	8.2	1.9	1.2	1.1	4.6	7.1	2.2	0.4	1.6	3.7	0.8	9.9	6.6	5.7	2.1	7.4	2.0	2.8	1.4	5.9	1.8	1.2	1.1	0.6	0.9	1.2	2.1	0.9	0.8	1.5	3.3	1.1	1.3	7.3	0.4	1.3	3.4	3.9	4.0	6.1	3.6	3.7	5.8	4.5	5.3	3.0	4.1	3.2	4.1	73.7	21.9	8.5	13.2	3.3	0.8	10.7	5.2	70.6	4.8	2.2	6.0	4.3	14.0	5.5	175.2	4.6	9.1	14.7	1.9	2.7	7.3	8.9	1.4	2.9	3.5	13.3	12.9	2.5	303.3	1.5	5.6	6.9	10.1	2.0	2.5	4.9	7.9	15.2	11.5	4.7	16.2	12.6	7.5	4.8	0.0	12.7	0.0	4.7	19.6	13.1	9.2	1.5	2.4	7.0	9.6	0.0	12.0	1.5	1.7	1.3	17.5	149.1	0.0	2.7	2.7	0.7	2.0	6.6	3.4	25.7	12.6	1.0	5.3	1.9
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 115.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 197.6;Cardiomyocytes: 61.7;Hepatocytes: 116.0;Oligodendrocyte precursor cells: 63.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 75.3;HHSteC: 77.6;HSkMC: 89.4;hTERT-HME1: 90.9;hTERT-RPE1: 76.2;TIME: 103.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		30000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	68.4	7.4	19.2	3.8	18.0	0.5	57.6	49.7	19.1	12.5	6.8	11.1	2.7	10.4	6.3	33.2	14.4	7.1	87.8	20.4	26.7	19.8	115.8	20.0	5.3	37.2	25.2	3.9	2.7	59.6	6.8	34.4	28.7	9.1	5.0	28.6	6.5	8.2	45.8	8.3	7.8	10.6	34.0	8.7	5.4	2.0	29.9	2.2	9.2	38.7	4.5	14.1	17.7	30.2	23.6	4.8	0.0	0.2	39.6	75.3	0.1	16.1	44.8	9.1	15.8	0.1	16.2	0.0	2.7	20.5	47.9	0.5	0.1	18.9	17.7	0.1	0.2	0.0	1.4	0.6	77.6	0.0	0.1	89.4	5.1	32.5	90.9	76.2	41.1	0.0	0.0	7.2	54.8	9.2	0.0	0.0	0.2	1.5	63.0	0.0	0.1	0.0	50.3	16.0	6.3	0.1	3.3	1.1	8.7	1.2	1.5	0.1	103.9	18.9	4.2	19.9	27.7	0.1	0.0	0.0	33.5	0.0	55.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	2.7	19.2	18.0	49.7	19.1	20.4	26.7	37.2	25.2	28.7	34.0	29.9	30.2	197.6	0.0	3.7	21.5	1.3	1.5	1.2	2.6	0.6	2.5	7.6	3.9	61.7	18.6	5.3	0.0	0.0	0.2	0.3	0.0	5.9	8.7	3.0	0.5	2.5	39.6	0.0	0.0	31.0	3.5	0.7	9.4	3.6	2.5	1.3	0.0	34.2	116.0	12.3	28.6	33.7	0.0	8.2	13.5	1.1	0.5	0.3	8.5	5.4	21.5	0.9	19.3	0.0	63.8	25.6	22.5	0.0	0.7	0.1	2.5	0.0	23.5	4.9	25.1	0.0	7.4	7.7	1.7	2.7	2.0	1.6	0.4	0.7	0.5	0.0	22.2
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AL358113.1		ENSG00000285130	"Novel protein"		9	69035747-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.6;Endometrial ciliated cells: 3.8;Glandular and luminal cells: 3.8;Respiratory ciliated cells: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"		"Cluster 14: REH - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		0.0	0.3	0.1	0.4	0.1	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.6	0.0		0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0		0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.7	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.7	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.6	0.8	0.5	0.1	0.1	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	3.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.8	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0
AL645922.1		ENSG00000244255	"Novel complement component 2 (C2) and complement factor B (CFB) protein"		6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"liver: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;Club cells: 3.1;Fibroblasts: 1.2;Respiratory ciliated cells: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552190-73565667	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	7.8	11.3	4.6	5.7	5.1	14.0	10.1	5.7	5.4	9.4	5.2	8.9	9.6	12.4	13.1	7.5	11.4	9.7	8.2	4.2	5.1	5.9	10.8	7.0	9.9	5.0	4.9	14.1	8.3	8.0	7.5	10.0	5.3	12.4	10.4	9.9	10.9	8.4	7.6	9.1	9.6	8.3	5.1	8.8	10.0	6.7	5.2	10.0	14.3	6.6	8.1	7.4	7.7	6.2	6.6	4.5	6.6	7.5	12.3	19.3	20.6	9.0	13.2	7.6	11.0	1.4	9.4	6.2	7.0	8.8	7.3	4.5	3.1	15.4	10.9	11.9	5.5	5.4	3.6	6.5	9.6	3.1	9.3	19.8	21.0	9.1	9.2	13.6	8.7	6.7	5.3	9.9	8.6	3.8	5.6	8.5	3.9	2.5	3.7	3.5	7.1	8.7	5.6	8.2	9.0	6.9	6.9	5.3	11.0	10.2	8.2	5.0	11.2	3.0	3.4	4.9	6.3	19.7	15.1	5.3	7.5	5.1	8.8	19.9	5.1	11.2	7.6	4.5	9.3	9.9	8.9	10.7	4.6	8.0	13.3	12.4	8.4	7.3	7.8	5.3	11.5	6.8	4.6	5.1	5.7	5.4	4.2	5.1	5.0	4.9	5.3	5.1	5.2	6.2	10.7	3.2	11.5	10.4	23.5	15.8	30.1	29.8	26.2	26.2	20.7	15.9	8.9	31.5	22.7	18.4	10.4	26.3	27.1	16.0	27.4	14.1	1.3	18.1	11.0	12.8	24.1	21.5	10.0	16.6	22.2	13.8	10.7	13.4	19.0	18.8	15.7	23.8	10.5	23.5	12.9	22.6	36.7	18.5	6.7	2.2	32.6	11.1	12.4	16.9	15.1	16.2	17.5	21.1	22.3	16.9	20.0	29.0	14.6	25.7	21.5	18.0	21.4	21.2	26.3	11.3	17.8	25.6	15.9	16.0	12.4	48.8	20.4	16.3	17.0	36.8
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"liver: 27649.0"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 84691.9"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 107.3;Hep G2: 296.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	45000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			4.1	1.2	0.0	1.0	0.0	0.0	2.5	0.0	0.1	0.4	0.0	7.2	907.0	0.5	0.0	1.1	1.9	0.0	1.6	0.0	0.0	18.2	27649.0	1.4	0.9	0.0	0.0	0.8	2.4	0.0	0.8	0.9	0.0	0.6	0.0	0.0	0.6	0.0	0.6	1.2	1106.7	0.5	0.0	8.0	1.5	1.0	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.0	0.0	0.1	107.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	296.2	0.0	10.7	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.2	2.3	0.2	0.0	0.0	0.0	6.3	3.9	0.0	0.1	1.1	3.8	4.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.2	0.0	3.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	67.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	674.9	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	4.2	0.0	0.0	39.7	0.0	823.7	0.0	0.4	1.5	0.1	0.0	0.0	0.0	0.3	707.9	84691.9	1.1	0.0	0.0	264.5	0.0	1107.4	0.0	12.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	224.0	0.0	0.0	0.0	10473.3	121.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	39.8	0.0	135.5	0.0
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723887	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 111.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 266.5;Oligodendrocyte precursor cells: 336.7;Oligodendrocytes: 827.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 68: Oligodendrocytes - Mixed function"	"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	28.4	18.0	44.3	10.3	77.7	7.2	16.1	56.7	58.1	19.7	0.0	16.6	12.9	19.9	8.6	10.8	17.5	17.9	21.2	49.1	48.3	11.0	13.1	21.7	5.3	76.3	63.1	31.9	14.9	14.6	12.1	16.6	66.7	10.8	18.5	41.3	24.5	11.5	17.7	6.8	16.3	17.8	48.4	8.9	27.1	14.6	58.0	11.4	12.8	23.0	6.0	13.8	9.0	111.2	59.0	25.1	60.9	52.3	42.2	59.1	21.6	41.6	26.6	24.5	34.0	18.4	36.8	10.9	14.0	64.3	37.7	38.1	31.6	40.4	35.9	38.0	20.5	64.9	54.7	13.8	25.5	0.0	9.9	24.4	45.0	32.1	34.4	36.9	42.3	16.1	27.9	96.3	50.0	11.6	30.2	2.3	9.7	20.8	13.6	7.0	21.4	6.2	17.2	10.2	10.5	10.9	27.9	16.0	32.6	18.1	16.3	9.1	47.8	35.3	22.7	40.0	30.6	11.0	20.3	7.8	36.2	11.4	24.7	0.9	0.2	0.4	0.1	0.4	0.1	0.0	0.2	0.3	0.3	0.0	0.6	0.3	0.0	0.2	0.2	0.4	0.4	0.2	44.3	77.7	56.7	58.1	49.1	48.3	76.3	63.1	66.7	48.4	58.0	111.2	47.9	86.6	33.1	246.8	6.5	29.6	13.2	23.6	14.8	144.0	17.5	26.0	37.4	24.3	45.0	5.5	68.8	23.8	6.9	44.6	1.9	21.4	5.0	36.2	148.7	34.9	16.2	15.2	266.5	27.6	21.0	73.0	82.0	54.2	17.1	135.8	26.0	20.9	14.6	132.9	153.8	28.3	14.2	32.8	31.8	8.3	92.9	38.9	19.6	171.4	11.0	194.0	2.1	336.7	827.4	37.1	34.6	59.5	15.2	27.4	21.9	6.5	30.3	53.5	26.3	60.4	43.2	27.4	35.6	18.1	20.2	12.6	11.8	62.2	29.0	29.5
ARL15	"ARFRP2, FLJ20051"	ENSG00000185305	"ADP ribosylation factor like GTPase 15"	Q9NXU5	5	53883942-54310582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 441.6;Inhibitory neurons: 285.2;Microglial cells: 408.5;Oligodendrocyte precursor cells: 184.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044604, HPA063820"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Plasma membrane, Cell Junctions"	"HPA044604: AB_10960542, HPA063820: AB_2685131"	"unprognostic (2.18e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.08e-1)"	14.0	12.5	6.6	5.6	7.5	1.9	13.0	5.6	10.0	17.7	7.2	10.6	11.9	16.0	7.6	9.8	8.2	14.5	14.0	8.5	7.1	17.9	9.8	7.6	6.3	5.8	6.2	5.7	5.0	3.2	8.5	22.3	6.0	10.0	10.9	7.6	10.5	6.8	3.3	11.3	9.9	16.6	6.1	8.2	8.3	9.3	6.8	10.6	8.4	11.7	8.0	13.6	8.8	6.2	3.2	5.5	8.5	15.6	7.0	7.8	11.8	10.2	15.1	9.4	20.7	21.1	8.0	32.0	14.9	9.1	11.0	7.7	13.2	14.1	12.4	3.2	13.9	36.9	7.1	2.8	2.5	4.5	43.8	10.0	10.1	15.8	9.5	14.2	20.8	7.0	32.4	5.3	6.5	7.7	7.5	4.3	3.0	1.6	3.9	6.2	10.4	0.8	12.8	30.3	11.3	7.1	13.1	6.7	7.9	15.6	8.6	4.7	11.4	5.7	9.6	5.4	6.7	1.8	1.7	34.8	9.9	10.6	9.5	1.1	1.8	2.2	1.3	1.4	0.7	1.0	0.9	0.9	2.4	0.7	0.9	0.7	3.5	0.7	1.2	0.3	2.3	1.2	6.6	7.5	5.6	10.0	8.5	7.1	5.8	6.2	6.0	6.1	6.8	6.2	44.5	3.2	7.7	33.6	6.5	9.7	7.9	5.8	8.0	5.1	4.8	5.8	7.5	5.7	4.5	12.9	14.6	52.5	5.2	7.5	21.5	3.2	3.4	4.1	6.9	35.1	20.9	8.6	441.6	4.9	4.9	8.5	6.6	5.1	2.5	3.2	26.0	4.9	8.4	1.7	285.2	7.6	18.3	8.7	8.7	1.5	4.4	12.5	1.8	408.5	5.0	3.2	6.2	184.5	104.7	6.9	7.6	3.8	4.7	5.4	5.7	10.0	3.9	3.0	6.6	3.6	5.3	1.0	3.5	5.9	10.1	42.7	8.9	24.4	7.1	8.4
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145569-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 2.2;dendritic cells: 1.4;Gastric mucus-secreting cells: 1.5;Late spermatids: 1.1;Plasma cells: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 2.0;U-266/70: 3.1"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"		"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	0.2	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.6	0.3	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.6	0.2	0.2	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.2	0.1	0.3	0.2	0.3	0.2	0.1	0.2	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.1	0.1	0.7	0.2	0.1	0.1	0.4	0.3	0.4	0.0	1.4	0.3	0.1	0.0	0.5	0.5	0.2	0.1	0.2	0.1	0.5	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.9	0.1	2.0	0.5	0.2	1.3	0.1	0.6	0.0	0.7	0.7	0.1	0.0	0.1	1.6	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.3	0.0	0.0	1.5	0.0	3.1	0.6	1.7	0.3	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.4	0.8	0.0	0.3	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.2	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.5	0.0	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.6	0.0
C8orf37	"BBS21, CORD16, FAP418, FLJ30600, MOT25, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244913-95269201	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease variant, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	1.7	1.8	1.7	1.2	1.9	0.9	2.3	2.3	2.2	2.3	3.2	1.0	0.9	2.4	3.1	1.0	3.9	1.4	2.7	1.7	1.8	2.4	1.8	1.5	2.2	2.3	2.9	4.8	1.2	3.5	2.3	1.8	2.2	2.0	0.9	5.0	1.5	1.7	1.1	1.5	1.0	2.3	2.7	1.7	1.1	1.7	1.8	2.4	2.4	1.8	1.9	1.2	1.4	2.9	2.8	4.5	3.6	1.9	1.2	3.3	1.0	1.2	2.7	1.5	2.0	0.7	6.0	5.6	2.8	2.0	3.8	2.3	1.5	3.1	3.3	1.8	1.4	4.4	2.7	2.0	1.4	0.9	2.3	3.3	1.4	1.8	5.0	3.9	2.3	3.3	2.3	3.2	2.0	2.1	4.8	1.1	1.1	5.6	3.0	2.5	1.9	1.4	3.4	1.2	3.5	3.4	2.5	0.5	2.1	2.7	4.2	0.8	2.0	1.9	2.4	1.6	1.2	2.9	3.0	3.8	3.6	2.1	2.4	0.3	0.3	0.1	0.2	0.2	0.5	0.4	0.3	0.3	0.5	0.8	0.3	0.5	0.4	0.7	0.1	0.2	0.1	0.2	1.7	1.9	2.3	2.2	1.7	1.8	2.3	2.9	2.2	2.7	1.8	2.9	2.4	3.2	2.6	6.8	2.5	0.9	3.7	2.9	4.0	2.7	1.3	2.4	5.3	0.0	3.3	7.3	2.1	2.5	1.8	0.1	7.9	1.8	10.2	3.4	1.3	1.5	0.0	0.4	6.8	2.7	2.9	2.8	1.1	1.0	0.0	1.9	1.1	3.8	1.3	3.3	5.2	0.1	2.0	1.6	1.2	8.7	3.1	0.8	1.8	1.9	1.8	5.3	0.0	8.5	5.7	1.2	0.2	3.0	0.7	1.9	0.1	4.7	7.9	4.1	0.0	2.5	4.2	6.0	3.5	0.9	1.8	0.8	1.1	3.0	0.5	1.8
CABLES2	"C20orf150, dJ908M14.2, ik3-2"	ENSG00000149679	"Cdk5 and Abl enzyme substrate 2"	Q9BTV7	20	62388632-62407285	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 51.3;Late spermatids: 25.6;Spermatocytes: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052138			Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nuclear bodies"	"Nucleoplasm, Cell Junctions"	"HPA052138: AB_2681743"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.26e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.37e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-2)"	2.4	3.0	6.8	4.2	7.2	8.1	2.8	11.5	9.1	3.9	3.5	4.4	2.9	3.5	2.6	3.2	4.8	2.2	10.6	7.1	7.4	2.6	4.0	2.9	5.1	7.9	6.6	4.3	3.2	3.9	5.9	2.8	7.8	4.3	3.2	5.6	3.3	3.1	5.8	4.3	4.4	3.3	5.9	4.2	4.0	31.0	7.5	5.3	5.1	4.1	4.4	3.7	3.3	7.2	16.3	12.0	20.4	20.9	3.1	4.4	2.8	9.2	8.9	24.8	11.4	43.6	9.1	16.3	7.6	5.9	33.9	10.1	12.6	6.0	9.6	7.3	6.9	19.0	6.3	10.6	5.5	7.8	9.4	2.7	6.7	7.1	2.6	4.4	5.8	20.8	4.9	13.9	5.6	20.0	20.6	6.2	6.8	16.4	13.7	28.1	17.2	7.1	3.7	10.6	11.1	16.8	13.3	17.4	3.6	7.6	11.9	11.7	6.0	22.7	6.8	30.3	9.5	13.3	11.7	19.4	20.4	8.8	12.1	0.0	0.2	0.0	0.7	0.3	0.4	0.5	0.4	0.5	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.2	1.3	0.1	6.8	7.2	11.5	9.1	7.1	7.4	7.9	6.6	7.8	5.9	7.5	7.2	1.5	3.2	1.7	2.0	2.1	0.9	0.5	1.7	2.8	6.0	2.9	2.4	10.7	2.8	2.5	0.0	4.2	1.3	3.1	3.5	1.9	2.2	51.3	1.1	1.2	1.6	3.5	1.7	4.4	2.4	0.7	2.6	3.6	2.2	0.0	5.3	2.2	1.4	2.1	13.5	5.2	4.1	0.0	1.6	3.0	25.6	1.8	2.0	0.0	1.0	1.0	1.9	1.0	3.5	3.3	2.1	2.3	3.4	2.5	0.7	1.8	0.7	0.2	3.4	0.0	3.0	1.3	21.8	6.9	1.3	2.0	2.3	2.0	1.0	2.8	0.6
CALCR	CTR	ENSG00000004948	"Calcitonin receptor"		7	93424486-93574730	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in some"		"brain: 5.8;kidney: 1.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Late spermatids: 7.7;Microglial cells: 15.9;Skeletal myocytes: 46.0"	"Cancer enriched"	"Detected in single"	5	"renal cancer: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 1.6;SuSa: 2.9;T-47d: 2.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.3;hypothalamus: 24.6"	"Low region specificity"	"Detected in all"			"HPA028962, HPA061428"	Enhanced	Supported	Approved	"Vesicles,Cell Junctions,Centriolar satellite"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 6: T47d - Mammary gland"	"Cluster 50: Fibroblasts - ECM organization"	"Cell Junctions"	"Vesicles, Centriolar satellite"	"HPA028962: AB_10602339, HPA061428: AB_2732661"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.73e-5)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.49e-4)"	"unprognostic (1.05e-2)"	0.1	0.2	1.6	0.0	0.5	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	5.8	1.5	0.0	0.2	0.0	1.8	1.6	0.2	0.0	0.0	0.1	0.6	3.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	2.9	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.2	0.0	5.8	1.8	1.6	3.4	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.8	0.6	7.7	0.6	0.6	0.0	15.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.0	0.0	3.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB, CaMKIIβ"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 248.8;skeletal muscle: 132.5"	"Cell type enriched"	"Detected in many"	7	"Bipolar cells: 857.4"	"Cancer enhanced"	"Detected in many"		"glioma: 6.0;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		600000	"Cluster 11: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	0.5	11.3	77.9	0.6	109.0	0.1	1.4	113.0	248.8	0.1	0.0	1.0	1.0	0.2	28.3	1.4	1.1	0.2	65.4	197.6	12.6	1.6	7.7	0.3	1.3	4.4	11.9	0.3	3.8	6.1	51.3	0.1	4.6	3.2	0.4	21.4	1.4	1.6	132.5	1.2	0.9	0.1	3.2	0.3	2.3	2.1	25.9	0.8	20.3	59.2	1.6	0.0	0.3	80.4	0.0	0.8	0.4	0.6	0.0	0.4	0.4	0.3	0.1	0.3	0.0	0.3	0.1	0.2	1.6	0.4	0.1	0.3	0.4	1.4	0.1	2.0	4.5	0.1	0.2	0.2	0.1	0.0	0.9	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.8	0.1	10.1	0.0	0.4	0.2	0.1	4.4	0.2	1.7	0.3	0.0	0.0	75.5	4.0	0.4	0.0	0.0	0.1	3.5	0.3	0.4	0.5	0.7	0.4	0.1	0.9	0.8	0.2	0.2	0.0	0.5	1.0	0.1	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.3	0.2	0.2	0.4	0.7	0.3	0.2	0.2	0.2	77.9	109.0	113.0	248.8	197.6	12.6	4.4	11.9	4.6	3.2	25.9	80.4	0.1	0.0	0.0	67.3	0.2	1.1	21.5	0.0	10.8	857.4	3.1	17.5	88.9	2.8	0.0	0.0	45.9	0.1	0.0	0.5	9.8	0.0	0.9	2.3	0.4	1.6	40.7	0.0	111.4	0.0	0.2	2.9	4.1	5.6	4.5	15.4	0.0	4.3	0.2	60.6	90.9	1.5	2.0	0.6	0.4	2.9	1.8	0.5	1.8	5.6	0.0	23.2	0.0	19.6	5.4	0.1	1.2	0.0	0.1	3.3	0.1	1.9	0.0	53.1	0.0	6.9	1.7	0.2	7.8	0.9	0.4	0.3	0.2	0.2	0.3	6.6
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 159.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 272.9;Excitatory neurons: 182.9;Inhibitory neurons: 200.0;Microglial cells: 187.4;Oligodendrocyte precursor cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 272.6"					"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		240000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	28.6	25.6	52.7	26.6	45.1	5.7	21.0	45.8	52.0	18.9	1.6	36.4	28.8	23.5	9.8	29.7	18.8	30.7	159.3	60.2	23.9	19.3	37.3	22.9	35.2	11.8	33.9	25.4	15.2	56.5	9.1	19.8	12.6	32.2	39.1	79.2	13.4	41.7	105.1	15.8	34.1	24.9	21.0	18.4	37.1	19.8	46.7	16.3	23.7	60.0	31.4	27.4	19.7	22.9	4.8	62.5	67.5	22.8	144.0	272.6	24.0	145.4	96.3	56.0	48.0	42.3	17.6	91.2	20.7	102.3	70.7	2.1	42.6	22.8	56.6	35.1	10.8	0.0	22.0	49.2	73.0	0.1	0.2	176.3	30.5	43.5	107.1	88.5	50.6	11.3	3.6	39.4	106.8	17.1	9.3	3.6	9.8	60.3	22.8	17.9	79.0	0.4	57.3	42.7	18.2	18.3	20.0	29.3	19.5	55.9	0.6	23.7	30.7	146.9	34.8	63.6	29.1	30.4	16.5	76.7	75.7	5.5	70.8	0.0	12.7	0.0	6.7	7.0	12.7	11.2	6.6	7.5	15.7	22.6	7.4	6.5	0.9	9.7	2.5	0.1	13.2	7.7	52.7	45.1	45.8	52.0	60.2	23.9	11.8	33.9	12.6	21.0	46.7	22.9	43.7	41.7	37.6	128.3	55.1	18.4	16.6	8.3	22.8	83.3	14.0	17.1	272.9	62.9	24.7	29.5	87.6	0.5	19.0	70.9	5.9	8.4	3.2	18.2	35.2	27.2	103.8	3.6	182.9	20.1	0.4	50.1	71.9	47.0	10.1	13.0	24.3	57.2	18.6	72.3	200.0	88.1	14.2	17.3	22.3	6.2	20.2	31.5	5.4	187.4	16.0	35.9	28.8	203.1	128.0	11.6	57.3	19.9	20.4	36.2	52.4	23.1	21.7	74.0	6.6	32.8	44.4	3.1	3.4	37.1	31.8	1.1	27.8	12.3	48.6	27.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: AB_2681128"	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	91.6	61.0	35.1	19.1	34.6	7.8	75.3	37.4	40.6	48.5	36.0	117.8	19.2	74.2	31.1	25.1	60.6	15.3	90.3	34.5	35.3	37.7	50.3	43.6	15.4	35.5	35.7	32.3	62.7	12.8	33.0	13.9	36.0	55.9	16.8	13.9	26.6	29.2	64.4	32.5	47.1	28.2	34.7	41.2	74.4	17.1	37.3	26.0	31.4	22.4	14.4	76.6	39.1	35.0	17.9	15.7	12.8	16.3	63.3	40.3	7.4	29.5	26.4	18.5	17.2	7.2	5.2	11.5	12.8	38.9	47.6	5.9	9.6	14.2	13.6	34.4	15.3	5.5	25.1	18.3	15.0	8.5	20.1	24.1	16.6	19.8	15.3	34.4	13.1	19.2	7.2	21.7	23.4	11.6	9.5	12.6	9.5	12.6	48.2	13.7	2.9	9.3	62.8	9.6	8.4	14.0	15.2	21.1	15.4	9.5	11.1	10.4	16.7	29.5	16.3	21.6	27.3	9.6	15.4	23.1	54.6	13.5	26.2	33.3	39.3	20.1	128.7	43.2	168.8	79.5	111.6	113.8	45.0	79.5	53.2	74.2	7.8	69.3	25.9	123.8	140.8	75.1	35.1	34.6	37.4	40.6	34.5	35.3	35.5	35.7	36.0	34.7	37.3	35.0	68.7	67.3	25.0	11.1	104.8	70.2	38.0	76.9	8.6	31.9	39.2	65.3	0.7	60.1	48.4	82.8	8.4	15.0	175.2	143.9	17.6	74.1	7.6	33.5	34.1	36.1	88.1	15.8	8.6	140.2	66.2	60.0	121.8	30.5	34.3	24.4	53.9	77.3	90.9	32.0	10.2	100.5	69.2	46.9	185.9	28.3	59.4	82.0	113.8	13.1	43.5	57.2	133.9	7.5	10.8	86.7	108.6	102.3	53.3	45.3	146.7	66.9	48.2	34.1	118.3	33.7	135.3	37.9	63.1	17.8	66.9	13.8	132.7	44.9	51.7	29.5
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Adipocytes: 298.7;Endothelial cells: 292.4;Fibroblasts: 121.9;Hepatic stellate cells: 136.0;Leydig cells: 146.3;Peritubular cells: 123.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 64.3;MOLT-4: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		93000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	202.7	28.5	29.2	13.9	28.8	5.7	122.3	27.3	34.2	95.4	21.0	54.2	13.5	71.6	42.3	28.9	82.8	54.3	153.2	25.1	27.5	49.4	5.6	69.1	18.1	29.8	29.5	35.4	18.9	21.8	10.1	219.5	30.8	36.2	19.3	2.3	37.4	33.2	58.5	67.5	39.3	75.5	24.8	21.7	34.4	20.2	32.9	19.0	79.5	68.2	17.1	74.0	61.6	28.0	0.0	0.0	0.2	0.0	3.2	0.3	0.2	0.4	2.4	0.7	1.7	0.0	0.0	0.0	6.2	0.7	0.2	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.7	64.3	1.1	0.0	0.0	1.7	0.0	66.5	0.3	0.5	0.0	0.0	0.1	3.7	0.0	0.3	0.0	0.1	0.2	0.0	0.6	0.1	0.4	2.3	0.0	9.9	0.2	2.8	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	29.2	28.8	27.3	34.2	25.1	27.5	29.8	29.5	30.8	24.8	32.9	28.0	298.7	3.2	7.8	1.6	1.0	16.7	0.2	0.3	4.6	0.6	2.1	3.0	21.9	2.8	0.1	3.7	2.1	0.2	1.5	0.0	0.0	0.5	11.6	1.0	5.2	292.4	0.0	22.3	0.2	0.2	0.3	121.9	0.5	1.0	1.3	0.1	136.0	0.6	0.4	0.0	0.1	0.0	0.0	1.2	21.8	5.0	146.3	2.4	17.8	33.7	0.3	0.2	0.0	0.5	0.3	0.2	0.0	123.0	1.6	0.3	0.0	0.1	0.0	0.2	6.6	7.7	15.2	1.0	2.0	1.5	12.9	0.1	2.2	4.0	0.0	0.3
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737292-68835537	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 197.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 451.6;Glandular and luminal cells: 321.0;Pancreatic endocrine cells: 264.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.7;plasmacytoid DC: 4.7"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 4.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 683.3;CACO-2: 241.9;CAPAN-2: 328.1;HaCaT: 318.7;hTCEpi: 217.2;MCF7: 199.6;OE19: 207.2;RT4: 237.7;T-47d: 209.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		78000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.0	0.2	1.5	16.1	2.0	6.5	64.2	0.6	1.9	30.0	19.3	127.5	133.9	9.6	39.5	76.9	51.5	45.7	0.3	1.5	1.3	39.8	97.2	36.8	5.6	2.0	1.3	1.3	84.0	197.8	8.0	60.9	1.3	91.7	131.0	0.1	71.9	41.7	0.3	107.7	127.9	5.1	2.1	10.3	104.2	0.4	2.3	20.1	162.7	0.1	29.0	58.2	38.1	2.7	147.0	14.8	0.0	0.5	0.0	0.0	683.3	0.0	0.0	0.0	0.0	241.9	328.1	0.0	3.1	0.0	0.0	318.7	0.0	156.3	0.0	28.6	3.5	0.1	0.7	48.0	0.0	0.0	0.6	0.0	217.2	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	199.6	0.2	1.0	5.5	207.2	0.8	0.1	0.1	2.1	53.9	237.7	8.5	0.8	1.4	0.2	58.9	91.8	209.2	0.4	0.0	0.4	0.9	0.7	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.1	1.5	2.0	0.6	1.9	1.5	1.3	2.0	1.3	1.3	2.1	2.3	2.7	0.6	131.4	69.8	0.7	1.4	94.1	130.3	73.8	45.5	0.0	137.6	83.6	0.9	128.7	95.3	163.7	0.0	117.6	2.5	451.6	1.9	129.1	0.1	159.3	29.2	4.4	86.7	9.0	0.7	113.5	29.6	3.4	132.0	321.0	1.3	2.8	0.4	63.4	11.7	0.0	1.4	208.3	75.3	1.2	13.4	0.0	0.3	3.2	53.4	1.0	3.3	0.0	0.0	0.5	32.1	264.6	204.6	0.4	2.2	195.5	159.5	4.5	118.2	0.0	0.0	0.0	7.1	0.1	0.1	100.6	131.6	50.5	2.7	0.0	154.8	251.5
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053815-151057897	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	6.3	16.8	50.2	9.4	53.2	11.2	8.6	44.9	65.8	8.6	40.0	9.3	10.9	6.7	24.9	10.2	8.2	9.5	9.8	57.5	50.9	13.5	12.5	8.3	9.8	48.6	45.3	4.5	9.5	22.8	14.7	8.6	48.4	8.8	9.9	11.3	9.6	10.2	8.5	9.5	8.6	10.4	43.2	9.4	7.9	4.9	50.1	14.2	10.0	7.2	11.6	8.8	6.0	50.9	31.9	40.8	37.3	59.7	48.8	36.1	17.8	24.4	41.7	47.9	40.3	31.2	31.0	34.7	71.3	31.8	63.5	23.5	67.8	40.6	22.6	24.9	43.3	38.2	32.4	30.7	31.6	29.0	64.4	37.9	28.7	39.0	13.5	62.8	38.8	57.6	36.3	24.0	50.7	68.4	76.4	57.9	39.3	57.2	80.5	38.9	14.8	41.5	46.2	27.9	23.0	97.8	30.9	37.7	43.8	36.0	18.6	25.9	22.7	42.2	10.3	31.2	39.2	52.1	61.4	13.7	66.4	46.5	75.8	18.9	39.4	20.1	13.5	46.2	11.1	13.3	12.8	13.6	44.7	12.8	9.8	11.8	5.7	19.9	36.4	26.9	31.9	23.8	50.2	53.2	44.9	65.8	57.5	50.9	48.6	45.3	48.4	43.2	50.1	50.9	7.6	0.0	6.0	1.6	6.2	3.6	8.2	18.0	6.2	12.1	9.6	10.4	3.1	8.6	14.7	11.0	2.1	26.8	5.4	8.0	39.2	21.4	0.8	14.9	10.9	8.9	9.0	12.2	5.8	18.9	12.3	7.6	9.7	9.3	30.5	23.6	7.9	11.1	41.9	0.0	6.4	8.9	18.3	21.9	6.2	1.3	4.7	16.6	10.6	1.9	19.9	12.6	12.3	1.5	3.7	22.8	15.0	11.3	12.4	4.3	20.2	35.7	14.4	7.1	6.6	4.5	13.1	3.9	11.2	11.4	6.3	9.0	7.3	14.2	9.5	9.0
CERCAM	"CEECAM1, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Metabolic proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 551.5"	"Cell type enriched"	"Detected in many"	7	"Oligodendrocytes: 626.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 280.5;ASC TERT1: 284.1;fHDF/TERT166: 271.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	26.1	8.9	249.9	12.3	411.3	2.5	24.5	248.6	378.3	42.4	140.1	20.9	7.9	35.0	9.7	13.1	23.4	31.2	34.0	261.5	322.7	25.9	3.7	16.9	4.1	344.1	349.4	31.2	30.1	31.0	106.4	49.4	323.9	27.9	7.7	1.0	21.4	22.8	7.0	15.0	12.3	47.4	224.7	10.9	15.8	11.1	386.4	2.4	23.4	7.0	3.9	29.9	30.8	551.5	44.7	26.0	35.2	38.2	280.5	284.1	27.4	145.5	149.7	41.2	32.0	10.3	2.4	0.0	58.3	271.9	33.5	33.8	14.7	22.2	13.9	11.7	25.6	2.9	24.1	15.5	89.7	5.4	84.4	171.6	11.7	48.4	10.5	157.7	44.3	3.0	13.0	36.5	51.8	82.3	2.3	55.7	1.8	2.3	25.4	4.7	23.6	7.3	18.4	15.5	4.9	8.5	33.8	43.1	16.7	10.1	34.4	13.7	48.2	103.5	27.3	138.1	23.2	42.2	35.0	0.8	99.7	17.1	21.0	0.1	0.6	0.0	1.8	0.7	0.1	0.1	0.1	2.1	0.7	0.0	0.0	2.3	0.0	0.6	0.0	1.0	0.0	1.3	249.9	411.3	248.6	378.3	261.5	322.7	344.1	349.4	323.9	224.7	386.4	551.5	8.5	6.4	10.3	7.2	3.5	8.9	6.5	7.0	10.8	1.7	8.7	6.9	3.9	0.0	13.6	11.0	0.0	18.4	5.8	0.0	0.0	11.6	2.7	3.1	18.7	7.7	0.0	2.5	2.9	3.4	61.1	82.3	3.6	6.7	8.8	9.8	16.8	0.1	6.2	6.7	3.3	0.0	2.0	0.8	10.4	2.3	24.2	2.9	40.9	3.7	1.3	0.1	17.5	11.6	626.9	4.5	0.0	26.4	17.9	5.0	0.0	0.9	3.9	0.9	6.6	27.8	26.4	8.6	22.2	2.4	4.1	19.6	3.3	5.9	0.0	2.8
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 2613.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	143.7	18.0	3.6	32.8	3.6	0.1	28.5	3.4	9.9	16.3	3.9	22.3	28.1	8.2	14.2	24.1	53.7	0.8	42.6	3.7	3.4	58.7	2613.2	39.2	4.2	4.1	3.7	9.9	51.8	0.2	17.7	5.0	3.8	60.3	14.5	1.4	43.3	0.0	3.0	7.7	73.1	48.3	3.4	12.9	54.5	2.1	3.7	1.9	15.5	0.7	6.7	17.8	9.2	3.6	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.4	9.9	3.7	3.4	4.1	3.7	3.8	3.4	3.7	3.6	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424171-86456553	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 117.5;skin 1: 88.7;vagina: 53.1"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 47.4;Basal respiratory cells: 57.5;Basal squamous epithelial cells: 39.9;Club cells: 37.1;Early spermatids: 30.2;Squamous epithelial cells: 167.1;Suprabasal keratinocytes: 54.8;Urothelial cells: 52.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 146.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 210.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		96000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.8	0.1	0.2	0.1	0.6	0.0	4.6	0.4	0.5	22.8	0.1	0.6	0.2	0.0	0.5	117.5	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.7	0.4	2.4	0.7	0.0	13.2	0.2	0.2	88.7	0.8	0.0	0.4	0.0	0.1	0.6	0.3	1.0	0.0	0.0	26.0	21.2	53.1	1.0	0.0	0.0	0.0	0.0	0.6	3.0	38.9	1.7	2.7	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	9.7	0.0	33.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	210.8	1.0	10.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.9	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.4	0.5	0.2	0.3	0.4	0.3	0.4	0.4	0.3	1.0	0.0	0.0	0.0	0.7	0.0	47.4	13.1	57.5	39.9	0.0	7.7	2.8	0.4	0.0	37.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	5.3	4.1	0.0	3.1	4.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	2.5	2.1	0.3	0.0	8.0	0.0	0.0	0.0	0.6	0.2	0.0	167.1	54.8	0.1	0.5	0.0	0.1	52.9
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701937-8704096	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.4;stomach 1: 15.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 418.8;Paneth cells: 449.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;Daudi: 6.4;RT4: 6.7;SK-BR-3: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061306			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cell Junctions"	"HPA061306: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favorable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	6.2	1.1	0.3	2.3	0.4	0.1	5.7	0.2	0.3	2.4	2.3	16.4	4.1	1.0	1.9	3.3	1.4	1.2	0.7	0.3	0.3	4.5	10.4	4.7	0.3	0.5	0.4	1.6	4.0	2.1	0.9	1.5	0.4	1.3	6.8	0.1	6.8	1.3	0.5	13.5	10.1	0.3	0.4	1.8	15.6	0.5	0.5	0.1	4.9	0.3	0.3	5.0	2.7	0.6	0.1	2.6	0.0	0.1	0.7	0.1	7.7	1.9	1.5	2.0	3.1	1.5	4.2	6.4	0.0	0.1	0.7	2.5	0.0	0.0	0.2	1.3	0.0	0.0	0.7	0.1	3.5	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.3	0.0	0.2	1.9	0.3	1.3	0.0	0.0	0.0	0.9	6.7	0.3	0.9	2.6	6.8	0.1	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.9	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.5	0.4	0.4	0.4	0.5	0.6	13.0	9.6	3.1	0.3	1.1	0.1	6.6	4.2	2.2	0.1	6.8	3.4	0.7	30.0	6.9	1.8	0.0	19.1	2.8	418.8	7.9	26.9	0.0	6.0	2.5	3.4	7.7	0.0	0.0	10.7	14.9	3.3	59.7	6.7	4.5	0.8	8.2	10.6	16.8	0.0	0.0	49.9	26.4	2.4	1.4	0.0	0.3	4.6	3.6	1.9	1.4	1.1	0.0	0.0	0.0	28.1	449.9	0.4	0.1	3.3	99.1	4.7	10.3	1.1	6.6	1.5	3.2	0.0	0.0	3.9	0.6	9.4	1.3	0.3	55.2	12.2
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316737-500722	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 31.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 104.4;Cytotrophoblasts: 149.0;Fibroblasts: 79.6;Hofbauer cells: 155.9;Microglial cells: 245.4;Muller glia cells: 74.5;Syncytiotrophoblasts: 111.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 14.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 24.3;BJ: 12.1;HSkMC: 20.0;U-2197: 31.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		NA	NA		580000	"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"	"Cell Junctions"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.01e-3)"	12.4	1.7	5.1	2.4	4.8	0.2	5.5	4.7	5.7	31.6	9.7	5.5	1.5	9.0	1.0	2.0	6.5	4.4	6.6	4.6	7.2	2.4	0.3	11.4	2.0	7.7	6.5	2.0	1.1	0.9	0.9	20.0	5.2	4.0	2.4	5.3	4.1	1.4	3.1	3.6	3.5	5.1	4.3	0.3	3.4	1.4	6.5	1.3	5.2	2.0	2.5	8.1	4.0	5.5	0.0	0.0	2.1	0.0	2.3	24.3	0.8	12.1	4.2	1.7	3.1	0.0	0.0	0.0	0.1	2.0	0.1	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.1	0.0	0.0	20.0	0.0	1.0	0.0	0.7	4.7	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.7	0.0	6.5	0.0	0.0	0.1	0.3	0.0	0.1	0.0	1.9	0.1	0.0	0.0	2.8	0.4	31.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	5.1	4.8	4.7	5.7	4.6	7.2	7.7	6.5	5.2	4.3	6.5	5.5	6.8	3.2	104.4	34.3	2.1	4.1	3.2	0.0	1.2	6.4	2.6	1.7	4.0	2.8	10.7	3.7	10.4	149.0	1.4	0.3	0.0	0.2	11.1	0.5	3.9	15.8	15.7	2.7	0.5	0.0	5.3	79.6	0.0	0.8	13.9	1.2	5.7	0.4	155.9	6.7	1.4	1.0	0.0	4.9	8.9	31.4	61.5	32.1	1.8	245.4	16.2	74.5	3.1	2.0	10.4	0.3	0.6	7.2	1.2	6.5	1.4	0.2	1.7	12.4	0.0	13.2	21.6	1.3	2.5	1.8	3.8	111.2	4.8	11.6	0.8	1.3
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971836-11904446	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 93.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2382.9;Excitatory neurons: 1253.9;Inhibitory neurons: 1124.0;Oligodendrocyte precursor cells: 1418.0;Oligodendrocytes: 433.8"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.1;MCF7: 9.0;SK-BR-3: 5.3;U-266/84: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	0.2	0.7	79.2	0.2	79.3	0.0	0.9	49.7	75.7	0.1	15.2	1.1	0.1	0.1	0.3	0.1	0.2	2.6	3.8	84.6	56.7	0.0	0.5	0.7	0.1	93.8	72.6	0.5	15.8	0.0	9.0	0.3	71.5	0.9	0.3	7.0	0.8	0.2	0.1	0.7	0.5	0.1	77.7	3.9	0.6	2.6	83.7	0.2	0.2	0.1	0.0	0.1	0.2	76.1	0.0	0.2	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	9.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	3.4	0.0	17.5	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.2	79.3	49.7	75.7	84.6	56.7	93.8	72.6	71.5	77.7	83.7	76.1	0.1	0.0	0.0	2382.9	0.1	0.0	0.1	0.0	0.0	24.0	7.9	4.1	12.7	28.6	0.0	1.8	0.0	0.0	0.0	0.1	3.9	6.5	25.6	0.8	0.1	0.8	4.9	0.0	1253.9	6.1	0.2	0.5	0.0	0.9	0.0	0.0	0.0	0.2	0.1	8.4	1124.0	0.1	0.0	0.0	0.7	31.1	1.5	0.2	0.0	69.3	0.0	33.0	0.0	1418.0	433.8	2.2	0.0	0.0	0.0	2.8	0.0	0.4	0.0	3.6	0.0	3.3	0.3	4.6	5.9	0.0	0.0	0.0	0.1	0.5	0.3	0.1
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924491-7926135	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 275.1;endometrium 1: 85.7"	"Cell type enriched"	"Detected in many"	4	"Endometrial ciliated cells: 127.7"	"Group enriched"	"Detected in all"	4	"endometrial cancer: 69.5;glioma: 56.3;ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 96.4;HEK 293: 67.5;NTERA-2: 72.4;REH: 57.3;SCLC-21H: 56.2;SH-SY5Y: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	6.5	12.5	176.3	0.9	275.1	0.1	3.2	0.0	173.0	36.9	0.0	61.3	0.9	85.7	2.9	2.6	43.0	0.2	1.0	199.1	58.0	11.7	0.4	7.0	0.0	0.0	21.3	6.2	2.2	1.1	57.0	0.3	1.0	16.3	0.4	0.2	6.4	12.4	0.5	4.1	4.7	4.9	0.0	1.4	8.8	27.8	85.5	0.3	2.8	0.1	0.0	21.2	13.2	40.7	33.5	8.1	20.5	96.4	0.0	0.3	4.8	8.5	2.3	4.1	2.4	2.4	5.0	0.2	16.2	2.0	2.2	35.9	4.7	0.9	0.2	3.0	67.5	0.7	5.3	1.5	0.9	1.8	1.9	0.0	2.7	1.4	0.9	9.8	5.4	9.1	21.3	0.3	0.5	40.5	18.5	13.6	72.4	2.4	34.1	57.3	0.0	6.4	15.0	1.4	56.2	94.5	5.2	2.8	9.9	1.7	21.2	0.6	8.3	2.1	33.1	3.9	4.8	0.7	1.0	4.8	8.0	3.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.3	275.1	0.0	173.0	199.1	58.0	0.0	21.3	1.0	0.0	85.5	40.7	0.6	0.0	0.0	3.3	0.7	1.1	4.1	1.5	2.2	0.3	15.3	6.7	0.4	1.5	1.0	9.2	4.2	0.2	0.2	0.5	3.9	7.8	9.5	127.7	22.4	1.6	9.1	0.0	20.6	0.4	0.4	3.0	0.0	7.9	0.0	13.3	0.7	0.1	0.3	0.0	3.5	0.5	2.0	0.3	0.5	27.1	1.2	0.5	1.8	4.7	0.0	0.6	0.0	1.5	2.9	1.7	1.2	1.9	0.0	19.9	0.0	11.9	21.0	0.4	0.0	0.2	17.7	6.0	16.0	0.3	2.0	0.3	0.6	3.2	0.2	6.4
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113022195	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	4.6	4.0	5.9	8.1	6.0	14.0	6.9	9.8	5.7	6.0	6.6	3.9	3.7	4.3	3.4	4.1	4.7	3.5	3.4	5.9	7.2	4.8	4.7	6.9	12.6	5.5	4.9	6.7	3.3	3.1	3.7	12.1	5.8	4.4	4.1	7.4	5.3	3.5	4.8	5.8	5.1	3.3	4.5	10.2	4.0	3.8	8.5	17.9	3.7	3.9	12.3	4.4	5.2	5.1	6.4	5.6	24.1	19.0	4.5	5.3	37.0	6.7	4.3	7.2	9.8	25.0	13.1	32.2	8.5	3.2	5.6	7.9	27.6	7.1	8.8	9.0	11.0	29.5	4.6	9.9	5.4	20.1	15.3	4.8	5.3	8.4	9.0	6.9	12.5	24.8	22.7	12.0	6.1	8.1	29.6	19.6	20.8	4.0	2.9	27.0	22.7	12.2	10.5	15.4	5.6	11.4	8.3	8.8	11.3	24.1	25.3	24.4	7.7	7.8	13.9	4.4	8.8	8.8	19.8	23.6	4.7	26.0	6.3	14.0	4.9	3.7	3.0	6.1	4.2	3.8	3.7	3.0	5.1	2.5	3.4	3.7	9.4	3.5	7.3	2.9	4.3	2.6	5.9	6.0	9.8	5.7	5.9	7.2	5.5	4.9	5.8	4.5	8.5	5.1	30.0	19.2	16.8	16.0	50.7	27.8	19.9	22.3	31.9	24.7	43.5	26.4	12.4	8.6	24.1	20.2	79.2	66.7	65.0	11.6	19.6	11.2	24.3	21.7	38.1	28.9	16.2	41.9	25.5	11.8	49.6	25.7	17.3	25.7	19.6	66.7	28.5	7.0	31.7	28.6	34.1	8.9	20.3	78.1	41.5	53.8	19.0	57.4	26.6	56.2	90.7	36.9	35.0	26.7	28.8	17.3	10.6	10.9	27.1	33.3	13.8	14.4	22.7	34.6	6.6	16.5	32.3	36.6	29.5	20.0	26.6	64.4	50.1	52.0	13.1	48.8
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 21: OE19 - Mitochondria"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	19.0	18.8	18.5	8.1	18.6	2.9	19.2	19.6	28.3	17.8	19.9	15.1	15.6	11.4	25.7	12.8	15.9	11.9	22.2	18.6	19.2	22.8	20.2	13.4	7.7	19.3	19.2	8.4	20.2	32.9	7.9	13.2	19.4	15.1	15.8	10.8	18.3	10.2	30.8	18.7	14.5	9.6	19.3	9.2	18.1	24.0	18.3	6.8	16.6	19.5	9.0	12.4	11.1	20.7	17.2	19.9	7.1	15.6	18.5	12.7	12.4	16.0	8.9	11.4	20.7	25.2	17.6	7.2	23.8	13.7	9.0	23.7	10.6	26.2	16.1	13.8	33.9	9.9	13.8	21.8	10.2	5.5	7.0	10.0	17.0	14.6	22.1	5.6	11.3	12.5	6.0	8.6	13.5	35.2	6.0	21.6	9.9	55.4	8.5	10.0	18.8	12.7	39.1	20.5	3.9	8.3	19.8	17.4	17.9	56.8	11.7	11.2	5.6	9.4	6.4	28.7	18.3	4.7	7.9	13.6	14.9	20.3	14.4	19.2	34.3	29.3	6.7	33.9	6.0	7.6	6.5	4.6	21.6	5.9	7.0	6.1	25.0	8.4	40.8	9.4	10.9	14.4	18.5	18.6	19.6	28.3	18.6	19.2	19.3	19.2	19.4	19.3	18.3	20.7	31.1	16.0	18.1	29.4	11.9	16.3	26.7	59.0	11.4	21.3	19.8	17.4	14.1	25.8	38.5	29.5	31.3	52.9	11.3	25.9	17.6	47.2	69.5	38.1	13.6	23.7	7.2	21.9	32.9	39.0	31.8	18.9	14.3	22.2	8.8	13.8	27.5	20.5	29.4	18.5	37.3	28.5	48.8	17.9	15.5	24.4	22.4	14.3	19.6	14.0	20.8	27.6	22.6	36.7	36.2	30.0	24.8	35.0	10.5	29.0	44.4	25.2	50.7	40.1	6.6	15.1	18.2	71.5	22.3	10.7	18.6	51.6	11.2	27.3	22.2	25.1
DOC2A		ENSG00000149927	"Double C2 domain alpha"	Q14183	16	30005514-30023270	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.2;choroid plexus: 26.5;testis: 37.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 284.7;Late spermatids: 200.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;MCF7: 10.8;REH: 11.0;SCLC-21H: 35.9;U-937: 17.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA065676			Uncertain	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"	"Nucleoplasm, Nucleoli"	"HPA065676: AB_2685528"	"unprognostic (1.46e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-1)"	2.7	4.5	47.5	0.2	57.6	1.0	1.9	34.7	72.2	2.8	26.5	6.8	0.7	1.4	0.3	1.8	8.7	0.7	1.4	60.3	28.3	5.3	0.9	5.6	0.3	34.0	38.5	15.4	1.6	0.8	9.4	0.1	35.4	8.2	1.3	1.1	1.4	0.5	0.2	0.6	2.6	0.7	27.5	6.0	0.8	37.8	38.2	0.1	1.0	0.0	0.1	1.1	2.2	42.5	0.9	1.8	1.2	0.7	0.4	0.0	13.1	0.4	0.9	0.5	0.4	5.6	3.3	0.0	1.1	0.1	1.6	0.3	7.1	2.7	0.3	0.0	0.7	1.1	0.3	0.2	0.5	1.0	3.5	1.6	0.8	0.2	0.8	6.5	0.0	3.9	0.3	0.0	0.0	10.8	2.2	4.0	1.7	4.0	5.1	11.0	0.0	0.5	0.4	0.8	35.9	2.3	0.3	3.0	0.3	2.6	3.4	2.0	0.0	0.0	1.5	0.1	0.2	0.2	0.0	0.0	0.2	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.5	57.6	34.7	72.2	60.3	28.3	34.0	38.5	35.4	27.5	38.2	42.5	1.5	0.0	4.6	8.8	0.4	0.6	3.5	2.5	6.8	3.7	4.0	3.4	0.7	1.5	7.8	1.8	22.9	0.3	0.2	3.0	1.9	0.1	284.7	12.2	0.2	1.7	1.2	0.0	28.2	0.0	1.0	2.1	1.5	0.3	0.0	3.5	2.5	0.0	0.5	0.0	10.7	3.6	10.2	1.9	1.0	200.4	0.6	2.2	1.8	4.7	0.1	2.3	0.0	3.5	2.6	0.0	1.0	1.9	0.1	2.3	0.3	0.3	57.5	2.0	0.0	0.5	0.9	3.2	6.1	0.6	0.9	0.1	0.3	2.5	4.3	1.1
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"DNA replication fork stabilization factor DONSON"	Q9NYP3	21	33559542-33588706	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 57.3;Erythroid cells: 42.1;Spermatocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	5.5	2.9	5.8	5.5	6.5	10.9	4.1	7.9	7.5	8.5	4.2	5.2	5.4	5.7	2.4	5.0	7.0	5.5	4.4	5.4	6.5	3.9	7.9	4.6	10.5	6.7	6.2	10.8	3.4	5.6	5.5	6.6	6.7	4.8	6.3	13.3	3.5	3.4	4.4	8.5	6.1	4.5	5.7	3.6	4.9	21.2	6.5	10.6	3.5	4.8	9.2	4.7	6.2	8.6	67.9	15.5	34.8	30.4	10.7	18.5	23.9	53.7	23.2	41.2	45.1	41.9	19.7	40.5	13.9	28.3	30.6	20.0	43.6	20.2	45.1	36.5	36.5	73.8	34.9	41.5	8.1	39.0	18.2	13.9	5.7	44.4	11.1	13.1	25.1	19.8	67.0	65.2	35.4	14.7	34.0	17.2	35.9	34.8	17.3	33.2	68.4	41.3	21.3	19.0	36.0	14.8	82.1	25.3	23.1	17.1	34.9	19.4	16.4	38.0	25.3	28.6	37.7	56.8	58.1	59.3	22.1	52.1	43.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	6.5	7.9	7.5	5.4	6.5	6.7	6.2	6.7	5.7	6.5	8.6	6.3	3.2	1.9	10.4	4.8	8.2	8.1	3.1	5.2	2.8	5.6	5.7	3.9	7.2	2.3	3.7	10.4	13.2	7.8	3.0	1.9	3.3	57.3	3.0	6.6	8.0	1.2	42.1	9.7	4.7	27.9	6.9	7.1	4.4	8.2	7.5	7.5	6.2	8.9	6.7	11.2	4.2	6.1	3.4	6.3	25.3	10.2	5.5	7.2	4.7	4.0	2.1	4.1	7.5	12.7	3.9	2.5	13.9	19.3	5.7	2.9	4.4	2.8	3.6	0.0	4.4	7.6	62.3	33.5	7.6	9.8	16.6	7.6	3.0	6.8	9.2
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
ELOC	"SIII, TCEB1"	ENSG00000154582	"Elongin C"	Q15369	8	73939169-73972287	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 266.1;Extravillous trophoblasts: 326.2;Hofbauer cells: 313.7;Pancreatic endocrine cells: 317.3;Proximal tubular cells: 341.3;Syncytiotrophoblasts: 332.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078113			Approved	"Nucleoli,Vesicles,Cell Junctions"		NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cell Junctions"	"HPA078113: AB_2686877"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.02e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.99e-3)"	"unprognostic (4.02e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.95e-2)"	78.3	83.9	86.5	45.0	89.6	93.1	59.9	88.6	116.1	47.9	79.8	61.3	30.2	48.1	67.0	75.3	46.2	39.3	141.0	92.5	85.3	97.2	76.0	62.0	52.5	83.6	83.9	46.1	41.1	58.5	57.2	56.0	83.9	45.2	44.8	69.4	46.7	43.7	190.3	48.4	40.7	54.8	84.2	48.2	57.3	111.2	85.1	64.4	43.3	125.6	65.7	69.3	52.0	89.5	211.2	169.2	151.1	110.2	113.0	146.7	108.1	203.6	165.3	194.8	199.0	151.1	178.2	106.3	160.7	181.9	263.4	147.2	168.7	203.6	256.8	123.2	141.5	185.7	174.2	243.0	147.3	120.4	133.6	149.4	159.9	177.0	226.8	144.2	184.8	180.2	166.2	137.8	260.2	155.9	311.7	214.9	137.5	341.9	271.8	111.9	95.1	100.8	216.2	181.9	142.1	134.3	85.2	458.9	202.4	155.1	169.2	127.9	142.2	140.1	160.6	156.1	208.1	155.6	204.5	198.9	169.6	130.2	175.0	138.6	66.4	85.6	62.0	78.6	68.3	83.1	74.2	70.8	73.6	73.9	66.5	67.5	79.8	73.4	77.3	118.4	99.1	60.0	86.5	89.6	88.6	116.1	92.5	85.3	83.6	83.9	83.9	84.2	85.1	89.5	236.0	67.3	98.9	0.0	24.8	0.0	0.0	0.0	0.0	0.0	147.6	185.4	0.0	0.0	49.5	119.5	0.0	220.1	74.5	0.0	266.1	216.7	0.0	147.9	98.9	77.1	0.0	0.0	0.0	227.2	326.2	66.0	0.0	168.8	69.4	65.9	0.0	0.0	313.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.9	0.0	0.0	112.7	0.0	0.0	0.0	0.0	317.3	0.0	0.0	12.1	0.0	0.0	341.3	63.4	0.0	0.0	0.0	78.2	0.0	0.0	0.0	0.0	332.5	40.7	98.8	0.0	0.0
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.0;intestine: 11.0;lymphoid tissue: 8.5;testis: 5.7"	"Group enriched"	"Detected in many"	4	"Erythroid cells: 44.6;Spermatocytes: 62.0;Spermatogonia: 80.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	0.5	0.4	0.0	2.7	0.2	6.0	1.2	0.4	0.2	0.5	0.0	3.7	11.0	0.6	0.0	2.4	0.2	0.6	0.2	0.0	0.0	0.1	0.7	0.4	4.6	0.0	0.0	0.1	1.0	0.3	0.0	1.1	0.1	0.3	4.3	0.5	0.3	0.1	0.0	1.1	7.9	0.7	0.0	0.8	2.5	5.7	0.0	8.5	0.3	0.2	5.7	0.8	0.5	0.2	54.6	39.9	17.9	22.0	2.3	3.9	10.2	31.6	12.9	27.8	32.5	14.2	10.7	21.0	16.6	8.3	24.7	29.2	22.0	8.5	43.6	15.8	9.2	24.4	16.2	15.3	0.3	12.5	21.4	0.7	0.9	17.0	4.2	3.0	11.6	15.2	20.0	30.0	17.7	10.5	49.8	5.9	12.2	29.9	13.4	21.7	53.0	14.8	9.6	31.9	8.0	11.7	15.5	19.6	7.9	6.5	13.2	14.1	5.2	17.9	37.0	36.2	25.7	4.0	11.1	25.2	10.2	20.5	25.2	0.0	0.2	0.1	0.0	0.4	0.0	0.4	0.2	0.2	0.6	0.0	0.1	0.1	0.2	0.3	0.1	0.0	1.3	0.3	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	4.7	0.0	2.4	2.3	0.6	2.1	1.8	1.2	1.5	1.7	1.2	0.0	3.3	0.0	4.2	4.6	1.3	8.2	0.0	0.4	5.4	1.3	2.6	1.0	1.2	44.6	0.3	0.0	6.6	3.2	5.6	3.1	1.3	11.4	1.4	1.5	5.4	0.0	0.4	4.4	2.0	2.5	3.5	0.8	1.8	3.2	0.0	1.0	0.5	0.1	4.1	1.0	0.9	0.1	1.5	0.0	11.5	0.6	15.1	0.1	1.6	2.0	6.6	0.8	2.3	62.0	80.0	6.8	0.6	1.0	3.1	1.8	8.0	1.4
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"FA core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 337.5;Proximal tubular cells: 290.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	39.3	57.5	18.1	3.2	18.9	5.6	41.2	20.8	28.0	52.5	20.5	48.5	4.6	50.0	1.3	38.8	37.8	1.5	50.0	14.5	19.6	64.8	52.1	37.9	3.6	24.6	18.9	45.3	38.7	5.1	75.5	3.2	19.6	61.1	1.8	3.7	30.7	7.1	26.4	42.7	31.8	1.8	20.2	45.0	47.3	54.8	26.9	2.9	52.9	4.0	3.1	43.7	40.7	18.9	27.7	4.4	5.8	7.3	3.6	4.7	34.8	30.4	11.0	9.6	12.9	6.7	18.0	31.7	43.7	4.8	9.0	13.5	4.2	4.6	4.9	68.3	61.0	26.5	6.8	14.4	13.5	18.7	24.8	8.1	9.8	5.8	6.3	5.9	11.9	24.6	37.1	7.6	6.7	11.6	27.0	57.6	20.8	5.4	55.6	36.0	18.1	30.7	4.6	4.5	47.4	63.5	19.8	8.6	58.5	5.3	8.5	7.5	25.6	15.1	35.8	18.7	17.4	68.9	39.9	48.2	28.0	11.4	6.4	9.8	16.4	63.4	18.4	16.9	18.1	28.3	16.5	19.8	17.0	25.7	22.2	18.6	20.6	10.8	15.6	42.4	16.2	10.6	18.1	18.9	20.8	28.0	14.5	19.6	24.6	18.9	19.6	20.2	26.9	18.9	71.7	6.4	11.9	0.0	82.3	0.0	97.7	0.0	79.6	29.1	120.9	138.2	22.1	62.9	6.8	97.5	4.2	119.7	83.6	14.5	170.2	128.5	102.7	44.3	77.2	62.1	43.7	36.8	0.0	110.8	144.1	65.3	64.7	49.9	7.6	74.8	84.6	94.5	134.0	15.2	0.0	56.0	0.0	110.8	0.0	337.5	86.0	82.3	0.0	0.0	178.9	84.7	91.6	0.0	0.0	141.1	40.8	82.8	60.9	152.8	56.2	290.1	8.0	29.5	65.7	63.3	68.8	101.5	38.3	88.4	0.0	89.8	62.4	102.5	42.2	113.2
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 178.0;Oligodendrocyte precursor cells: 157.8;Syncytiotrophoblasts: 279.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	49.2	12.8	8.5	9.9	9.0	12.7	31.8	14.2	11.8	17.6	13.2	18.3	50.5	12.5	7.5	7.6	23.5	16.3	9.9	9.7	7.3	21.9	39.1	11.8	6.3	8.6	8.4	27.8	38.6	49.2	8.4	35.1	9.5	10.6	14.8	15.9	23.4	10.5	9.7	20.4	29.0	13.3	8.3	5.4	16.3	13.9	9.0	5.6	32.8	21.9	4.8	16.9	10.4	8.8	4.5	6.7	9.8	12.8	55.5	22.7	16.0	10.2	12.4	4.0	3.6	5.6	10.3	0.1	4.0	7.4	6.3	2.7	14.5	7.4	8.9	0.6	10.0	7.5	8.9	0.7	16.3	6.3	1.0	21.9	5.9	10.1	3.6	17.5	6.9	2.5	19.7	0.7	8.7	0.2	0.7	2.8	12.1	0.8	6.9	10.2	16.6	4.0	7.4	21.8	24.6	6.5	2.5	7.9	9.9	9.6	5.5	0.2	2.5	11.2	6.2	5.5	5.9	3.4	2.1	0.1	16.6	0.6	5.9	0.0	4.1	0.0	1.0	2.0	0.7	0.0	2.7	0.3	3.5	0.0	2.9	0.7	0.9	0.4	0.6	1.2	1.5	1.6	8.5	9.0	14.2	11.8	9.7	7.3	8.6	8.4	9.5	8.3	9.0	8.8	42.6	12.8	34.9	95.3	4.3	10.1	22.3	20.4	28.5	16.3	29.7	20.6	25.9	38.6	39.3	11.0	35.5	72.9	12.9	50.4	29.4	10.7	3.4	82.0	33.6	14.1	4.9	31.3	178.0	16.9	35.3	42.1	33.1	98.2	1.3	70.2	12.8	143.0	20.7	0.0	46.5	54.1	26.4	29.6	11.9	5.1	45.1	21.7	19.6	104.9	16.9	22.6	5.2	157.8	17.4	20.7	73.4	33.4	10.3	13.6	37.5	50.4	74.6	11.3	0.0	24.7	31.9	5.3	10.2	14.4	7.7	279.5	9.7	41.2	22.3	19.5
FAM222A	"C12orf34, FLJ14721"	ENSG00000139438	"Family with sequence similarity 222 member A"	Q5U5X8	12	109713825-109770495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Early spermatids: 29.1;Horizontal cells: 77.4;Oligodendrocytes: 78.5;Rod photoreceptor cells: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 116.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040181, HPA075616"	Uncertain		Approved	"Golgi apparatus,Cell Junctions,Midbody ring"		Yes	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"	"Cell Junctions, Midbody ring"	"HPA040181: AB_10796448, HPA075616: "	"unprognostic (8.59e-3)"	"prognostic favorable (1.82e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.66e-2)"	"unprognostic (8.17e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.16e-2)"	"prognostic favorable (8.59e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	0.7	19.0	23.7	0.7	45.2	0.6	1.2	36.7	34.2	0.6	5.6	1.9	4.8	0.3	0.8	2.3	0.4	0.8	8.9	20.0	27.6	10.6	4.0	2.1	0.4	41.2	43.1	13.4	3.9	0.7	22.4	0.1	37.7	1.8	1.0	22.1	3.4	0.5	4.3	3.2	2.2	0.4	29.0	6.2	7.2	23.4	48.4	0.4	0.7	0.6	0.6	0.9	1.8	65.6	2.0	3.1	1.6	3.7	1.0	0.0	1.1	0.6	0.3	1.6	0.2	28.1	0.5	0.3	2.2	0.8	1.7	1.2	1.9	0.1	0.6	16.8	4.0	3.5	0.9	6.5	0.2	2.8	3.6	0.2	0.2	0.3	0.0	0.4	0.1	2.0	1.2	0.6	0.3	11.5	0.7	3.6	3.0	3.3	5.3	2.3	8.0	1.2	3.5	1.5	19.2	116.4	2.5	3.7	8.2	0.5	4.5	3.0	0.2	0.5	3.2	1.3	2.4	2.9	4.0	2.4	0.3	2.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	45.2	36.7	34.2	20.0	27.6	41.2	43.1	37.7	29.0	48.4	65.6	2.1	0.0	0.0	2.3	3.6	2.2	0.9	0.1	3.4	23.4	7.4	6.1	8.1	1.5	0.8	1.8	33.3	0.3	10.4	1.2	7.9	1.7	29.1	1.2	0.5	1.3	7.7	0.0	1.3	0.8	0.2	1.5	1.5	1.8	0.0	0.7	0.7	1.3	0.3	77.4	6.7	5.8	0.0	0.0	2.1	13.4	1.2	1.9	7.2	0.0	0.1	11.2	0.0	9.5	78.5	1.1	0.2	0.4	1.3	1.7	0.9	0.7	0.6	50.3	0.0	2.6	1.5	1.1	5.7	3.3	1.8	0.8	3.7	6.0	1.6	0.4
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 207.3;Paneth cells: 153.6;Peritubular cells: 191.5;Proximal enterocytes: 145.9;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 255.9;TIME: 420.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	32.4	17.9	2.7	21.5	3.3	0.8	28.1	3.2	4.8	43.2	5.2	75.6	82.2	75.7	15.6	24.1	43.5	69.8	45.6	2.5	2.4	26.7	7.1	39.3	9.6	2.6	3.2	39.1	27.5	36.2	11.0	29.4	2.9	47.0	53.2	1.8	31.7	63.1	5.4	16.8	86.1	47.1	2.5	27.6	64.0	12.8	3.8	2.8	17.6	5.6	6.8	44.6	29.3	2.6	34.2	17.2	15.9	0.6	3.7	8.1	21.6	55.2	84.3	38.4	30.4	6.0	48.8	0.3	114.5	87.8	67.3	62.5	11.3	121.0	19.2	0.3	6.6	0.2	4.7	31.7	98.5	0.2	0.6	39.7	81.7	31.9	75.1	82.7	255.9	2.0	1.2	7.6	13.2	0.8	0.6	1.1	16.5	50.9	25.0	0.1	0.4	1.0	51.4	22.1	0.2	38.9	29.0	3.4	6.0	33.9	6.8	0.6	420.4	50.7	7.1	0.8	25.7	0.4	1.0	0.5	8.0	0.2	0.5	1.7	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.2	0.1	0.5	0.3	0.3	0.8	0.4	0.2	0.4	0.1	0.1	2.7	3.3	3.2	4.8	2.5	2.4	2.6	3.2	2.9	2.5	3.8	2.6	10.8	12.8	18.1	0.0	3.1	86.3	82.7	41.4	20.5	3.7	28.6	23.9	37.1	47.1	30.6	16.5	6.2	8.9	4.8	207.3	0.0	99.1	3.4	13.6	75.9	19.2	46.0	0.0	0.7	53.5	114.2	29.3	133.5	20.5	18.9	9.4	55.0	2.5	5.6	1.7	5.5	54.8	26.4	1.9	23.5	4.0	80.2	5.8	14.2	2.8	2.7	9.1	1.0	1.0	1.2	113.0	153.6	191.5	1.2	29.8	145.9	2.5	11.6	6.4	144.7	11.9	64.8	2.8	1.9	17.4	62.8	19.4	6.0	6.6	53.8	62.6
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478332-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 273.8;choroid plexus: 198.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 228.2;Cholangiocytes: 213.1;Oligodendrocytes: 562.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	24	"basophil: 13.2;eosinophil: 3.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 189.0;BEWO: 60.9;CACO-2: 49.6;HaCaT: 55.6;HAP1: 63.7;NTERA-2: 57.8;T-47d: 49.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		1200000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	5.7	21.3	103.9	8.2	186.8	0.3	22.9	178.9	198.9	19.7	198.1	44.8	10.4	54.6	15.3	25.2	29.6	31.3	5.6	109.9	124.7	26.3	41.0	30.9	2.9	250.9	185.9	18.0	31.0	61.0	6.8	15.7	220.5	27.4	21.2	1.2	59.1	54.6	0.5	109.3	12.2	43.6	165.5	0.8	22.5	7.6	148.0	10.1	54.6	0.2	9.1	16.6	27.4	273.8	7.2	0.4	30.2	189.0	0.1	0.0	60.9	0.4	0.0	0.0	0.0	49.6	1.1	0.1	12.5	2.8	0.1	55.6	63.7	13.0	0.0	0.1	12.7	0.0	0.2	1.2	1.5	0.2	11.7	0.1	26.2	0.0	0.6	0.0	0.0	0.3	0.2	0.2	0.0	11.7	0.2	0.1	57.8	8.7	0.0	0.1	0.0	7.5	18.0	15.8	0.5	0.5	0.4	33.4	0.0	36.6	49.3	0.0	0.1	0.3	8.5	0.2	0.7	0.1	0.1	0.0	0.3	0.0	0.5	13.2	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	103.9	186.8	178.9	198.9	109.9	124.7	250.9	185.9	220.5	165.5	148.0	273.8	1.4	19.2	36.0	228.2	0.6	40.1	34.3	18.4	58.6	0.2	8.7	25.4	9.1	213.1	38.4	36.8	0.0	16.5	0.3	7.3	0.0	7.4	4.1	28.1	4.4	1.0	2.4	2.7	14.8	0.2	3.0	9.0	13.3	53.1	0.0	0.1	1.8	5.0	2.3	0.0	31.2	40.8	10.2	0.6	4.4	9.6	1.2	1.1	5.4	10.3	0.6	2.0	1.0	6.0	562.5	0.7	3.0	6.0	0.1	15.0	1.8	13.6	15.3	0.2	0.0	1.6	2.6	0.7	9.9	18.7	27.7	4.0	1.5	0.4	3.8	31.4
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322985-14337614	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 23.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 156.5;Basal prostatic cells: 168.3;Club cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;hTCEpi: 51.3;RPTEC TERT1: 17.3;WM-115: 62.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		1100000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	5.0	3.7	2.3	0.8	3.0	0.0	2.3	6.4	5.3	3.2	0.9	1.6	11.8	2.3	3.1	1.6	2.4	5.0	0.6	5.3	1.3	23.2	7.0	17.7	0.1	0.0	1.3	10.6	1.2	8.2	1.0	1.8	0.8	8.2	0.8	1.6	1.2	14.0	2.0	6.3	2.3	1.4	0.6	0.7	9.7	1.2	2.3	7.3	5.2	0.7	0.3	7.9	2.1	1.8	0.0	12.2	27.5	0.0	0.0	0.0	0.0	2.7	0.8	0.1	0.0	15.3	5.6	0.0	0.9	0.6	0.0	8.0	0.0	8.3	0.1	0.0	1.8	0.0	0.4	0.3	2.4	0.0	0.0	4.6	51.3	0.0	9.7	0.0	0.1	0.2	0.0	0.2	5.3	0.4	3.7	0.0	8.9	6.2	0.1	0.1	0.2	0.0	17.3	3.6	0.5	5.7	0.0	0.0	9.2	15.5	0.5	0.0	0.0	0.0	1.8	0.1	0.7	0.0	0.0	0.0	0.2	0.0	62.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	3.0	6.4	5.3	5.3	1.3	0.0	1.3	0.8	0.6	2.3	1.8	0.3	218.0	156.5	2.3	0.5	8.7	168.3	26.1	55.8	23.9	4.4	6.5	1.2	24.3	73.1	22.0	6.2	0.5	0.0	2.2	13.7	23.6	0.2	0.7	1.7	1.9	11.3	0.0	27.2	14.9	0.0	8.7	37.8	0.7	5.1	5.0	2.9	8.5	0.2	6.7	39.3	2.5	2.0	0.3	0.7	0.5	3.7	1.3	5.4	1.9	1.6	0.6	0.0	26.2	3.9	10.0	3.0	0.4	0.1	24.9	3.5	49.2	13.4	3.3	0.0	25.0	1.8	0.0	0.1	5.9	16.6	0.0	0.8	1.4	1.5	18.3
FLT4	"PCL, VEGFR-3, VEGFR3"	ENSG00000037280	"Fms related receptor tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"Adipocytes: 27.4;Endothelial cells: 27.1;Extravillous trophoblasts: 37.1;Hepatic stellate cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.8"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 10.1;BEWO: 12.4;HEK 293: 15.6;HL-60: 9.5;HUVEC TERT2: 9.9;JURKAT: 12.3;T-47d: 14.6;TIME: 15.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	20000000	290000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	17.2	11.3	3.5	4.7	4.6	0.8	14.7	2.6	3.4	9.0	2.6	4.9	2.8	8.0	3.0	4.4	9.8	3.8	9.7	5.1	2.6	20.1	6.2	16.9	5.5	3.4	3.0	4.5	2.0	2.3	7.8	6.4	3.6	5.6	1.3	0.3	2.0	2.5	4.7	4.0	7.2	4.1	2.8	17.6	3.5	3.1	4.2	1.0	25.7	4.1	1.4	5.6	5.5	2.7	0.1	2.5	3.2	10.1	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.4	0.3	0.3	0.9	0.1	0.6	0.4	3.4	0.2	0.3	0.1	15.6	1.2	0.5	0.5	0.1	9.5	0.3	0.2	0.1	0.2	0.4	0.3	9.9	12.3	0.4	0.4	2.1	5.6	0.1	0.5	7.0	0.3	0.6	8.2	0.1	0.1	0.1	0.3	0.3	1.1	0.1	0.2	0.1	3.1	14.6	0.3	15.7	0.2	6.9	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.5	0.0	3.8	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	3.5	4.6	2.6	3.4	5.1	2.6	3.4	3.0	3.6	2.8	4.2	2.7	27.4	0.0	1.7	0.7	0.7	0.9	0.2	0.0	1.2	0.2	1.4	1.4	4.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	27.1	0.0	0.0	0.2	0.0	37.1	0.8	0.0	0.1	2.5	2.4	64.6	0.6	1.2	0.0	0.1	0.0	0.0	3.3	0.8	0.7	0.3	0.6	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.7	0.7	0.1	5.2	0.1	1.1	1.0	1.8	0.2	0.0	0.1
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557484-44561262	"Cancer-related genes, Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 10.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Kupffer cells: 9.8;Leydig cells: 23.3;Peritubular cells: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 1.1;myeloid DC: 1.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;monocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 53.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	1.5	1.6	1.0	1.4	1.5	0.2	1.3	0.9	1.2	5.9	10.5	1.8	0.9	5.3	1.3	0.9	3.8	1.8	2.8	1.1	1.3	2.8	0.2	2.9	0.8	1.3	1.9	3.3	1.5	2.1	1.1	3.6	2.0	1.7	0.4	0.7	1.0	1.9	0.4	0.6	1.6	1.5	1.3	2.1	1.2	1.5	1.4	0.3	2.4	0.7	0.7	2.0	2.5	1.6	12.9	37.7	38.3	13.8	8.7	6.4	0.4	39.5	30.4	53.4	38.2	28.4	6.2	0.0	8.9	13.9	13.1	5.5	3.6	2.8	30.2	2.9	7.2	1.7	6.6	0.1	7.7	0.2	7.5	10.7	2.8	9.6	8.8	40.8	1.8	4.9	2.5	0.3	20.9	5.9	6.7	3.6	26.8	0.1	6.7	18.1	8.6	1.9	7.7	0.6	3.8	10.9	5.2	1.1	2.3	32.4	14.6	8.4	0.7	24.1	17.5	4.4	22.6	0.8	0.7	3.0	4.0	2.4	11.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.2	1.0	1.5	0.9	1.2	1.1	1.3	1.3	1.9	2.0	1.3	1.4	1.6	0.5	19.2	0.0	1.6	0.6	0.6	0.3	0.9	0.0	0.0	0.9	2.9	1.9	0.0	0.2	1.8	0.0	1.6	1.8	0.0	0.0	0.3	0.6	1.1	8.4	0.7	1.2	1.3	0.0	1.8	0.5	5.9	0.0	1.5	0.0	1.4	0.7	0.0	4.8	0.0	0.0	0.3	0.0	9.8	6.0	0.4	23.3	5.6	0.0	6.5	6.2	6.0	0.0	0.0	0.2	0.7	0.0	18.0	0.3	0.1	0.0	0.3	0.2	0.4	0.0	0.4	5.3	0.3	1.2	0.3	0.4	2.3	0.2	2.4	0.0	0.0
GALNT12	GalNAc-T12	ENSG00000119514	"Polypeptide N-acetylgalactosaminyltransferase 12"	Q8IXK2	9	98807670-98850081	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 74.7;intestine: 55.8;stomach 1: 54.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 101.2;Intestinal goblet cells: 142.4;Undifferentiated cells: 42.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 128.4;U-2197: 160.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA048292, HPA071076"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA048292: AB_2680343, HPA071076: "	"unprognostic (7.85e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.97e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.71e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (9.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.60e-3)"	"unprognostic (6.87e-2)"	5.0	2.0	1.2	7.7	1.3	2.2	3.4	6.5	1.8	8.7	4.3	55.3	34.2	3.7	74.7	19.6	7.5	10.5	1.2	1.1	1.4	4.8	0.4	11.7	3.2	2.6	1.4	0.4	13.6	6.3	3.4	2.6	2.7	4.6	55.8	0.6	25.5	4.3	1.3	3.4	27.1	14.0	1.1	2.2	54.8	4.6	1.5	3.3	14.7	0.6	6.1	11.9	4.6	1.6	5.4	4.1	3.4	13.5	10.0	7.8	0.0	1.4	2.1	2.0	4.6	0.8	21.6	0.0	5.0	0.9	12.2	38.0	2.9	1.3	1.6	26.2	1.7	2.4	0.2	0.0	0.5	1.6	0.5	3.8	0.9	6.4	0.0	2.7	2.3	19.3	30.2	0.0	0.6	13.9	2.6	4.7	16.7	128.4	5.6	6.5	0.3	0.1	2.3	7.7	12.4	1.1	0.5	30.6	3.0	7.7	4.5	4.5	4.3	0.0	0.3	160.9	0.0	2.1	4.8	2.3	37.1	0.0	0.9	0.0	0.0	0.5	0.3	0.0	0.6	0.0	0.4	0.2	0.0	0.1	0.6	0.3	0.0	0.6	0.0	0.1	0.0	0.1	1.2	1.3	6.5	1.8	1.1	1.4	2.6	1.4	2.7	1.1	1.5	1.6	1.3	3.2	25.7	2.0	2.3	2.4	1.3	8.3	1.2	2.4	0.4	0.1	1.0	18.6	16.9	11.0	16.7	1.0	2.6	101.2	0.0	11.2	1.8	4.8	1.6	1.6	19.9	1.3	7.4	25.4	1.7	12.5	32.1	8.7	2.5	2.4	0.0	0.0	2.3	0.0	5.7	142.4	2.0	0.3	3.9	1.4	2.1	3.9	0.0	3.7	0.2	0.8	3.1	3.5	7.0	32.0	36.5	7.5	1.7	7.4	21.9	2.7	16.9	0.2	0.0	0.7	1.5	5.9	10.5	9.9	1.3	1.1	4.5	5.1	42.5	11.1
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Human disease related genes, Predicted intracellular proteins"			"Congenital muscular dystrophy, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 345.8"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		11000	"Cluster 35: T-regs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	51.0	54.8	80.0	22.4	91.5	3.3	54.3	88.7	94.4	99.8	64.7	120.2	24.7	53.7	17.6	345.8	48.9	23.4	66.1	74.5	82.1	104.1	58.4	76.3	15.9	89.4	91.4	34.4	43.5	20.8	56.0	28.7	88.1	63.6	41.1	17.9	100.9	31.0	65.1	150.2	45.5	17.5	82.0	37.7	78.7	24.9	91.1	18.6	55.8	23.3	21.0	74.1	140.1	92.3	328.1	148.6	44.7	70.6	40.6	40.7	35.2	119.7	59.8	96.7	87.3	80.3	120.6	4.7	220.3	85.2	64.6	183.8	38.7	100.6	32.6	33.8	69.0	63.9	100.7	79.7	123.7	6.9	75.3	46.7	98.5	58.8	51.3	57.4	66.0	47.2	30.1	54.4	49.9	243.8	21.3	13.3	48.6	182.1	147.8	21.7	37.4	43.7	121.6	281.6	41.8	46.2	67.1	163.2	157.0	23.1	102.5	35.1	115.4	135.7	74.6	191.7	130.1	50.5	70.5	17.3	113.9	51.9	146.2	3.0	0.7	0.1	5.1	1.1	4.7	1.9	5.1	5.1	1.1	0.8	4.2	3.3	0.3	1.5	0.5	3.6	12.0	1.7	80.0	91.5	88.7	94.4	74.5	82.1	89.4	91.4	88.1	82.0	91.1	92.3	30.6	28.9	15.2	22.9	8.3	113.9	77.4	52.1	35.9	69.8	73.6	31.6	14.8	37.1	62.8	82.8	35.5	36.3	19.3	501.1	52.8	167.9	1.1	92.2	30.5	32.4	43.1	1.7	28.8	164.3	77.1	32.6	69.3	76.8	10.2	37.3	23.2	18.0	55.9	75.7	32.2	87.8	42.7	10.8	29.8	2.4	20.5	16.1	58.7	10.3	23.4	73.3	18.6	17.1	71.6	296.7	285.4	25.2	6.8	120.4	36.0	52.7	38.0	46.0	19.7	18.1	44.5	6.4	20.4	107.0	169.8	25.7	22.9	47.7	138.1	199.7
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435595-121449727	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	121.2	287.6	313.5	24.7	310.2	0.9	60.6	260.1	409.0	261.7	193.1	17.5	18.2	98.7	10.6	74.9	32.7	99.9	168.9	273.6	362.6	21.2	10.6	67.9	21.1	340.3	380.9	43.5	19.4	236.2	31.3	290.2	307.4	83.3	19.7	3.3	35.6	148.0	10.3	388.2	24.7	112.5	335.9	4.2	30.7	36.9	373.3	24.3	169.1	22.1	34.9	116.0	184.9	341.0	0.1	43.5	186.8	0.4	99.7	61.5	0.4	142.5	286.9	46.9	113.7	0.7	0.4	0.0	15.8	55.8	40.2	18.3	5.1	87.4	151.3	0.1	51.6	2.3	15.7	0.0	124.1	0.0	0.4	164.6	92.1	172.5	61.7	462.7	362.3	0.0	0.1	4.3	9.4	8.4	0.1	80.6	365.8	0.1	47.2	0.1	0.0	3.7	188.6	21.0	0.4	2.9	0.0	0.3	0.1	453.4	14.9	0.3	269.5	143.8	39.4	122.8	93.5	0.1	0.1	0.1	350.4	0.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.5	310.2	260.1	409.0	273.6	362.6	340.3	380.9	307.4	335.9	373.3	341.0	152.2	250.0	80.0	276.2	0.1	234.9	133.6	71.1	77.4	0.3	9.5	20.1	199.7	0.0	17.5	1.8	2.1	53.4	0.4	0.0	0.0	76.9	0.5	21.5	215.5	166.6	0.0	0.0	0.3	4.2	7.9	124.4	0.5	51.7	8.8	494.3	33.9	0.1	8.6	0.0	0.6	0.0	4.1	0.9	55.3	1.7	2.5	3.6	44.4	15.0	0.6	0.3	0.0	4.0	1.0	10.8	0.0	4.1	0.1	29.7	0.0	0.1	6.2	0.3	0.0	5.9	80.2	0.9	1.8	68.3	378.2	20.0	4.9	127.1	0.4	52.7
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.0"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 157.8;Smooth muscle cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	9.5	0.7	3.1	3.6	2.8	0.8	5.2	10.1	3.8	9.2	5.5	28.6	1.6	24.7	2.9	2.7	5.3	5.4	11.8	2.3	1.4	2.2	0.7	7.2	2.7	2.1	2.9	2.2	1.4	3.4	0.6	40.0	2.6	8.9	2.9	1.0	1.1	18.6	4.6	2.0	5.3	32.7	1.3	0.7	7.6	8.8	4.0	1.6	6.7	5.9	2.0	11.4	6.1	3.0	44.5	21.9	62.0	18.9	8.3	10.6	20.5	50.3	36.6	50.0	52.6	12.4	24.7	0.5	2.3	46.4	69.9	10.1	29.2	13.7	70.8	0.5	19.8	0.4	12.1	1.6	3.8	0.3	1.7	8.8	1.6	37.0	11.8	20.4	17.1	9.6	1.8	0.5	31.4	0.4	6.7	4.3	29.5	0.1	16.2	39.5	73.8	0.3	11.4	16.8	10.2	21.5	4.6	0.5	16.2	41.3	10.9	8.0	12.3	43.8	39.3	22.2	38.9	0.4	11.3	32.5	15.9	0.3	40.7	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.2	0.2	0.2	1.0	0.5	0.1	0.2	0.1	0.1	3.1	2.8	10.1	3.8	2.3	1.4	2.1	2.9	2.6	1.3	4.0	3.0	11.7	0.0	0.0	0.7	0.2	2.0	1.7	0.5	0.0	3.4	0.6	1.4	25.1	0.0	0.2	1.8	2.1	0.5	0.4	0.1	0.0	1.5	1.5	1.4	14.9	19.5	0.0	0.0	8.1	0.0	2.6	6.3	0.0	3.0	0.0	9.4	4.2	0.3	1.5	13.5	1.4	0.0	0.0	0.3	4.2	0.3	1.5	1.2	3.6	1.0	0.6	0.2	0.0	0.0	0.3	0.6	0.0	2.2	0.0	1.4	0.0	0.3	0.2	0.9	157.8	4.8	101.1	15.6	28.4	0.6	3.0	0.5	0.8	7.8	0.1	1.3
GPATCH1	"ECGP, FLJ10206, FLJ38686, GPATC1"	ENSG00000076650	"G-patch domain containing 1"	Q9BRR8	19	33080899-33130542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043430, HPA043604, HPA074327"	Approved		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Cell Junctions"	"HPA043430: AB_10960493, HPA043604: AB_10960499, HPA074327: "	"unprognostic (2.38e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.95e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.56e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-3)"	3.5	3.1	3.0	3.5	3.2	3.7	4.4	5.1	4.0	4.0	2.0	4.8	5.4	4.5	4.4	4.3	3.9	2.8	3.8	3.1	2.9	4.4	3.4	3.4	4.9	2.8	3.0	7.2	3.8	6.3	2.6	4.2	3.0	4.2	4.5	3.9	4.6	3.4	4.2	5.6	4.6	4.4	2.7	4.3	4.9	4.4	3.3	5.9	4.7	3.2	5.0	3.6	3.6	3.4	8.8	18.2	8.4	9.1	5.5	6.2	7.1	7.8	5.4	11.6	9.7	12.9	7.9	12.3	9.7	6.2	5.5	7.7	10.6	6.4	10.1	21.4	6.6	11.7	6.8	9.8	7.2	20.3	7.6	5.3	7.4	7.9	7.2	5.6	6.6	9.6	12.5	7.7	5.8	11.2	11.8	7.1	5.9	11.5	7.5	11.9	10.6	5.5	5.4	5.4	9.3	6.2	12.3	7.6	4.6	7.2	6.4	14.5	7.5	10.2	7.6	5.6	11.3	6.4	11.1	10.6	6.3	10.3	9.5	23.1	6.4	7.4	6.0	6.6	4.1	6.2	5.6	7.7	6.0	7.0	9.6	6.0	4.7	3.5	3.7	5.3	9.2	5.0	3.0	3.2	5.1	4.0	3.1	2.9	2.8	3.0	3.0	2.7	3.3	3.4	6.5	9.6	7.9	5.9	9.1	6.1	5.0	6.0	10.8	9.7	5.2	4.6	11.8	1.5	9.8	7.3	14.6	10.5	10.7	12.0	15.6	6.8	3.2	5.2	9.4	6.4	4.2	4.2	7.2	4.5	5.2	7.5	10.2	6.8	16.5	10.1	7.9	4.6	4.1	3.3	7.0	7.7	8.2	6.0	5.2	2.1	10.2	5.8	8.8	2.8	5.8	7.1	16.5	5.5	7.0	9.0	8.7	8.2	5.5	3.3	6.8	6.6	10.3	11.9	0.0	8.0	7.3	19.5	14.8	6.5	3.7	5.5	9.1	7.0	6.5	3.4
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"pancreatic cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA						"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379572-6393981	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 228.3;Late spermatids: 391.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Vesicles, Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	35.0	38.1	36.7	34.0	38.4	71.0	34.2	43.6	43.0	48.8	30.2	41.2	40.5	48.5	25.9	46.0	44.8	36.1	32.8	39.1	35.8	37.6	30.0	31.5	43.5	34.4	34.3	73.6	57.5	42.6	49.8	26.8	34.6	39.5	23.3	24.9	43.8	31.7	36.8	36.8	39.2	25.1	30.1	36.4	43.9	68.3	36.1	37.1	49.6	22.6	29.8	37.3	41.0	36.1	115.6	97.1	62.0	100.9	46.5	73.1	47.3	81.7	84.7	112.0	106.0	104.4	48.5	76.3	111.9	67.2	73.5	109.9	69.3	65.6	57.1	106.6	90.1	97.2	60.7	86.9	78.6	107.1	79.5	82.8	78.2	85.5	64.1	86.4	69.0	72.9	115.9	91.7	63.9	96.2	115.4	79.7	108.2	59.7	124.3	101.5	68.0	94.6	67.5	74.2	76.1	99.8	83.0	64.5	95.6	36.4	84.0	94.0	79.8	78.5	62.6	134.0	110.1	153.9	197.2	79.7	98.1	124.9	91.0	10.2	29.7	20.8	26.1	28.4	29.7	32.9	23.5	24.9	23.3	31.6	27.0	24.6	40.1	27.6	30.2	30.3	25.4	19.8	36.7	38.4	43.6	43.0	39.1	35.8	34.4	34.3	34.6	30.1	36.1	36.1	29.2	48.1	56.6	5.2	51.9	24.3	50.2	40.5	53.5	27.6	43.1	34.7	28.9	32.9	58.4	25.8	8.4	46.1	51.6	88.2	21.5	48.5	228.3	70.5	70.7	41.0	30.5	51.7	6.9	50.8	43.0	43.3	51.0	57.4	63.8	32.7	58.9	26.0	60.2	25.2	7.0	53.4	24.4	54.8	25.9	391.6	44.4	42.1	33.8	5.6	66.0	35.6	49.4	3.5	4.9	47.4	66.0	49.7	55.4	29.9	65.3	48.8	83.6	33.5	32.9	44.8	52.9	71.8	38.3	44.9	21.0	54.0	48.3	41.8	54.4	40.6
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.3;ovary: 16.2;retina: 50.6;testis: 35.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 133.9;Early spermatids: 257.9;Inhibitory neurons: 139.1;Late spermatids: 334.0;Oligodendrocytes: 283.2"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;HEL: 5.9;SK-MEL-30: 35.1;U-266/70: 11.9;U-266/84: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	0.3	7.8	19.5	0.4	34.0	0.0	0.2	26.9	22.2	0.8	1.5	4.1	0.2	0.5	1.1	1.2	0.6	0.8	2.2	19.3	18.6	8.2	0.1	0.1	0.1	30.5	28.0	16.2	3.7	1.3	1.7	0.1	29.9	0.7	0.8	50.6	0.6	0.8	3.9	1.5	0.9	0.5	23.3	0.1	1.6	35.7	25.6	0.3	3.4	5.0	0.2	0.6	0.8	46.3	0.0	8.0	0.2	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	2.7	0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.7	0.6	0.0	0.1	35.1	2.1	0.7	0.1	0.0	0.0	1.4	0.0	0.1	11.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	34.0	26.9	22.2	19.3	18.6	30.5	28.0	29.9	23.3	25.6	46.3	0.1	0.0	0.0	133.9	0.6	0.4	0.1	0.3	2.8	9.1	0.3	0.1	1.3	0.0	0.5	0.0	75.0	0.2	0.1	0.0	0.0	0.9	257.9	4.2	0.8	0.3	0.0	0.0	77.8	0.7	0.0	2.0	0.0	7.2	0.0	26.8	0.0	0.0	0.0	16.8	139.1	0.0	6.1	0.0	0.4	334.0	3.7	0.4	3.6	4.7	0.0	22.3	0.0	43.2	283.2	0.2	0.0	1.9	0.2	0.1	0.0	5.9	0.4	25.7	0.0	0.8	0.9	22.4	6.0	0.7	0.0	0.1	0.2	6.8	0.0	0.4
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 50: Non-specific - Ribosome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	57.6	96.3	53.1	39.5	57.2	130.1	80.1	84.6	57.8	117.2	52.8	106.0	79.8	101.8	108.4	95.4	78.3	47.9	62.3	53.7	58.4	106.9	83.5	55.4	53.7	56.2	53.3	99.1	91.2	48.0	121.8	44.8	55.1	111.6	88.0	63.7	88.7	42.2	45.8	145.4	89.1	43.1	49.7	78.9	79.5	55.5	55.2	72.2	108.8	31.5	43.5	66.7	113.4	64.2	25.9	49.5	100.6	71.2	55.5	69.3	72.6	48.0	54.0	54.0	62.2	41.1	67.0	45.5	38.7	45.5	67.8	65.3	50.6	72.1	50.0	54.1	44.9	52.2	172.7	89.5	45.0	50.3	48.9	65.7	103.0	73.3	59.7	71.8	76.2	143.8	39.5	55.4	63.9	57.3	107.4	68.3	77.4	50.0	90.4	44.4	33.3	50.0	73.7	121.7	62.4	94.6	103.9	69.5	53.0	79.6	67.7	83.3	54.8	58.3	57.4	37.0	48.7	50.6	65.4	64.2	53.3	57.7	52.4	158.1	50.5	92.7	63.4	50.8	57.6	60.8	55.1	60.4	50.1	60.2	51.1	52.7	80.3	67.5	65.3	52.0	84.2	46.8	53.1	57.2	84.6	57.8	53.7	58.4	56.2	53.3	55.1	49.7	55.2	64.2	63.3	70.5	52.9	38.5	41.3	83.1	87.2	182.5	174.2	66.5	69.9	77.5	12.9	38.6	109.1	99.3	39.6	114.3	39.4	157.4	76.3	58.7	43.8	50.8	64.8	46.1	110.2	40.1	31.1	47.4	73.9	73.7	64.2	56.9	54.5	60.3	32.5	25.1	41.4	20.2	40.6	108.6	150.5	16.6	33.5	16.4	81.1	24.5	26.6	22.5	30.3	32.4	44.3	50.8	52.6	60.5	105.7	68.4	34.0	59.0	84.7	65.5	68.4	56.0	52.6	31.5	50.6	71.6	57.9	90.3	83.0	124.0	43.3	87.9	89.8	89.3
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387729-184474550	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 163.6;Karpas-707: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	25.1	30.1	18.2	47.8	23.4	18.0	21.9	22.1	19.3	25.6	21.4	27.8	31.1	21.8	22.7	26.7	25.3	24.9	19.5	17.5	21.9	18.5	37.4	27.6	62.5	25.3	22.1	28.1	14.8	20.2	12.3	28.9	25.2	20.6	28.7	9.3	29.1	21.2	28.1	19.4	33.3	23.2	21.7	54.9	31.5	6.1	23.5	49.8	21.7	23.8	52.2	35.6	22.5	29.6	20.3	14.9	17.5	12.0	37.4	37.9	10.5	14.4	44.8	34.8	36.0	4.2	37.9	12.2	7.4	21.7	28.4	18.3	12.0	27.4	22.1	163.6	6.6	34.4	7.9	26.8	37.1	21.1	27.7	41.2	24.8	19.8	50.1	29.8	26.7	14.5	6.9	165.3	14.6	14.1	40.6	25.8	4.0	18.5	10.7	52.7	6.9	55.1	26.6	30.4	7.5	11.6	20.4	16.8	31.3	7.3	13.0	18.9	22.0	9.9	10.7	11.3	12.8	47.3	40.6	11.0	20.9	20.3	17.8	106.7	95.7	175.8	76.4	126.3	77.9	104.9	74.5	82.2	79.6	107.7	78.8	78.8	407.6	94.8	145.7	20.2	111.7	100.3	18.2	23.4	22.1	19.3	17.5	21.9	25.3	22.1	25.2	21.7	23.5	29.6	58.9	38.5	24.5	53.5	68.9	49.1	50.5	60.4	45.5	13.1	25.8	27.3	21.9	27.1	36.0	25.8	6.2	31.3	48.8	40.3	37.2	30.9	0.2	53.4	40.2	42.9	30.6	62.7	23.8	30.1	16.2	35.8	34.1	63.2	26.6	23.1	38.2	37.6	48.5	20.2	27.8	29.5	44.7	90.3	53.5	3.0	37.3	65.9	19.6	41.2	144.0	23.4	70.0	43.7	77.1	28.7	38.9	53.0	63.4	72.9	42.1	46.1	58.7	8.4	39.5	25.4	44.8	0.6	2.4	49.5	44.5	26.7	56.3	37.7	22.8	70.9
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099667-160200313	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.3;skeletal muscle: 80.0;tongue: 64.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 153.8;Alveolar cells type 2: 202.5;Basal prostatic cells: 153.5;Basal respiratory cells: 125.9;Pancreatic endocrine cells: 195.2;Spermatocytes: 286.0;Urothelial cells: 129.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 139.2;RPTEC TERT1: 269.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.1	0.0	0.0	1.9	0.0	0.0	20.2	0.0	0.0	2.7	0.0	8.0	8.4	5.4	1.7	14.2	3.4	14.8	0.6	0.0	0.0	68.3	0.1	45.3	0.0	0.0	0.0	0.0	3.3	32.2	1.8	5.5	0.0	5.1	7.4	0.0	3.9	8.9	80.0	2.6	6.3	0.3	0.0	0.0	18.7	0.1	0.0	0.0	4.7	64.5	3.0	44.9	6.5	0.0	14.5	0.2	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.1	139.2	0.1	0.8	0.1	0.0	28.7	0.0	45.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	31.4	0.0	0.1	0.4	0.1	0.0	0.0	0.0	3.8	4.3	0.0	0.0	0.0	9.0	0.0	0.0	10.9	0.0	269.9	45.7	0.0	0.1	0.1	43.7	0.0	1.6	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	153.8	202.5	0.0	0.0	10.5	153.5	125.9	46.1	0.0	35.5	31.0	38.7	10.0	60.4	71.7	0.0	13.6	0.5	30.3	0.0	57.5	89.4	9.6	0.7	2.6	0.0	0.0	0.3	105.4	7.0	2.6	37.8	24.4	3.8	0.0	1.1	1.0	2.2	0.0	0.2	11.6	24.4	0.3	0.4	48.3	2.8	2.2	1.8	0.0	2.0	1.7	0.0	0.5	0.1	195.2	25.6	1.2	0.0	57.3	10.0	1.9	17.7	0.1	0.0	5.7	3.8	286.0	3.0	42.2	8.5	4.7	2.1	0.0	12.4	129.3
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 952.2;skin 1: 932.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 315.9;Pancreatic endocrine cells: 356.2;Squamous epithelial cells: 318.3;Suprabasal keratinocytes: 383.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.1;eosinophil: 28.7;intermediate monocyte: 22.6;memory B-cell: 13.5;myeloid DC: 14.5;naive B-cell: 11.7;non-classical monocyte: 43.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 1090.1;OE19: 3919.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		64000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	46.5	16.0	13.6	23.6	21.6	20.7	68.6	20.8	18.9	243.7	25.8	94.9	88.1	57.0	15.3	952.2	69.9	39.8	145.1	14.6	14.3	120.7	70.9	57.1	15.7	20.7	16.2	46.2	59.6	19.9	37.3	51.5	19.6	68.0	49.0	4.7	226.4	41.8	110.8	932.4	95.7	23.1	14.8	22.7	86.3	12.5	16.2	29.6	86.4	62.2	92.0	68.7	432.6	33.6	268.8	217.8	21.7	18.5	0.2	0.1	330.6	15.3	89.2	5.9	5.2	332.6	289.0	5.4	157.8	9.7	7.5	1090.1	31.6	242.4	1.0	0.6	74.2	11.6	165.1	74.4	34.7	7.3	113.6	0.5	538.6	0.9	43.9	64.2	96.1	7.0	99.6	94.0	0.0	342.6	1.9	96.5	42.3	3919.9	36.2	313.5	0.2	202.5	165.8	674.0	52.2	38.6	33.8	652.1	1.9	98.6	545.9	8.0	152.4	0.3	14.8	6.8	5.1	8.2	31.2	5.5	1.5	12.7	2.6	3.9	13.1	28.7	0.0	22.6	0.0	13.5	0.0	0.2	14.5	11.7	0.2	0.1	0.6	0.8	43.8	4.5	0.1	5.7	13.6	21.6	20.8	18.9	14.6	14.3	20.7	16.2	19.6	14.8	16.2	33.6	56.9	60.9	36.8	4.6	10.6	196.9	218.5	104.5	100.2	1.9	87.3	77.0	87.8	48.6	80.9	132.4	4.2	98.9	1.1	315.9	27.4	212.2	28.5	112.6	21.1	55.2	66.8	3.4	0.5	135.4	167.3	25.6	136.1	247.0	11.4	16.5	41.4	34.1	14.4	0.0	1.6	125.0	81.4	7.7	32.7	8.3	5.0	10.9	12.4	2.8	6.3	18.2	0.0	7.1	13.6	356.2	223.7	0.0	3.9	220.1	141.1	35.6	45.7	4.3	6.6	37.4	18.8	2.5	4.5	318.3	383.3	185.7	6.1	3.2	129.2	301.6
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741830-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 154.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.7;hTCEpi: 103.0;RT4: 117.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	7.9	93.0	14.6	7.0	10.7	1.2	24.3	1.8	15.6	14.5	27.1	42.5	51.7	10.1	12.2	76.7	23.5	16.0	5.1	12.4	6.5	43.9	12.0	18.2	1.2	5.2	5.5	22.3	70.7	37.8	9.1	8.4	4.3	40.9	30.9	1.2	68.3	20.2	3.1	74.1	45.9	6.7	4.2	1.4	61.8	5.1	7.7	8.2	39.4	3.2	12.1	22.2	28.1	8.8	65.7	33.6	5.4	9.3	2.4	4.6	24.6	7.9	15.3	8.9	8.7	37.0	125.7	0.2	32.3	11.6	26.5	95.1	10.3	67.8	4.6	0.2	13.4	13.6	49.4	30.4	4.0	0.2	33.3	1.7	103.0	23.6	28.2	40.1	18.6	2.7	20.1	0.4	4.3	54.3	0.3	0.6	11.0	56.3	20.9	8.7	6.7	16.7	85.8	117.5	4.6	4.7	49.5	70.1	9.7	33.7	74.7	4.3	17.6	14.9	39.3	13.7	17.3	0.8	0.3	0.3	15.2	2.3	17.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	10.7	1.8	15.6	12.4	6.5	5.2	5.5	4.3	4.2	7.7	8.8	5.7	12.8	56.9	5.5	0.6	73.9	37.0	52.7	59.2	0.6	69.8	42.3	3.8	72.9	52.0	27.6	2.1	15.6	1.5	154.4	9.8	47.3	4.2	54.7	5.6	8.7	28.9	1.3	10.2	66.7	5.2	6.7	51.0	50.2	27.8	10.2	4.6	10.6	2.9	0.0	5.2	54.0	48.8	0.8	6.5	5.1	8.7	2.2	7.2	3.7	2.4	0.8	0.0	2.0	0.4	60.7	64.6	4.9	0.3	80.9	84.7	14.8	60.7	0.1	6.6	3.1	7.5	3.8	2.7	59.7	83.1	7.9	2.1	59.9	65.4	99.6
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716340-143722458	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 54.9;fallopian tube: 46.7"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 62.5;Respiratory ciliated cells: 107.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.6;HeLa: 20.7;MCF7: 14.3;T-47d: 14.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	1.6	0.1	3.3	0.2	4.0	0.0	1.9	1.7	8.1	6.9	54.9	1.0	0.3	2.5	2.4	1.1	46.7	0.2	0.6	5.0	3.6	10.5	0.3	12.1	0.4	10.2	14.5	0.9	4.4	9.4	6.9	0.3	7.0	2.2	0.2	0.0	2.2	1.7	0.1	4.0	0.8	0.4	6.6	0.7	0.8	11.4	6.4	1.1	16.1	0.0	0.2	0.5	2.1	3.0	0.4	0.6	1.9	0.0	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.5	9.6	0.0	1.6	0.0	0.0	5.5	0.1	0.2	0.0	1.0	2.0	0.0	20.7	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.2	3.4	0.0	0.0	14.3	0.0	0.0	2.5	1.2	1.2	0.0	3.7	0.5	1.0	1.6	3.6	5.1	0.0	3.3	0.0	0.2	14.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.0	1.7	8.1	5.0	3.6	10.2	14.5	7.0	6.6	6.4	3.0	0.1	0.0	6.4	0.0	0.1	0.4	0.3	5.7	0.0	0.0	1.0	1.3	0.7	0.0	11.8	0.0	0.0	0.0	0.0	0.1	0.0	1.1	13.8	62.5	0.5	0.3	0.0	0.0	0.2	0.0	0.7	0.8	0.0	1.7	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.6	16.2	0.0	0.0	11.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	1.4	107.9	0.0	0.0	0.4	2.2	2.3	0.9	0.0	0.3	0.1	0.2	0.1	0.3	0.1
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	30.5	14.2	9.1	16.7	10.5	10.0	26.1	12.9	11.9	23.8	9.7	25.9	13.3	26.7	10.8	25.0	23.7	12.1	18.2	9.4	10.4	16.1	18.6	24.9	18.9	11.3	10.2	22.2	17.0	16.1	11.0	25.3	11.5	15.2	16.6	12.3	20.5	13.7	30.1	25.6	19.6	18.3	11.5	19.5	20.3	11.8	9.9	20.7	17.5	15.9	19.7	25.1	24.1	12.4	54.4	28.6	49.6	40.3	24.0	27.1	27.0	49.2	55.9	62.2	63.3	42.5	32.9	69.7	20.3	34.8	20.7	46.8	65.1	46.8	74.1	46.0	50.3	34.7	20.8	38.3	35.7	71.3	80.6	24.1	25.8	47.4	60.7	27.6	38.9	37.5	35.3	43.9	41.7	28.5	77.4	52.6	33.3	34.7	26.5	49.8	104.0	30.8	29.0	30.0	25.0	28.7	32.9	33.1	39.3	33.0	20.4	50.2	34.3	26.5	24.1	29.8	56.3	36.1	37.7	71.1	35.5	46.1	16.2	9.8	2.3	1.4	2.0	4.2	2.0	2.0	2.0	1.9	3.2	0.9	2.0	2.2	3.0	1.8	2.5	1.5	1.9	1.1	9.1	10.5	12.9	11.9	9.4	10.4	11.3	10.2	11.5	11.5	9.9	12.4	39.0	16.0	16.5	11.8	26.2	42.8	35.0	12.3	24.5	11.4	18.1	14.2	18.6	25.8	15.6	20.2	4.2	40.5	35.4	23.7	13.7	11.7	4.6	18.8	31.7	38.3	10.8	25.0	14.0	13.7	52.6	27.4	12.2	26.2	18.3	18.2	26.7	25.6	38.5	32.0	17.3	20.8	12.2	35.5	35.0	6.2	30.1	35.9	23.2	15.0	34.2	18.3	26.8	17.6	25.3	15.8	11.9	22.6	28.0	32.8	15.6	18.7	12.5	18.3	19.7	32.8	27.4	42.5	68.7	29.9	42.8	39.7	31.6	12.7	29.1	29.1
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145567-19192131	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 39.3"	"Cell type enriched"	"Detected in some"	4	"Plasma cells: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"Daudi: 223.4;U-266/70: 217.6;U-698: 299.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	3.0	1.8	4.4	13.9	5.4	2.3	2.6	4.4	6.1	4.0	4.4	3.1	1.8	2.3	0.7	2.2	3.5	1.4	2.2	4.5	4.7	2.7	3.8	2.6	39.3	5.2	4.9	3.9	1.5	0.4	2.6	1.0	4.8	4.5	1.1	0.9	2.6	1.3	1.0	2.8	4.9	1.3	4.3	8.8	2.6	3.2	5.2	1.8	3.4	0.7	31.5	2.3	3.3	6.1	2.3	0.5	1.5	2.1	1.3	2.5	2.2	1.3	0.9	1.8	2.2	0.0	3.2	223.4	1.0	0.9	0.5	2.0	0.3	0.8	0.3	1.0	5.1	1.4	0.6	1.1	2.8	1.2	2.0	1.0	1.8	1.1	1.6	1.0	0.1	4.2	0.9	3.9	0.8	3.9	1.6	1.8	0.2	0.2	12.8	4.6	0.9	5.2	0.5	0.3	0.3	1.8	2.5	0.3	1.7	0.0	0.0	2.5	0.7	1.1	4.0	6.9	1.8	217.6	24.0	299.5	2.6	3.9	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	4.4	5.4	4.4	6.1	4.5	4.7	5.2	4.9	4.8	4.3	5.2	6.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	29.3	0.0	0.0	0.0	0.0	0.0	6.6	0.0	1.4	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 414.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	63.6	100.6	41.9	31.1	52.7	118.7	54.5	39.5	53.2	62.9	53.1	45.2	28.3	46.3	70.5	67.8	42.4	32.9	42.0	44.9	41.7	140.8	16.5	49.2	36.1	44.7	43.4	48.6	39.7	68.1	44.7	36.8	40.3	45.6	31.1	38.6	49.8	28.0	77.4	51.5	39.2	33.1	47.1	54.7	44.3	11.0	46.5	56.9	52.7	52.9	44.1	49.5	57.5	48.2	50.8	41.8	95.3	77.0	99.5	156.2	36.1	85.7	103.8	58.8	68.5	30.4	79.9	92.4	64.8	132.6	53.3	33.0	61.1	71.4	71.2	70.5	72.0	41.1	34.1	120.6	75.1	35.8	81.0	111.6	76.6	54.3	81.1	119.4	111.4	97.8	61.8	57.6	112.3	60.2	93.7	71.2	87.6	60.8	64.0	124.8	80.8	82.7	116.3	44.5	61.8	116.0	66.1	53.1	195.0	65.6	44.5	16.7	75.0	96.9	43.9	62.2	49.5	72.8	102.8	71.4	107.6	80.8	66.3	111.0	75.7	33.4	11.4	14.3	13.5	18.3	19.0	21.1	42.5	20.6	20.4	16.2	36.1	17.0	12.0	14.3	20.4	28.8	41.9	52.7	39.5	53.2	44.9	41.7	44.7	43.4	40.3	47.1	46.5	48.2	82.4	19.2	26.1	32.3	66.9	71.8	89.5	143.8	51.2	52.6	77.7	61.7	53.6	34.3	81.3	86.5	45.9	79.4	94.3	49.6	281.8	119.5	7.8	56.4	68.9	89.2	84.9	146.9	48.2	122.9	124.2	67.6	42.8	64.7	47.7	70.0	98.6	11.2	95.8	45.4	37.8	80.4	101.7	181.7	103.3	6.3	63.3	124.2	104.9	40.3	270.1	92.9	109.2	34.2	28.3	114.9	51.5	65.1	58.0	149.4	81.1	414.2	50.4	43.7	65.7	48.9	108.8	17.1	25.1	74.7	77.0	139.1	111.4	57.4	80.5	142.9
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 101.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	9.6	5.8	8.2	9.3	14.8	6.2	10.2	15.7	10.3	18.4	8.0	38.6	6.4	28.4	3.1	46.6	13.6	6.4	10.7	8.7	9.8	8.7	7.0	11.7	5.9	19.7	16.8	4.8	18.5	10.6	4.4	17.3	17.4	17.0	4.6	0.8	17.8	24.0	10.8	36.6	12.5	19.7	14.1	7.2	44.0	10.8	15.3	5.4	10.0	5.2	7.1	25.4	26.0	22.2	25.4	13.7	13.0	15.4	10.4	11.9	59.9	32.3	17.5	34.8	25.3	17.3	13.1	10.8	10.5	22.2	22.7	65.0	9.1	69.9	17.2	21.2	31.3	5.7	11.6	16.7	24.0	11.6	11.8	11.3	101.2	42.5	70.1	10.4	22.1	4.9	8.9	8.1	22.7	10.6	2.9	6.7	5.0	12.9	12.1	16.6	27.4	6.1	8.1	53.0	9.6	8.5	19.3	19.7	20.2	15.4	10.8	10.9	34.3	61.1	47.3	37.8	27.5	9.4	3.7	7.2	55.2	5.8	29.0	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.3	0.5	0.3	0.5	0.3	0.2	0.5	0.5	0.1	0.6	0.1	0.4	8.2	14.8	15.7	10.3	8.7	9.8	19.7	16.8	17.4	14.1	15.3	22.2	10.9	0.0	7.8	1.3	4.8	7.5	10.1	12.8	23.9	0.7	7.3	7.9	11.9	7.2	9.5	5.5	0.0	31.0	7.8	7.7	1.9	10.5	18.1	11.3	5.4	12.2	3.5	1.3	0.7	10.2	26.3	4.3	27.5	6.8	1.3	5.8	6.4	5.9	8.7	5.0	4.4	3.9	6.1	4.4	3.4	28.8	1.8	4.3	1.8	1.0	7.2	0.7	7.2	2.5	17.8	15.4	2.2	4.1	6.4	13.6	4.4	2.7	6.0	0.7	0.0	3.5	9.4	5.5	2.2	27.2	9.1	39.4	5.2	1.5	3.7	15.2
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	20.0	7.1	8.4	20.3	8.7	30.7	12.1	8.6	12.7	9.0	9.6	11.0	11.0	6.0	2.0	15.6	8.0	11.5	10.6	7.8	8.2	15.4	9.3	25.6	15.4	10.1	9.8	3.0	9.9	1.6	3.7	9.2	9.3	8.4	11.4	0.3	13.3	4.3	3.1	4.9	14.4	7.6	9.1	36.1	10.8	1.2	10.3	6.7	8.7	3.1	13.8	12.3	11.5	9.6	13.5	24.4	0.1	0.1	6.0	12.4	0.2	17.0	14.8	15.4	22.4	13.9	26.6	0.3	19.1	14.2	13.7	21.7	4.3	24.9	5.8	8.3	0.6	18.8	17.6	16.2	4.2	12.3	18.6	8.5	2.4	16.8	5.7	9.0	37.3	21.3	2.7	2.5	11.9	22.0	7.0	24.3	2.2	29.3	30.0	13.5	1.8	23.8	22.0	10.2	1.0	0.8	13.4	8.7	7.2	0.1	6.2	12.5	41.4	7.8	4.8	7.0	11.7	11.2	40.2	3.2	13.7	42.3	3.9	21.9	36.2	45.8	11.2	22.2	15.4	8.1	12.6	12.0	18.9	6.7	6.8	10.4	48.6	3.6	23.3	1.2	17.4	16.0	8.4	8.7	8.6	12.7	7.8	8.2	10.1	9.8	9.3	9.1	10.3	9.6	32.1	3.2	10.7	1.0	9.8	3.4	6.8	3.1	7.4	0.2	3.3	3.4	3.1	2.8	5.5	1.8	0.0	0.2	9.6	8.9	1.9	4.6	3.5	1.2	1.9	25.9	1.2	3.4	0.5	5.2	0.8	7.1	15.3	1.6	29.1	0.3	16.8	1.3	16.6	1.7	0.5	10.9	0.0	18.2	7.8	5.2	0.9	28.9	7.2	11.2	16.7	0.1	11.3	1.5	5.2	4.9	9.4	0.4	18.5	2.8	5.5	0.6	2.0	0.6	0.0	3.0	3.1	0.1	0.2	13.4	2.8	0.3	16.5	0.2	9.5	7.5
MLST8	"GbetaL, GBL, Lst8, Pop3"	ENSG00000167965	"MTOR associated protein, LST8 homolog"	Q9BVC4	16	2204248-2209453	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 105.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019935, HPA041841"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Golgi apparatus, Cell Junctions"	"CAB019935: AB_561447, HPA041841: AB_2677701"	"unprognostic (2.19e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.70e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.60e-4)"	"unprognostic (8.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	16.7	29.4	31.5	9.8	31.8	13.3	17.1	31.4	51.1	16.0	25.5	17.3	12.5	15.5	5.6	24.8	14.6	9.1	25.0	32.4	29.9	26.0	31.3	13.3	10.5	32.0	31.0	19.4	35.8	13.3	19.8	11.1	32.4	20.5	4.6	5.7	19.7	8.0	39.4	22.2	15.6	4.5	29.4	16.5	22.3	33.6	32.5	9.7	22.4	21.8	5.2	16.7	15.5	34.1	20.5	61.9	23.1	60.5	29.6	20.8	38.2	17.9	20.4	26.7	22.9	83.4	29.5	51.3	40.6	20.1	12.7	25.8	23.1	51.4	3.1	39.4	113.4	36.0	61.0	51.7	44.7	57.3	49.7	29.7	34.8	31.7	41.8	22.6	28.6	74.1	54.9	35.9	14.8	89.4	55.5	74.9	47.3	18.1	57.4	55.6	23.4	93.8	20.7	13.4	73.5	40.1	26.6	62.1	46.3	8.7	38.6	54.2	22.4	33.5	38.9	27.3	23.7	43.0	26.4	57.8	17.6	47.5	29.9	0.0	25.0	4.2	14.1	29.9	11.8	14.4	13.1	15.2	24.6	12.5	15.0	15.1	2.8	14.6	30.1	13.3	13.1	20.7	31.5	31.8	31.4	51.1	32.4	29.9	32.0	31.0	32.4	29.4	32.5	34.1	11.5	6.4	16.0	10.4	24.6	14.7	16.2	29.6	21.6	31.5	24.7	29.8	3.3	15.7	16.2	16.5	20.9	63.2	13.0	44.6	35.2	34.4	48.7	9.6	13.1	16.8	28.8	26.9	8.9	42.6	50.4	19.2	42.8	11.2	8.2	26.8	20.3	16.7	46.9	30.3	8.4	37.9	22.4	19.1	14.6	105.4	14.9	18.4	17.8	1.0	28.0	29.4	19.6	5.5	5.9	28.6	37.9	15.1	34.1	17.9	43.2	36.3	11.1	30.6	19.7	11.6	16.5	34.7	28.2	29.4	15.5	52.7	15.4	26.8	49.3	17.4
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459477-88467390	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 119.3;Proximal tubular cells: 133.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050166, HPA076046"	Approved		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: AB_2681039, HPA076046: "	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	25.1	51.5	20.3	12.9	21.7	11.3	22.7	23.7	25.4	14.6	22.0	24.2	20.0	17.1	18.2	26.4	17.1	13.0	76.1	20.8	23.6	34.7	70.9	12.7	20.9	23.1	22.1	17.2	16.2	24.6	16.2	19.6	23.6	14.9	23.6	16.8	17.1	15.2	73.3	17.9	19.7	18.4	21.7	19.1	24.8	28.1	22.7	18.9	17.2	84.6	20.3	20.7	16.2	22.6	27.8	87.2	27.2	29.8	38.0	28.6	51.5	38.6	35.5	56.9	50.4	108.6	59.3	64.9	38.6	34.9	51.0	65.9	107.4	47.4	44.8	26.3	86.4	53.6	61.5	114.3	24.6	54.2	40.4	32.7	56.6	42.8	28.7	29.0	50.2	63.2	60.7	26.6	42.7	59.6	44.2	68.4	43.5	50.5	52.9	51.9	37.9	49.2	44.5	88.2	42.1	26.5	36.6	57.7	81.8	44.6	64.8	65.7	31.3	44.0	41.9	23.3	56.4	24.2	55.7	53.0	48.5	58.1	34.2	27.1	45.5	33.7	60.0	60.5	69.6	78.8	63.3	58.7	58.7	69.5	69.5	61.6	7.9	62.9	45.0	50.5	68.0	61.5	20.3	21.7	23.7	25.4	20.8	23.6	23.1	22.1	23.6	21.7	22.7	22.6	18.9	0.0	10.3	5.2	21.0	13.8	22.4	59.8	9.6	21.2	17.3	21.3	70.4	37.1	32.3	36.8	27.1	94.3	10.7	20.4	119.3	35.0	67.1	20.0	16.6	18.4	28.3	17.7	4.2	38.0	42.1	19.2	19.9	19.5	22.2	25.8	17.2	105.0	35.6	15.2	5.9	20.6	44.7	13.4	5.5	16.3	14.3	10.8	7.2	3.7	42.1	25.1	20.6	4.5	6.1	31.7	18.4	18.8	17.3	21.9	32.1	133.6	26.2	28.4	26.3	19.5	25.5	55.3	27.4	27.1	23.3	80.7	18.5	66.9	36.1	29.4
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 101.2;monocytes: 57.7;Prostatic glandular cells: 90.5;Urothelial cells: 80.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 14.3;neutrophil: 15.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.1;granulocytes: 15.6;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"AF22: 25.2;EFO-21: 29.5;HUVEC TERT2: 27.8;TIME: 16.3;U-937: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049771, HPA075115"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA049771: AB_2680872, HPA075115: "	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	4.7	1.3	8.1	3.0	9.6	2.2	3.2	11.8	6.6	3.2	12.3	4.9	0.8	3.2	1.4	3.1	2.3	4.3	2.2	6.6	5.9	1.1	0.9	3.4	0.8	1.5	9.1	1.6	0.6	1.6	2.6	2.2	4.6	3.5	1.9	0.3	1.5	4.8	0.8	1.4	1.7	6.9	0.8	2.8	1.9	2.4	6.9	1.0	2.7	2.4	0.9	3.7	2.3	0.0	0.4	0.6	25.2	0.1	0.3	1.0	0.2	0.9	4.7	0.1	0.4	0.1	0.0	0.2	29.5	2.6	0.1	0.0	1.6	0.0	0.6	0.1	0.6	0.1	0.1	0.0	0.1	0.1	1.4	0.5	0.0	0.9	0.0	0.1	27.8	0.1	0.0	4.1	0.2	0.2	0.1	2.1	4.8	0.0	0.0	0.1	1.4	0.0	0.1	2.9	0.6	5.7	0.0	0.0	0.0	7.1	0.1	1.7	16.3	0.0	1.6	2.0	0.0	0.1	0.0	0.1	1.1	20.5	0.0	5.0	7.1	14.3	2.0	4.7	1.9	0.0	1.0	1.7	4.1	0.0	0.1	0.2	15.6	1.0	3.7	0.0	0.1	2.3	8.1	9.6	11.8	6.6	6.6	5.9	1.5	9.1	4.6	0.8	6.9	0.0	29.2	0.0	1.9	1.0	7.3	0.5	101.2	0.0	0.6	0.9	5.0	3.7	19.6	21.5	0.0	1.8	0.0	17.9	10.1	2.0	0.0	0.2	4.7	3.3	2.8	32.9	1.2	17.3	7.8	0.7	24.3	15.2	0.5	9.0	7.6	0.9	51.0	19.0	19.1	0.0	5.8	3.7	0.0	49.0	0.5	7.4	31.7	19.7	1.8	19.7	57.7	1.5	32.0	5.5	1.1	0.6	3.1	21.4	2.8	90.5	7.8	2.9	0.0	0.5	26.3	39.7	12.6	2.7	3.7	0.3	0.3	24.9	17.0	2.9	3.8	80.7
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 78.6"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 154.3;Early spermatids: 261.1;Excitatory neurons: 315.5;Late spermatids: 355.3;Oligodendrocytes: 366.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	45	"basophil: 29.9"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 29.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	8.2	36.6	16.7	8.6	27.6	9.9	9.4	5.7	41.9	7.9	1.0	9.0	10.3	7.0	11.2	5.5	6.4	8.7	11.5	28.5	9.2	16.6	11.1	9.1	16.4	11.9	10.4	5.0	14.3	28.2	11.1	12.2	8.4	8.2	9.2	78.6	7.4	10.8	6.6	5.9	10.2	5.9	6.5	12.2	8.9	22.0	12.2	13.2	16.8	6.7	15.4	10.1	4.5	30.1	9.5	11.6	28.4	9.7	6.1	7.6	12.1	9.6	10.9	16.9	13.1	59.4	9.1	13.6	13.8	8.4	20.2	8.6	19.6	18.7	19.3	29.7	12.2	52.2	11.2	9.9	10.3	11.6	51.0	9.6	11.9	10.4	12.5	16.0	20.4	36.3	20.1	15.9	16.4	11.6	28.8	13.4	10.4	20.1	5.5	23.8	17.2	10.0	32.0	12.2	19.6	7.2	14.4	14.4	62.4	32.2	22.0	18.2	19.2	11.7	14.1	9.0	19.5	17.6	17.9	13.1	11.6	12.6	13.0	29.9	0.3	0.3	0.5	0.4	0.2	0.6	0.5	0.6	0.3	0.3	0.3	0.6	0.2	0.2	0.5	0.5	0.5	0.3	16.7	27.6	5.7	41.9	28.5	9.2	11.9	10.4	8.4	6.5	12.2	30.1	17.8	22.4	6.0	57.8	7.8	5.4	3.8	3.0	5.7	94.4	8.7	5.0	27.4	5.7	5.3	33.1	154.3	3.7	4.3	11.4	1.9	3.9	261.1	8.9	5.8	15.0	28.2	11.8	315.5	6.4	3.5	4.8	5.1	11.9	24.1	17.6	9.3	9.4	8.8	37.0	98.2	10.0	2.0	16.9	6.0	355.3	5.6	11.3	16.0	103.0	7.9	11.2	6.2	104.5	366.6	5.7	8.1	2.6	6.4	5.4	5.1	8.4	9.5	89.9	13.1	5.0	6.9	37.1	11.8	4.1	4.8	6.4	5.5	6.7	10.3	6.6
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 15.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 15.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	8.1	10.7	4.9	4.7	5.0	6.5	7.0	4.7	5.5	10.5	6.4	10.8	4.8	10.1	3.4	43.2	9.8	5.2	17.0	4.7	4.6	8.8	9.1	5.5	5.0	5.3	5.1	4.0	9.6	6.0	4.8	4.2	5.4	8.3	3.4	2.7	10.3	6.8	24.1	21.5	6.4	5.8	5.1	8.1	7.3	3.5	5.1	4.7	7.9	13.7	10.5	9.6	16.5	5.2	5.3	15.6	1.6	12.2	5.1	5.9	2.4	7.0	8.0	3.4	5.9	0.9	13.0	9.5	21.0	8.9	5.1	13.1	4.7	4.0	1.1	12.5	5.0	12.6	5.5	8.6	7.7	4.4	7.0	6.6	16.4	4.5	8.7	6.9	7.0	12.5	0.1	6.2	3.6	14.2	7.5	10.7	7.5	6.9	8.6	14.6	2.1	3.1	8.2	6.8	2.3	7.9	10.4	5.5	4.5	2.4	17.7	13.0	8.2	6.8	6.0	6.1	3.6	2.2	2.6	3.3	1.0	13.4	4.9	2.8	3.5	15.4	0.8	1.5	1.0	0.5	0.8	1.2	2.1	0.4	0.9	1.0	8.1	1.4	1.4	0.9	1.4	2.3	4.9	5.0	4.7	5.5	4.7	4.6	5.3	5.1	5.4	5.1	5.1	5.2	3.0	0.0	7.9	5.9	3.2	2.5	1.7	4.5	2.8	1.3	4.1	4.2	12.8	2.8	4.2	7.3	2.1	3.6	1.4	7.3	1.9	7.1	2.0	8.7	2.8	3.8	2.4	3.8	5.9	3.8	2.2	3.5	8.2	4.1	0.0	5.7	5.3	10.2	6.5	0.0	4.0	3.7	2.0	6.0	1.8	4.7	1.2	4.0	1.8	2.8	6.2	6.1	5.2	5.5	2.8	5.5	7.6	1.2	1.8	1.6	3.9	5.3	7.2	3.2	0.0	2.9	2.7	1.9	2.0	10.8	4.7	0.5	2.8	2.1	5.5	1.2
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 137.0;thyroid gland: 234.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 185.9;Alveolar cells type 2: 103.7;Club cells: 56.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.9;CAPAN-2: 19.1;HeLa: 32.3;Hep G2: 27.1;MCF7: 24.3;RPTEC TERT1: 37.7;T-47d: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	22.8	6.3	9.7	5.6	7.9	0.2	27.0	4.7	8.0	32.4	5.7	24.5	56.1	20.9	22.2	10.9	22.4	30.5	5.2	7.5	14.6	105.0	4.0	137.0	4.5	6.1	31.8	10.9	40.1	1.0	47.4	3.4	9.2	82.9	25.2	2.4	8.9	18.7	4.9	8.2	74.1	14.1	4.4	14.8	14.9	3.1	10.5	14.2	234.5	11.5	5.4	9.7	22.1	6.6	0.0	0.2	0.3	0.6	0.0	0.0	30.9	0.2	0.1	0.0	0.0	14.9	19.1	0.2	0.8	0.2	0.0	1.7	7.4	0.0	0.0	0.0	8.4	0.8	32.3	27.1	0.1	0.0	0.2	3.2	2.4	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.0	24.3	0.4	1.5	0.3	0.1	12.0	0.0	0.1	0.3	37.7	1.6	1.7	0.6	1.8	14.1	0.0	4.1	51.2	1.3	0.0	0.6	0.4	0.5	1.1	0.3	1.1	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	7.9	4.7	8.0	7.5	14.6	6.1	31.8	9.2	4.4	10.5	6.6	5.2	185.9	103.7	15.3	0.0	1.9	5.2	13.1	1.8	1.1	22.2	7.0	2.5	27.1	56.4	33.1	0.0	2.4	0.7	5.9	1.9	24.7	11.0	1.0	1.5	18.4	15.6	0.0	1.0	2.5	0.2	8.3	1.1	1.9	0.0	3.3	2.9	0.3	0.3	0.0	10.0	10.6	4.1	0.0	1.5	15.4	2.5	0.6	5.4	14.0	0.0	0.0	0.0	2.0	0.3	7.5	3.4	0.0	0.0	28.4	19.6	4.3	6.4	0.2	0.0	1.9	26.4	2.4	2.0	3.6	1.1	1.5	0.3	1.5	11.0	5.7
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073628	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	8.3	10.4	4.9	5.0	5.6	9.3	7.7	14.0	9.3	9.3	8.2	8.6	5.6	10.3	9.9	5.4	10.2	4.4	10.0	5.1	5.1	6.6	10.0	8.6	5.5	4.7	4.9	9.9	8.2	6.1	7.2	5.8	5.6	6.7	6.2	15.6	5.2	7.5	14.3	6.1	7.6	7.8	4.6	9.2	6.1	11.9	5.6	5.7	11.9	5.5	5.3	8.1	7.4	6.9	11.4	13.9	23.0	10.2	5.8	10.0	30.5	10.9	7.9	10.6	9.9	12.2	6.2	13.8	3.8	7.3	6.8	11.8	10.7	8.6	8.1	6.0	23.1	16.7	11.5	15.4	11.1	11.3	7.0	10.2	7.0	7.9	9.5	13.3	11.6	16.8	12.9	5.2	12.9	8.3	12.4	26.0	14.5	9.1	24.0	11.7	15.0	8.1	12.3	13.9	11.1	8.8	17.6	7.4	8.4	11.8	12.9	7.5	10.9	8.6	8.4	10.7	6.2	7.7	13.1	13.0	2.1	13.0	4.2	0.3	2.4	2.1	3.9	2.6	5.0	2.0	3.1	3.3	3.7	2.3	4.0	2.8	1.5	2.1	2.3	3.6	2.3	2.3	4.9	5.6	14.0	9.3	5.1	5.1	4.7	4.9	5.6	4.6	5.6	6.9	18.7	35.3	15.4	28.4	14.4	8.3	14.4	7.8	15.4	44.8	7.6	7.5	18.5	8.6	5.6	11.0	18.8	15.3	19.9	10.3	3.9	11.6	25.2	14.8	23.3	15.5	7.2	15.6	55.4	9.4	12.7	17.4	16.3	18.8	10.1	28.0	13.2	12.7	9.5	25.2	73.4	11.4	12.2	11.1	9.5	6.4	43.8	10.9	14.2	34.7	10.7	14.9	12.3	26.2	51.1	18.7	9.9	30.1	13.7	9.4	5.8	8.1	19.6	49.6	6.6	17.3	14.6	67.0	25.9	12.1	7.4	7.8	15.0	18.0	13.3	20.2
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40217428-40277487	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 25.6;skin 1: 28.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 52.7;NK-cells: 16.5;Suprabasal keratinocytes: 19.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 26.5;HaCaT: 32.2;hTCEpi: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.2	8.2	11.6	0.4	15.9	0.9	2.1	8.5	16.6	4.5	0.0	1.3	1.5	0.9	1.0	25.6	4.3	1.1	8.3	17.6	3.0	4.7	0.3	2.5	0.9	1.4	1.1	0.6	8.0	8.0	12.1	7.6	1.9	4.4	1.1	0.8	6.1	3.8	4.5	28.2	1.5	0.3	1.8	0.9	3.9	17.7	3.0	0.5	7.5	1.3	1.9	3.5	9.4	5.4	3.9	0.0	0.2	0.0	0.0	0.0	6.0	0.0	0.2	0.7	0.7	26.5	2.9	0.1	3.6	0.0	1.3	32.2	4.5	6.9	0.3	0.2	1.0	0.0	3.0	0.2	0.0	0.1	0.3	0.0	19.4	0.3	4.5	0.2	0.0	5.5	1.8	0.3	0.0	4.5	0.0	0.5	0.5	3.9	2.9	0.2	0.2	2.9	1.5	8.4	7.3	2.0	2.6	10.9	0.3	1.7	1.7	10.3	0.0	0.3	0.6	0.0	0.3	0.1	0.3	0.1	0.7	0.6	0.2	1.2	0.1	1.2	2.3	0.1	0.8	0.6	0.1	1.9	0.3	0.1	0.1	0.4	0.5	0.9	0.1	0.1	0.0	0.6	11.6	15.9	8.5	16.6	17.6	3.0	1.4	1.1	1.9	1.8	3.0	5.4	0.0	0.0	4.2	0.7	0.3	9.8	9.6	4.8	8.6	3.5	2.8	2.9	0.0	4.3	5.4	5.5	0.0	52.7	2.1	0.3	13.7	4.4	8.6	3.3	0.4	0.3	4.9	0.0	8.9	4.3	3.0	0.7	0.5	5.1	0.0	0.7	0.0	0.0	4.1	0.0	7.3	1.1	2.0	0.6	0.9	5.8	1.8	0.3	1.8	1.0	0.0	1.3	16.5	0.5	0.3	2.5	1.0	1.9	0.1	5.2	0.2	0.2	3.9	0.2	0.0	0.3	0.4	1.9	3.3	13.9	19.0	9.0	1.0	0.8	2.0	11.3
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662774	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.5;testis: 42.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 266.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.9;RPMI-8226: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cluster 24: B-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	3.2	8.0	25.1	2.4	24.8	1.3	2.8	32.4	38.5	2.1	19.3	7.7	1.1	2.6	2.1	2.0	2.7	1.9	4.2	28.1	22.3	8.8	6.5	3.1	3.1	25.3	22.8	3.9	27.9	6.6	30.2	0.7	26.8	3.6	1.0	2.7	2.7	2.7	8.7	1.8	4.1	1.6	21.9	4.8	5.9	42.9	25.8	3.4	2.4	5.3	2.2	3.7	1.7	25.4	8.9	9.4	2.6	23.5	1.7	0.4	4.7	0.2	1.1	3.4	3.2	4.7	3.6	14.8	4.3	0.3	1.2	7.0	5.2	1.1	0.7	6.9	5.0	6.0	4.1	5.5	2.4	2.5	13.5	0.1	0.5	3.2	1.3	2.1	1.7	21.7	0.6	3.4	0.6	8.7	15.6	3.2	3.3	12.0	6.0	27.9	1.7	24.5	8.8	5.1	21.8	11.7	1.4	3.2	3.7	0.7	19.9	0.9	1.4	0.3	0.8	2.1	4.6	3.5	12.1	13.5	2.6	5.3	1.0	2.1	0.9	0.4	4.3	0.6	7.8	10.9	5.9	5.4	1.1	8.3	2.8	2.2	3.4	1.3	0.1	5.1	6.3	2.0	25.1	24.8	32.4	38.5	28.1	22.3	25.3	22.8	26.8	21.9	25.8	25.4	4.4	3.2	5.8	2.0	17.0	0.9	2.2	1.6	1.2	11.1	7.7	6.7	1.7	10.0	2.6	20.2	4.2	5.7	8.2	3.5	33.2	7.2	61.0	4.1	0.5	3.2	34.0	4.0	7.2	15.0	0.4	3.3	6.1	2.7	5.7	5.2	3.9	4.6	4.3	32.0	7.3	3.3	0.0	4.1	5.7	266.5	3.7	4.7	5.4	3.7	2.2	19.1	1.0	2.0	2.2	6.0	2.1	1.5	12.1	2.1	2.9	16.3	3.4	10.1	0.0	8.0	9.7	5.5	3.9	1.4	1.6	2.9	15.0	1.9	4.7	2.4
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ crumbs cell polarity complex component"	Q8NI35	1	61742477-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 75.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 86.6;Alveolar cells type 2: 60.6;Club cells: 39.0;Collecting duct cells: 57.0;Endometrial ciliated cells: 55.7;Glandular and luminal cells: 98.3;Pancreatic endocrine cells: 47.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 75.0"	"Immune cell enhanced"	"Detected in many"		"eosinophil: 7.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 36.3;RPTEC TERT1: 30.3;RT4: 33.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 72.3"	"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	3.4	7.2	6.8	3.6	5.4	3.5	18.1	75.0	5.3	8.4	25.3	12.2	8.9	5.8	26.5	19.3	8.3	7.1	45.2	3.8	9.2	27.5	12.4	10.0	2.9	12.8	9.0	6.8	12.4	20.0	10.9	3.5	14.2	12.3	11.1	15.8	20.0	7.9	45.4	22.4	9.3	3.5	11.5	3.1	10.2	5.1	9.1	4.0	13.1	16.1	6.2	7.9	13.2	9.5	36.3	7.0	2.3	3.2	1.3	3.3	29.5	2.1	2.8	2.2	3.0	12.5	13.2	0.2	9.1	4.4	18.7	21.1	5.1	18.9	3.8	3.5	8.8	0.2	10.4	11.3	2.9	0.1	0.2	1.2	19.7	3.7	8.0	5.3	1.2	0.0	0.0	0.0	1.9	12.6	0.1	0.1	12.0	16.4	1.9	0.1	2.8	5.2	30.3	33.4	6.1	2.0	8.8	29.4	7.7	23.7	23.7	0.3	0.3	1.8	4.3	0.2	4.2	1.4	2.7	4.8	1.7	0.0	0.5	0.4	0.0	7.2	1.2	0.1	2.3	1.2	2.0	1.7	0.0	1.1	2.6	1.7	0.6	2.6	0.1	0.2	1.9	0.6	6.8	5.4	75.0	5.3	3.8	9.2	12.8	9.0	14.2	11.5	9.1	9.5	6.4	86.6	60.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	35.0	29.8	0.0	0.0	39.0	57.0	0.0	4.3	3.8	0.0	5.9	37.6	0.0	55.7	8.6	1.6	0.0	0.0	0.0	26.4	0.7	5.5	0.0	98.3	1.3	14.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.9	0.0	0.0	2.7	0.0	0.0	35.7	27.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	26.4	10.3	1.7	0.0	0.0
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853090-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.5;Distal enterocytes: 66.4;Exocrine glandular cells: 46.3;Pancreatic endocrine cells: 65.2;Urothelial cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 86.1;HaCaT: 108.0;HUVEC TERT2: 56.2;OE19: 77.8;RT4: 74.2;TIME: 74.5;WM-115: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		2500000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	24.0	4.0	11.7	7.7	15.9	1.2	22.8	3.3	15.1	11.6	0.0	23.1	21.4	9.2	6.4	41.7	9.1	6.6	19.3	17.0	2.3	21.3	19.3	27.7	2.0	0.0	0.8	2.5	13.8	3.8	6.5	19.2	0.0	10.8	14.3	3.4	28.8	11.2	8.2	27.4	17.1	7.2	1.1	1.8	23.6	1.1	2.7	1.0	12.6	11.1	9.1	9.8	19.2	5.7	18.9	1.0	7.7	8.5	0.3	0.0	5.5	0.2	0.2	0.1	0.0	4.5	86.1	0.1	43.7	0.6	1.0	108.0	9.9	7.9	0.0	0.1	0.3	0.0	0.4	0.1	6.9	0.0	0.3	0.0	17.8	0.1	1.2	18.1	56.2	0.0	0.1	9.2	0.0	15.1	0.3	0.0	32.5	77.8	14.6	0.3	0.1	13.2	6.3	74.2	0.9	1.8	0.5	23.3	20.0	21.6	18.8	0.4	74.5	0.1	0.7	0.1	6.9	0.0	0.1	0.2	0.5	0.0	52.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	11.7	15.9	3.3	15.1	17.0	2.3	0.0	0.8	0.0	1.1	2.7	5.7	61.5	0.0	5.3	3.6	0.2	1.0	12.0	4.6	0.0	9.6	9.5	4.7	4.4	20.0	8.6	12.9	0.0	0.7	2.0	66.4	3.9	15.3	1.3	10.1	2.1	34.2	7.7	2.7	12.3	46.3	0.3	2.6	21.9	21.3	0.0	0.0	7.5	30.1	0.2	26.9	6.1	21.3	12.2	1.4	2.3	2.5	0.6	0.5	0.0	6.5	0.0	4.8	7.2	5.5	7.2	65.2	30.3	0.4	1.4	25.8	36.4	5.2	7.1	0.5	13.1	0.9	18.5	0.3	0.2	7.4	2.6	20.1	0.9	0.5	18.9	54.5
PCDHA11	"CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11"	ENSG00000249158	"Protocadherin alpha 11"	Q9Y5I1	5	140868183-141012347	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.2;parathyroid gland: 2.7;retina: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;AN3-CA: 10.7;EFO-21: 7.6;MCF7: 4.4;T-47d: 6.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077160			Approved	"Vesicles,Cell Junctions,Cytoplasmic bodies"		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cell Junctions"	"Cytoplasmic bodies"	"HPA077160: AB_2686827"	"unprognostic (1.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.98e-3)"		"unprognostic (1.36e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-4)"	"unprognostic (9.91e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.26e-2)"	0.2	0.3	1.5	0.1	1.3	0.0	0.2	4.2	2.2	0.8	0.0	0.1	0.0	0.5	0.1	0.0	0.2	0.8	0.0	1.1	0.3	0.7	0.1	0.4	0.1	0.0	1.5	0.0	1.8	2.7	1.0	0.0	0.3	0.1	0.0	2.4	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.0	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.7	0.0	2.1	4.0	10.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.6	0.0	0.8	0.0	0.1	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.4	0.3	0.0	1.0	0.0	0.1	0.0	4.4	0.0	0.0	3.5	0.8	2.8	0.0	0.0	0.0	0.4	1.6	0.2	1.9	0.0	1.9	0.4	1.9	6.5	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	4.2	2.2	1.1	0.3	0.0	1.5	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291012	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 675.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 805.9;Basal respiratory cells: 763.8;Paneth cells: 769.2;Proximal enterocytes: 1059.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 189.7;memory B-cell: 223.8;naive B-cell: 213.0"	"Group enriched"	"Detected in all"	7	"B-cells: 223.8;granulocytes: 189.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 766.3;Hep G2: 635.3;HHSteC: 731.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		93000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	301.7	32.4	10.7	91.5	10.8	25.0	236.0	10.2	18.5	133.1	30.2	220.0	179.4	115.0	91.8	182.3	155.3	114.9	393.2	11.7	10.9	82.8	160.3	337.2	104.5	20.4	12.7	35.6	98.3	65.9	29.5	141.1	14.1	116.9	218.5	36.9	166.1	114.7	675.1	136.8	249.0	146.0	14.0	148.3	148.3	13.7	13.8	105.9	194.7	290.0	123.7	276.3	165.3	11.2	274.4	181.8	12.4	0.4	64.1	43.3	277.1	82.6	266.4	218.8	356.5	387.0	429.8	0.3	21.9	233.8	110.4	766.3	91.5	498.1	220.6	0.2	132.0	277.9	50.1	635.3	731.0	0.1	13.2	125.5	257.0	111.9	400.6	233.2	396.8	24.2	60.0	70.3	52.7	51.4	0.8	4.9	24.6	137.7	137.2	234.1	10.0	98.4	114.4	268.9	48.3	18.9	91.2	84.6	0.9	293.8	68.2	125.7	345.1	84.5	19.7	0.7	0.7	31.2	0.1	91.6	92.5	0.2	41.0	0.4	2.4	189.7	11.9	0.8	0.1	223.8	2.3	14.1	31.0	213.0	0.5	8.1	7.5	8.9	1.5	3.2	2.2	44.5	10.7	10.8	10.2	18.5	11.7	10.9	20.4	12.7	14.1	14.0	13.8	11.2	435.0	76.9	123.5	0.0	145.6	366.3	805.9	763.8	244.7	10.1	100.6	131.4	266.2	223.1	250.2	51.5	29.2	538.2	20.5	657.0	15.6	420.1	8.4	218.6	319.3	359.3	101.3	41.6	0.9	172.5	116.7	149.2	100.9	113.0	12.6	47.2	459.7	100.4	50.0	1.7	0.4	488.9	152.5	19.4	105.2	8.0	5.0	88.8	40.9	2.8	8.8	11.6	32.0	0.0	0.0	227.0	769.2	0.7	103.5	256.5	1059.7	109.0	316.4	59.5	315.5	21.0	213.1	4.3	35.7	170.4	197.9	117.0	25.8	1.9	419.2	554.3
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 135.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Basal respiratory cells: 98.5;Fibroblasts: 123.1;monocytes: 116.3;Muller glia cells: 97.7;Peritubular cells: 62.8"	"Group enriched"	"Detected in many"	4	"glioma: 83.2;head and neck cancer: 40.2;testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 149.5;EFO-21: 356.4;HAP1: 253.3;HHSteC: 216.0;NTERA-2: 116.0;SuSa: 119.0;TIME: 242.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	61.5	3.3	8.9	55.9	9.3	0.0	20.9	13.7	8.1	43.1	23.5	16.6	3.8	25.9	11.3	15.8	33.4	42.1	20.3	8.0	14.6	3.4	0.6	32.4	9.8	24.9	15.6	29.4	6.4	1.1	3.3	135.6	19.1	14.0	10.6	22.7	9.1	14.1	30.0	20.0	15.9	34.5	16.4	0.3	24.7	4.5	22.5	10.3	6.2	11.3	18.5	96.1	25.2	21.2	0.1	0.0	149.5	0.1	0.5	0.0	0.1	2.4	0.1	0.0	0.0	0.0	0.1	0.2	356.4	9.0	0.1	0.7	253.3	44.7	0.0	1.0	46.1	0.1	0.0	0.0	216.0	0.0	0.2	29.5	82.9	18.6	21.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	116.0	0.0	0.6	0.3	0.2	0.1	0.0	4.0	0.1	0.1	0.2	0.0	0.3	119.0	0.1	0.6	242.2	41.8	34.6	0.6	0.1	0.1	0.3	1.0	88.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.9	9.3	13.7	8.1	8.0	14.6	24.9	15.6	19.1	16.4	22.5	21.2	2.4	105.8	11.2	3.9	0.2	14.5	30.4	98.5	14.8	1.4	0.5	19.9	8.4	2.8	18.8	0.0	4.2	2.0	0.1	0.0	0.0	0.5	0.7	1.6	37.6	22.4	0.0	0.0	2.6	0.0	2.1	123.1	0.0	2.8	1.3	3.4	6.4	0.0	6.5	0.0	3.5	0.0	8.2	0.0	14.0	1.8	20.2	5.3	7.2	5.6	116.3	97.7	0.0	19.6	0.2	0.4	0.0	62.8	0.0	15.8	0.0	0.0	5.4	3.4	0.0	17.0	8.4	1.0	8.2	3.9	7.0	2.9	1.3	0.9	0.0	3.4
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 44.6;Endothelial cells: 30.6;Hepatic stellate cells: 40.0;Leydig cells: 44.4;Peritubular cells: 35.7;Sertoli cells: 26.3;Smooth muscle cells: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 19.5;HBEC3-KT: 29.9;HHSteC: 21.6;HUVEC TERT2: 52.2;TIME: 85.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		62000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	19.0	5.0	2.5	2.3	3.0	2.3	12.9	1.2	4.1	12.3	2.0	4.5	1.6	10.0	1.1	2.6	9.1	7.4	8.7	1.2	1.7	4.8	2.1	11.8	3.8	2.0	2.3	9.1	2.3	1.7	3.4	11.7	2.3	4.7	0.9	0.4	2.9	3.7	5.7	4.2	4.1	4.6	1.1	7.0	3.7	3.0	2.9	1.4	9.7	7.6	1.1	6.0	7.3	1.4	0.5	2.9	0.8	0.0	0.0	3.7	0.1	11.7	19.5	4.8	2.8	0.3	0.5	0.0	0.6	8.7	0.4	0.2	0.0	29.9	1.3	0.2	0.0	14.8	0.7	0.8	21.6	0.1	0.0	11.3	0.1	6.5	1.5	1.0	52.2	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	11.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	6.9	0.0	0.0	85.2	0.1	6.4	2.6	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.5	3.0	1.2	4.1	1.2	1.7	2.0	2.3	2.3	1.1	2.9	1.4	44.6	0.0	3.2	0.0	0.4	0.9	0.1	0.7	1.2	2.4	0.6	1.3	7.5	1.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.2	0.2	2.5	30.6	1.8	5.7	0.0	0.4	0.1	10.1	1.5	0.4	1.3	0.1	40.0	0.4	0.5	0.0	0.0	2.3	0.0	1.6	1.5	3.5	44.4	3.0	5.4	12.2	0.4	0.2	0.0	0.0	0.0	1.2	0.0	35.7	0.0	0.2	0.0	0.1	0.2	0.2	26.3	1.7	34.2	1.5	1.5	0.2	1.1	0.3	0.3	1.1	0.3	0.2
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777297-17014414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 111.0;Gastric mucus-secreting cells: 40.8;Microglial cells: 48.7;Oligodendrocytes: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 3.7;MAIT T-cell: 2.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.7;T-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 116.4;HaCaT: 75.2;OE19: 58.6;RT4: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	10.3	1.7	10.0	5.5	11.9	0.6	13.3	9.6	7.0	11.2	26.5	18.3	27.3	4.1	3.8	46.0	9.1	7.3	24.0	7.5	14.3	26.4	16.7	8.0	2.3	11.5	17.9	12.7	15.2	17.6	4.2	9.0	11.8	7.0	16.9	27.4	21.5	5.3	2.2	14.1	25.4	3.6	7.3	1.8	23.7	10.1	21.2	4.0	10.9	2.2	6.6	14.0	18.3	10.3	14.2	12.7	11.9	5.5	0.7	0.0	20.7	0.1	0.4	4.9	9.0	22.6	116.4	0.2	5.4	1.9	0.7	75.2	16.9	0.2	3.5	4.2	16.2	39.7	11.2	13.5	0.3	0.1	0.5	0.6	6.4	0.0	0.4	10.7	0.0	14.3	1.7	0.4	2.0	8.7	8.8	0.3	6.1	58.6	12.4	11.5	0.0	3.0	10.9	109.9	8.3	0.9	16.7	44.3	0.6	22.3	11.3	4.1	3.3	0.2	4.1	3.2	2.8	7.6	2.4	16.2	0.1	0.8	0.1	0.1	0.1	3.7	0.3	0.0	2.0	0.1	0.3	0.2	0.1	0.0	0.1	0.2	0.3	0.1	0.0	0.4	0.0	0.2	10.0	11.9	9.6	7.0	7.5	14.3	11.5	17.9	11.8	7.3	21.2	10.3	8.2	3.2	17.0	111.0	0.6	0.6	1.1	1.4	0.6	2.3	6.9	6.1	8.7	7.2	8.6	11.0	25.0	6.7	0.2	12.0	3.9	6.1	16.3	20.5	2.3	4.7	0.0	1.3	19.3	6.0	0.9	1.0	40.8	22.9	2.5	16.1	2.2	2.9	1.8	0.0	26.2	6.5	0.0	1.0	1.4	6.1	0.6	2.7	0.0	48.7	0.8	4.3	1.0	15.6	37.9	10.7	4.1	0.4	1.8	0.8	9.2	10.6	8.0	9.7	0.0	1.0	1.2	0.5	0.5	12.3	0.4	6.0	1.2	2.1	3.1	6.4
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274449-95291308	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.7	0.3	1.1	1.5	1.3	0.3	10.3	1.0	2.1	16.6	0.2	11.4	10.5	1.9	27.9	88.1	5.5	27.0	1.1	0.9	0.6	32.4	0.8	1.7	0.1	1.4	0.7	1.1	10.2	25.5	1.5	4.5	1.2	24.7	9.8	0.4	35.2	27.7	0.7	60.0	4.8	0.8	0.3	0.6	26.3	0.6	1.4	2.0	11.9	0.2	7.9	25.7	37.9	2.1	79.5	0.1	0.2	0.8	0.3	0.1	38.5	0.1	0.2	0.3	0.4	0.8	135.9	0.0	0.0	0.1	0.1	73.2	0.0	42.4	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	78.4	0.1	0.4	1.9	0.0	0.1	0.0	0.1	0.0	62.1	0.4	0.5	0.1	3.7	0.5	0.2	0.0	0.1	0.2	83.8	0.6	0.2	0.0	117.7	0.1	0.9	37.2	0.1	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.0	2.1	0.9	0.6	1.4	0.7	1.2	0.3	1.4	2.1	0.4	3.2	4.2	1.3	0.1	6.6	25.2	27.6	14.2	0.4	29.1	14.9	1.7	37.1	39.9	33.1	4.2	19.0	0.1	8.0	11.7	15.6	0.5	2.7	0.6	0.9	3.6	0.0	0.6	11.0	3.5	0.6	25.5	5.5	0.0	0.7	0.0	0.0	2.4	0.0	1.2	10.4	12.2	0.0	0.8	1.4	0.3	0.2	7.2	0.0	0.6	0.1	0.0	1.5	3.2	17.5	12.4	0.7	0.0	14.1	0.7	0.1	12.3	1.1	0.0	0.4	2.2	0.6	0.1	37.2	12.8	11.2	0.2	0.8	17.4	37.5
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase receptor type B"	P23467	12	70515870-70637440	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 215.9;Endothelial cells: 211.5;Hepatic stellate cells: 504.0;Microglial cells: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.3;hTERT-RPE1: 19.7;HUVEC TERT2: 61.4;TIME: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		14000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	26.7	9.4	16.0	4.7	14.1	0.1	18.8	12.3	12.1	12.8	7.1	10.9	7.5	12.3	4.4	6.8	10.8	14.7	23.2	10.1	12.4	22.5	16.7	35.7	3.2	15.9	14.2	4.0	6.2	7.8	4.7	32.6	18.1	6.3	11.1	1.4	3.3	8.0	17.1	4.1	9.3	18.1	12.4	30.0	6.2	2.5	19.0	3.0	14.8	38.8	3.4	7.7	5.3	11.9	4.4	0.3	1.9	0.2	0.0	0.1	0.9	0.9	4.2	2.2	5.2	0.1	3.4	1.7	24.3	0.6	0.4	15.2	0.2	0.7	7.8	1.3	0.7	0.4	1.7	1.1	0.2	0.7	0.0	0.1	0.7	6.1	0.0	19.7	61.4	0.0	3.6	1.0	1.3	0.0	0.1	0.0	2.3	4.4	0.9	0.1	1.6	0.9	11.3	1.8	0.0	0.8	1.6	0.0	3.5	0.4	0.0	1.5	90.3	0.9	0.9	0.4	5.4	1.1	0.9	0.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	16.0	14.1	12.3	12.1	10.1	12.4	15.9	14.2	18.1	12.4	19.0	11.9	215.9	0.0	13.2	2.0	3.1	3.7	0.8	1.0	0.0	7.1	0.9	0.9	12.3	11.5	1.3	3.7	0.0	0.0	2.0	12.8	0.0	1.5	4.6	2.2	0.7	211.5	0.0	16.0	52.5	0.9	0.0	7.3	1.5	4.0	25.2	0.5	504.0	4.7	0.4	5.0	68.8	6.4	0.0	20.0	4.6	3.0	1.2	1.2	5.4	164.9	0.0	0.4	0.0	2.5	2.9	12.2	11.1	0.0	0.1	0.8	3.2	0.1	0.2	0.9	0.0	6.4	5.2	0.7	0.7	0.9	1.6	0.0	1.0	1.8	6.8	0.7
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase receptor type R"	Q15256	12	70638073-70920738	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.4;endometrium 1: 5.5;intestine: 7.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 199.5;Inhibitory neurons: 160.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 3.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 5.7;cerebellum: 14.4;cerebral cortex: 6.5;hippocampal formation: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 20.0;RT4: 37.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 89.6"					"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.0	2.2	3.7	1.0	5.7	0.0	0.0	14.4	6.5	0.3	0.0	7.4	3.2	5.5	0.0	0.0	0.1	1.0	0.0	7.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.2	0.1	0.0	5.0	2.5	0.0	1.1	0.0	0.0	7.6	2.9	1.5	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	37.4	0.1	5.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.7	14.4	6.5	7.2	0.5	0.2	0.0	0.1	1.5	0.0	1.5	1.7	0.0	0.0	3.9	0.2	0.5	0.1	0.5	0.0	16.5	0.2	0.1	3.5	0.0	3.4	0.0	0.0	0.0	0.7	43.2	0.0	2.6	1.7	2.2	1.3	4.0	0.0	0.0	199.5	0.2	0.3	0.3	10.2	14.6	0.0	0.0	0.7	0.0	0.0	16.8	160.7	1.8	0.0	0.0	0.3	0.4	0.0	0.2	0.0	3.7	0.0	0.2	1.0	2.0	4.0	2.8	23.0	0.0	0.0	0.4	17.3	0.0	0.1	0.8	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.8	0.4	0.0	0.7	0.4
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 2129.3"	"Group enriched"	"Detected in some"	7	"Distal tubular cells: 641.8;Horizontal cells: 1527.7"	"Cancer enriched"	"Detected in many"	4	"renal cancer: 59.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Cell line enriched"	"Detected in some"	291	"RPMI-8226: 1561.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 2120.1"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.4	1.0	82.5	0.7	40.2	0.1	15.0	255.6	86.5	0.1	8.6	0.3	0.2	1.4	0.8	0.1	0.1	0.3	0.2	9.3	100.5	82.1	5.7	2.2	2.4	127.4	85.7	0.5	0.2	2129.3	1.2	2.4	105.7	0.3	0.3	373.5	2.7	0.7	13.6	0.1	0.3	0.5	50.9	3.2	0.8	1.5	275.5	0.3	5.0	0.4	3.1	3.8	0.2	51.8	0.0	0.0	3.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.1	0.4	1561.0	0.0	5.3	2.3	0.0	0.0	1.2	0.0	0.1	0.3	0.0	0.0	0.0	1.2	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	4.6	0.0	0.0	0.9	0.3	15.1	82.5	40.2	255.6	86.5	9.3	100.5	127.4	85.7	105.7	50.9	275.5	51.8	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	0.0	51.3	2.4	2.0	0.6	0.0	0.0	38.6	10.4	0.3	0.0	0.0	641.8	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	11.4	0.2	30.0	0.2	53.8	1527.7	29.7	0.0	0.0	2.9	0.0	0.1	0.6	15.7	0.0	2.8	0.1	37.4	0.0	3.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	150.5	0.0	1.0	0.0	0.0	3.6	0.0	0.0	0.4	0.9	0.0	0.0	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 59.8;salivary gland: 28.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 36.8;Excitatory neurons: 14.0;Gastric mucus-secreting cells: 57.1;Oligodendrocytes: 46.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.3;EFO-21: 19.3;REH: 22.3;RPMI-8226: 50.0;RPTEC TERT1: 19.0;U-698: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.0	15.4	10.9	1.2	13.8	0.5	1.0	0.5	19.1	3.5	1.1	1.7	0.4	0.1	0.1	22.6	1.6	0.3	0.0	23.6	4.0	17.2	0.1	0.2	1.1	1.7	4.3	0.0	1.1	59.8	5.0	0.2	1.8	0.2	1.1	0.5	28.5	3.9	0.0	11.4	0.5	0.0	0.6	0.2	10.6	0.7	7.7	0.2	10.1	0.0	2.7	0.2	5.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	3.9	15.3	19.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	4.3	0.0	0.0	0.6	5.5	0.0	22.3	0.0	50.0	19.0	0.0	0.5	0.0	0.0	7.2	0.0	0.1	2.9	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	42.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	13.8	0.5	19.1	23.6	4.0	1.7	4.3	1.8	0.6	7.7	12.1	0.0	0.0	0.0	1.3	0.8	0.5	0.0	0.4	0.0	0.5	2.4	2.0	4.3	2.8	1.0	36.8	0.0	1.1	0.0	1.9	0.0	1.4	0.1	1.8	0.6	0.3	1.2	0.0	14.0	0.0	0.2	0.3	57.1	4.6	2.5	0.0	0.0	0.0	0.4	0.0	1.0	4.8	0.0	0.0	5.5	0.2	0.0	1.2	1.8	0.0	1.0	2.7	0.0	0.0	46.5	5.2	3.3	0.0	0.6	0.0	0.1	5.2	0.5	0.0	0.0	0.0	0.2	0.1	0.7	4.6	1.1	1.2	0.4	0.1	3.3	0.6
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42508344-42519796	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	14.0	16.5	15.8	9.8	18.0	12.3	15.4	14.3	17.0	13.9	11.6	13.9	6.2	13.7	28.2	18.7	13.9	4.7	15.6	16.4	14.1	22.3	18.4	13.0	14.2	15.0	15.3	17.3	14.5	11.1	11.2	6.6	15.5	22.3	6.1	5.2	15.6	7.5	13.8	15.7	13.8	6.4	13.1	18.4	15.0	12.8	14.6	10.3	13.6	5.2	10.2	14.8	14.0	15.7	23.9	34.6	21.1	24.7	13.7	8.8	35.9	21.0	13.7	27.0	22.8	47.4	14.3	41.4	10.6	15.5	13.4	29.3	25.4	28.1	11.1	11.2	50.3	21.8	26.4	23.6	11.2	57.1	19.4	12.1	16.4	35.6	17.7	10.5	15.6	21.6	30.7	12.1	15.9	51.5	54.8	23.0	17.9	20.5	25.5	88.9	19.9	17.6	13.7	31.5	9.8	8.4	14.8	50.5	20.7	8.9	18.2	23.9	12.4	22.9	25.1	16.4	21.1	18.5	16.0	48.8	18.2	20.3	31.2	16.1	28.0	22.4	21.2	33.2	20.4	26.1	18.4	19.7	21.8	32.5	20.0	18.8	5.7	20.4	37.2	37.6	17.1	26.2	15.8	18.0	14.3	17.0	16.4	14.1	15.0	15.3	15.5	13.1	14.6	15.7	32.2	22.4	36.6	5.9	48.6	43.8	95.1	41.4	12.5	26.6	28.6	28.3	16.0	31.5	37.2	22.0	16.7	93.0	50.3	48.4	17.6	71.3	55.8	24.2	25.4	38.6	26.4	64.6	7.5	27.2	133.8	31.0	34.7	28.8	47.5	46.3	37.5	32.6	94.8	26.9	6.8	39.8	28.5	43.3	47.4	118.3	22.1	39.5	33.8	6.5	116.5	24.8	68.0	1.0	7.9	52.1	46.0	18.4	51.4	94.3	38.5	42.1	34.4	28.5	6.6	30.2	37.0	33.5	24.7	27.3	37.8	120.4	40.2	45.2	59.4	106.3
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361023	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32194.3;esophagus: 30581.7;vagina: 14027.7"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5771.3;Kupffer cells: 7537.0;Macrophages: 3678.1;monocytes: 11103.1;Squamous epithelial cells: 3263.1"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 24579.6;neutrophil: 33654.0"	"Group enriched"	"Detected in all"	6	"granulocytes: 33654.0;monocytes: 24579.6"	"Cell line enriched"	"Detected in many"	6	"SK-BR-3: 2398.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	706.4	126.1	19.7	1505.7	24.3	32194.3	189.8	21.4	67.8	7849.1	28.5	123.9	24.1	50.0	2.0	30581.7	486.1	147.4	208.5	19.4	21.9	171.7	284.0	1629.4	69.3	28.7	24.2	51.5	73.9	11.5	65.4	370.1	30.0	91.3	20.2	3.6	5790.0	9.6	92.2	416.7	120.6	480.7	22.0	5381.4	187.6	16.7	26.5	197.7	90.4	150.4	4378.8	955.1	14027.7	25.4	24.6	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.0	9.2	372.2	0.0	0.4	23.0	0.0	157.3	0.0	0.4	0.0	6.2	0.0	0.1	0.0	7.8	0.0	0.0	130.2	0.0	8.4	0.0	0.0	0.1	7.6	3.5	0.0	31.4	0.8	3.3	0.1	3.1	0.2	0.8	5.1	82.2	0.3	100.4	1.3	0.6	4.0	2398.2	1.7	1.2	38.1	312.3	6.8	0.0	3.3	0.4	0.4	0.7	1.6	3.3	0.5	71.7	0.0	373.8	24579.6	2626.3	30.5	1754.8	52.6	29.7	25.3	17.2	4664.8	24.8	17.7	15.4	33654.0	18.8	860.2	153.3	29.2	24461.7	19.7	24.3	21.4	67.8	19.4	21.9	28.7	24.2	30.0	22.0	26.5	25.4	1.8	230.8	392.4	0.0	92.1	20.0	123.1	5771.3	28.5	0.0	55.6	6.7	8.0	57.2	1685.0	36.8	0.0	126.1	115.1	7.7	5.9	102.6	1.7	1.2	1.9	26.9	0.0	92.8	0.0	39.4	52.9	50.9	3.6	9.4	164.0	0.2	70.6	54.5	1926.0	0.0	0.0	3.7	309.3	7537.0	13.4	4.0	5.9	3678.1	0.0	0.0	11103.1	0.0	483.0	0.0	0.0	15.3	1.4	0.0	13.1	55.6	0.8	25.2	262.8	0.3	0.0	13.3	60.4	0.3	1.2	3263.1	33.2	1236.0	79.9	0.0	12.5	551.3
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360611-78480739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Uncertain	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	17.9	22.4	18.4	12.7	20.5	8.5	28.2	24.5	29.1	23.9	23.9	19.6	16.0	25.0	23.2	24.7	29.6	20.2	24.7	20.4	22.4	28.6	17.8	17.8	12.1	18.4	21.5	22.8	25.2	47.1	15.7	23.4	21.4	34.3	22.3	40.2	31.5	29.8	10.6	17.7	15.6	26.6	20.0	13.6	27.9	14.1	23.3	14.6	39.8	16.3	13.4	25.0	11.4	19.0	32.7	23.9	23.4	76.1	35.5	45.5	40.8	30.0	46.1	26.5	56.1	9.3	61.1	48.1	31.4	45.5	65.7	26.2	34.9	57.0	45.9	17.4	32.5	20.5	17.8	20.1	22.7	13.6	16.5	28.6	54.5	27.3	41.2	62.5	41.3	25.0	8.4	33.6	50.9	39.2	25.2	26.7	19.9	14.3	26.0	29.5	38.3	55.3	43.5	38.6	70.9	40.6	27.6	38.5	26.7	24.9	52.5	26.1	36.6	26.3	19.3	30.0	24.2	20.9	29.4	27.6	50.1	50.4	22.6	20.3	11.4	13.2	7.5	12.7	9.3	7.6	8.7	9.2	14.8	6.5	7.1	6.3	6.8	10.3	16.6	4.5	9.1	8.0	18.4	20.5	24.5	29.1	20.4	22.4	18.4	21.5	21.4	20.0	23.3	19.0	59.5	25.6	22.4	45.7	20.3	39.1	31.5	33.6	38.7	72.1	33.4	22.7	36.1	21.5	30.4	40.5	70.9	13.8	21.7	19.1	13.7	24.2	42.2	34.9	30.2	31.4	35.4	12.0	80.0	30.5	24.8	34.3	36.7	34.1	12.0	41.7	27.1	15.7	19.2	32.0	100.1	34.2	20.3	33.7	33.1	15.3	20.2	25.1	30.2	45.0	19.1	47.4	19.6	76.4	60.3	29.8	14.9	28.6	23.9	44.6	14.2	24.7	65.4	68.2	13.1	33.5	25.4	25.6	23.1	30.8	45.3	10.5	21.2	30.8	18.8	33.7
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 35.0"	"Group enriched"	"Detected in many"	8	"Excitatory neurons: 336.7;Inhibitory neurons: 280.1;Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 35.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.7;ASC TERT1: 13.5;WM-115: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	0.2	1.0	5.6	0.4	8.9	0.7	0.5	2.5	35.0	0.4	0.0	0.7	0.2	0.4	0.7	0.1	0.2	0.9	0.1	11.4	0.2	0.9	2.6	0.1	0.4	4.2	0.0	0.5	1.6	0.5	6.7	0.1	3.8	0.6	0.9	7.9	0.6	0.2	0.3	0.3	0.2	0.1	0.0	0.6	1.0	1.7	2.4	0.5	0.5	0.1	0.2	0.2	0.2	11.5	1.7	1.3	13.7	0.2	1.8	13.5	0.3	8.0	12.5	9.1	8.5	2.8	1.6	0.4	1.9	9.9	4.4	0.1	2.3	0.0	10.5	1.6	0.8	0.1	0.3	0.3	0.1	0.2	1.1	1.8	0.0	6.5	1.4	3.4	9.8	3.5	0.2	0.2	5.5	1.0	2.5	0.2	4.9	0.9	4.8	0.1	0.7	0.0	0.0	0.5	5.6	2.2	4.5	2.1	0.3	2.1	0.4	0.2	2.8	8.9	6.3	3.3	5.2	0.2	0.1	0.0	1.8	1.9	13.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	5.6	8.9	2.5	35.0	11.4	0.2	4.2	0.0	3.8	0.0	2.4	11.5	1.2	0.0	0.0	27.1	0.0	0.0	0.5	0.0	3.4	16.7	2.6	1.8	1.4	1.5	0.0	0.0	10.4	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.7	1.3	11.4	0.0	336.7	0.5	0.0	0.1	3.1	0.0	0.0	0.7	1.1	4.3	0.0	5.0	280.1	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	20.6	0.0	4.7	0.0	104.5	14.2	0.7	0.5	0.7	0.0	0.4	0.0	0.7	0.0	11.2	0.0	0.4	0.3	3.8	10.2	0.1	0.0	0.0	0.3	0.0	0.9	0.3
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"	Q9NPR2	15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 124.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 16.9;naive B-cell: 14.9;neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 182.4;RPTEC TERT1: 111.1;RT4: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA		61000000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	11.9	37.6	20.3	18.0	21.9	9.8	22.5	18.8	21.6	35.1	12.8	50.2	30.2	17.1	8.2	124.4	22.6	17.1	24.9	17.3	21.0	47.7	43.2	20.5	12.0	23.5	24.0	21.6	38.5	18.1	18.6	18.3	21.4	31.4	12.1	27.1	41.2	17.6	7.8	50.9	34.7	13.3	21.0	30.3	32.2	10.7	22.9	13.2	34.2	7.9	13.0	42.2	59.8	26.8	21.2	56.3	4.2	13.2	3.8	2.6	30.4	6.4	13.9	7.8	8.3	7.0	182.4	14.9	69.2	4.7	45.0	97.8	3.7	91.2	6.4	85.4	11.7	19.7	13.5	9.4	15.1	2.6	8.7	10.8	39.1	8.5	17.5	32.5	8.8	4.4	9.6	23.0	4.3	15.6	5.4	8.4	18.7	46.8	51.1	6.4	3.1	33.1	111.1	124.0	13.3	13.5	22.3	35.4	8.5	9.3	24.7	6.0	20.0	6.3	11.4	13.1	14.5	33.0	43.2	7.5	58.8	16.1	6.3	0.0	2.4	0.3	0.9	1.4	0.6	16.9	0.5	0.5	1.2	14.9	0.5	0.6	5.1	0.4	2.8	0.2	0.2	1.5	20.3	21.9	18.8	21.6	17.3	21.0	23.5	24.0	21.4	21.0	22.9	26.8	1.8	16.0	22.5	67.3	29.2	65.0	40.0	51.4	23.9	5.7	29.1	18.9	7.8	8.6	44.6	16.5	25.0	13.9	2.4	47.8	3.9	27.3	0.9	15.6	19.6	4.4	4.2	4.0	23.5	35.5	74.5	6.4	34.1	28.3	0.0	8.6	4.6	16.8	13.3	16.8	28.2	17.5	18.3	6.9	7.5	1.2	13.1	5.5	5.4	2.8	5.3	25.1	1.0	8.0	8.3	44.7	26.1	12.0	8.0	46.9	19.6	4.5	22.6	48.3	19.7	5.7	15.3	0.7	3.2	65.3	57.1	12.4	4.3	5.2	20.2	52.0
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786429-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 20.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 26.4;Cone photoreceptor cells: 47.9;Microglial cells: 24.4;Peritubular cells: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 19.2;SK-MEL-30: 18.2;SuSa: 18.6;WM-115: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	0.7	1.8	4.3	0.4	6.0	0.0	1.0	3.6	10.1	2.4	5.4	1.5	0.7	1.5	2.7	5.0	1.6	3.1	0.7	5.9	4.0	3.7	4.0	4.1	0.3	4.8	5.0	6.9	3.7	2.4	4.4	7.6	4.3	5.3	1.3	20.8	3.2	2.6	0.1	4.1	0.5	0.8	4.3	0.7	1.5	3.4	4.7	3.6	1.4	0.1	1.3	2.4	3.1	5.2	6.2	0.7	11.0	1.5	0.6	1.7	6.2	0.6	2.0	2.4	3.8	7.5	0.1	0.0	2.0	1.6	0.4	4.8	5.7	15.9	2.8	0.0	4.3	0.0	0.0	1.2	3.5	0.0	7.4	0.3	10.9	18.0	0.7	3.9	13.7	0.0	0.0	0.0	3.9	6.5	0.0	0.1	9.7	0.0	0.0	0.0	12.1	0.0	10.2	19.2	1.6	0.9	0.5	0.1	18.2	18.6	6.5	0.4	6.4	17.3	2.2	0.1	0.6	0.0	0.0	0.0	11.4	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.3	6.0	3.6	10.1	5.9	4.0	4.8	5.0	4.3	4.3	4.7	5.2	1.1	0.0	1.5	26.4	0.0	1.9	3.3	2.8	10.8	9.5	3.4	1.7	4.1	4.3	3.1	3.7	47.9	8.9	0.0	2.0	3.9	3.0	0.5	4.8	2.5	7.2	1.2	2.7	9.5	0.0	1.3	1.5	3.1	5.9	0.0	5.4	10.0	5.7	0.7	1.7	9.5	0.3	4.1	0.8	0.0	1.0	3.7	0.2	0.0	24.4	0.0	2.4	0.0	9.5	4.6	1.6	0.1	83.1	0.0	5.4	0.1	1.0	2.8	18.0	0.0	0.6	1.8	0.1	1.1	10.8	2.0	2.1	0.5	5.5	0.9	5.3
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	7.6	9.1	6.0	4.7	6.6	2.9	7.4	6.1	9.5	7.3	8.9	4.8	3.1	5.1	13.2	3.3	5.6	9.9	3.7	6.9	6.5	12.0	6.3	8.6	7.8	5.4	6.0	5.8	3.4	21.3	7.2	9.6	6.0	5.1	6.6	7.5	5.9	3.9	2.1	2.9	3.5	5.3	5.0	6.6	3.8	5.0	7.4	5.0	6.3	3.0	4.8	7.0	5.0	6.7	16.2	21.5	6.8	12.3	68.7	25.3	4.9	11.6	34.5	10.7	10.2	5.4	41.0	4.0	19.2	10.6	22.5	13.5	6.8	11.9	9.8	6.0	3.2	6.7	8.6	14.2	22.7	3.7	12.1	19.9	4.9	10.5	12.2	43.2	14.3	6.8	9.3	8.4	37.5	9.2	6.6	8.4	4.0	9.5	14.3	1.6	20.1	11.9	30.7	8.5	3.3	3.0	9.9	7.0	19.1	9.3	10.4	5.8	15.6	16.4	7.1	20.0	6.5	1.6	4.9	1.6	34.0	3.0	13.1	0.0	6.6	0.1	1.7	7.1	2.2	2.2	3.1	2.4	3.6	2.0	2.7	3.4	0.2	0.8	4.5	4.4	4.5	2.8	6.0	6.6	6.1	9.5	6.9	6.5	5.4	6.0	6.0	5.0	7.4	6.7	6.8	22.4	6.7	31.6	6.0	5.2	11.4	14.6	8.0	19.7	7.2	7.5	4.3	7.2	10.0	5.5	22.9	5.6	4.9	2.6	1.9	5.3	178.2	13.0	11.0	7.2	4.2	3.4	98.8	2.8	9.4	11.2	5.1	6.2	6.3	7.3	4.2	4.6	100.3	5.0	77.4	3.1	6.1	24.8	10.0	124.4	10.8	26.2	5.4	20.6	6.4	11.7	2.1	54.3	30.8	7.4	1.9	6.0	5.8	6.6	3.3	23.1	40.4	24.9	0.0	12.3	9.1	16.6	11.5	6.4	2.8	6.7	7.8	5.0	2.8	6.9
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	3.0	0.0	0.1	0.0	10.3	0.7	1.0	2.6	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.3	0.3	0.0	0.2	0.0	20.2	21.2	0.2	0.1	0.0	0.0	0.0	32.9	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	2.8	0.0	0.5	0.1	1.6	0.0	1.2	0.1	0.0	1.3	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	10.3	0.2	5.3	20.2	21.2	32.9	2.8	1.6	7.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611606	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	1.8	2.1	2.1	2.9	1.9	3.0	1.6	7.1	2.7	2.1	0.4	2.3	2.2	2.1	1.3	2.4	2.0	1.1	1.9	2.3	2.1	1.9	1.9	2.1	4.1	2.3	2.0	1.6	1.7	1.1	3.9	1.1	1.8	2.3	0.9	1.7	1.6	1.0	2.7	1.8	2.8	1.2	1.1	3.4	2.2	10.6	1.9	2.7	1.8	1.3	2.9	2.1	2.0	2.1	2.7	8.4	5.3	6.7	2.0	2.1	5.6	4.3	2.2	4.9	5.4	4.2	3.3	10.0	4.2	2.2	3.8	6.0	3.6	3.0	2.9	8.4	4.6	6.8	6.5	2.7	1.8	6.7	9.3	1.5	2.2	4.6	2.6	1.2	3.6	5.6	6.7	5.3	3.9	4.7	4.2	5.9	4.5	1.7	3.1	8.2	8.9	2.8	1.9	1.9	4.5	4.1	3.8	2.6	1.3	2.8	6.5	5.2	4.3	5.6	7.8	4.9	5.1	4.8	4.0	11.4	1.8	6.7	5.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	2.1	1.9	7.1	2.7	2.3	2.1	2.3	2.0	1.8	1.1	1.9	2.1	2.7	0.0	2.3	4.6	4.5	0.8	0.8	1.1	4.0	8.7	2.0	1.4	1.7	1.5	3.2	0.0	2.1	1.7	3.4	2.0	0.0	1.5	6.5	5.5	4.2	1.8	0.0	6.5	9.5	2.4	1.6	2.4	3.6	4.6	0.0	4.8	1.1	1.4	2.9	0.0	9.3	2.4	2.0	2.9	1.6	2.3	2.1	5.1	0.0	4.7	2.2	2.7	4.1	7.1	5.5	2.0	0.3	1.9	4.0	0.4	2.3	0.6	2.3	10.1	0.0	4.9	2.5	20.0	9.1	2.3	0.6	1.0	4.4	3.0	2.1	0.6
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270415	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 139.8;placenta: 102.1"	"Group enriched"	"Detected in many"	7	"Cytotrophoblasts: 1219.9;Syncytiotrophoblasts: 842.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 131.2;OE19: 163.9"	"Low region specificity"	"Detected in all"							HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	14.0	17.2	2.7	9.9	2.7	3.5	16.1	5.2	3.2	33.8	3.4	57.5	17.6	6.5	20.7	139.8	8.3	16.2	10.3	3.0	2.5	43.0	10.2	17.7	6.0	2.8	2.9	11.4	16.5	11.1	4.3	102.1	2.8	10.5	59.3	1.0	24.1	8.6	3.4	34.8	19.6	8.5	2.6	13.7	35.9	8.1	3.3	1.5	8.7	6.8	27.6	17.5	67.9	3.0	81.6	24.2	2.9	2.7	10.5	40.9	131.2	61.1	60.9	30.6	18.7	48.9	83.2	1.0	10.5	37.9	11.6	28.3	17.1	23.5	42.6	4.1	14.2	10.9	3.3	16.5	28.8	2.7	10.1	26.7	17.8	66.3	59.4	69.4	74.6	20.6	8.7	4.7	49.9	71.4	13.4	9.8	12.3	163.9	93.9	0.8	0.8	3.1	44.0	18.5	3.3	4.1	13.4	53.2	10.2	31.3	45.0	4.2	26.1	33.9	32.7	1.7	37.8	1.7	2.4	1.6	49.8	26.3	18.7	4.6	6.6	12.0	15.4	4.6	10.0	36.9	6.8	11.1	4.7	38.1	6.3	11.0	16.0	19.8	5.4	2.9	5.3	6.8	2.7	2.7	5.2	3.2	3.0	2.5	2.8	2.9	2.8	2.6	3.3	3.0	44.1	0.0	25.7	0.3	26.3	21.7	74.3	35.5	12.0	1.3	23.4	25.8	1.7	55.8	44.7	16.5	0.0	1219.9	21.7	85.0	49.0	43.6	11.7	4.8	2.3	60.9	20.4	8.6	0.6	108.7	108.0	11.4	47.9	8.7	12.7	19.7	51.4	6.7	96.8	1.7	0.5	121.5	26.4	6.3	11.2	3.2	13.1	6.1	14.2	6.5	7.9	4.1	38.1	0.0	0.5	142.5	88.1	9.8	5.7	73.7	35.0	22.6	17.4	1.7	26.3	4.8	11.1	6.2	31.3	80.7	29.7	842.5	13.8	9.8	121.7	105.2
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440724-109443919	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.4;Late spermatids: 359.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.9	8.8	7.6	8.6	7.4	12.7	10.5	9.6	7.8	12.6	15.1	12.7	13.5	7.1	15.5	24.5	21.4	8.7	6.7	7.7	6.9	12.2	7.6	9.7	13.3	7.6	7.9	8.2	17.7	22.1	11.1	6.0	7.2	13.2	12.6	6.5	15.6	5.8	4.1	21.7	12.3	4.9	7.6	13.3	14.2	53.0	7.0	10.3	13.3	1.7	17.1	10.4	14.3	8.8	13.1	14.8	7.7	12.2	13.2	7.1	25.5	4.3	15.7	10.5	9.8	14.0	10.3	7.1	9.0	9.3	22.1	16.4	7.8	18.7	6.3	9.1	20.5	8.2	15.9	8.7	11.0	9.1	9.4	7.7	21.3	9.3	18.4	11.8	9.8	12.4	16.3	12.2	5.3	18.7	14.8	19.7	2.1	17.3	7.5	10.4	3.6	7.7	19.3	21.8	10.1	8.4	8.2	24.9	19.3	6.2	7.9	17.2	6.3	4.7	6.8	3.8	16.3	8.3	2.3	4.6	9.1	8.6	8.5	6.2	9.0	10.8	6.9	8.6	7.8	14.4	7.8	8.2	11.2	20.4	5.6	5.9	2.5	7.3	7.8	14.3	8.2	6.0	7.6	7.4	9.6	7.8	7.7	6.9	7.6	7.9	7.2	7.6	7.0	8.8	3.9	12.8	7.2	1.6	15.9	9.8	12.9	13.8	8.6	1.3	8.9	6.7	2.1	7.2	11.8	12.9	4.2	10.3	9.1	26.1	1.9	19.2	179.4	28.4	4.0	4.4	8.4	4.2	1.4	19.8	18.5	6.1	25.0	4.3	0.0	3.5	3.6	3.6	9.5	0.0	0.5	27.1	14.2	4.1	11.2	359.7	9.3	7.2	8.8	2.8	9.9	3.7	6.2	0.0	1.7	15.4	27.7	9.1	9.8	15.0	37.5	9.3	67.1	4.9	13.1	3.1	5.8	69.9	10.9	13.8	18.6	17.0	7.6	8.7	17.8	16.9
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"heart muscle: 262.3;skeletal muscle: 279.2;tongue: 87.2"	"Cell type enriched"	"Detected in some"	52	"Cardiomyocytes: 665.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 4.1;HSkMC: 3.2;RH-30: 3.0;SK-BR-3: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	0.1	0.5	0.7	0.1	0.7	0.3	3.6	0.8	0.9	0.4	0.1	0.0	0.1	0.1	0.1	11.8	0.1	0.1	262.3	0.7	0.5	0.1	0.1	1.2	0.2	0.7	0.6	0.2	0.4	0.0	0.1	0.6	0.5	3.1	0.0	0.4	4.8	0.0	279.2	0.3	0.0	0.0	0.5	0.2	0.1	0.3	0.6	0.1	0.2	87.2	0.2	0.0	1.1	0.7	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.6	0.1	0.0	4.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.3	0.1	0.0	3.2	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.7	0.7	0.8	0.9	0.7	0.5	0.7	0.6	0.5	0.5	0.6	0.7	0.5	3.2	0.0	0.3	0.9	1.5	1.4	0.0	2.2	1.9	1.0	0.8	665.1	0.0	0.7	0.0	2.1	0.2	0.5	0.0	0.0	0.0	2.6	0.1	0.4	5.0	0.0	0.0	0.3	0.0	0.2	12.6	0.0	0.3	1.3	0.3	0.0	0.4	0.2	0.0	0.9	0.0	0.0	0.6	2.1	1.1	0.9	0.8	1.8	1.0	0.3	0.4	0.0	1.5	1.1	0.0	0.0	0.4	0.3	0.9	0.0	0.2	0.7	1.2	0.0	12.0	5.2	0.8	1.3	0.4	0.4	0.0	0.7	0.2	0.0	1.0
TCAF1	"FAM115A, KIAA0738"	ENSG00000198420	"TRPM8 channel associated factor 1"	Q9Y4C2	7	143851375-143902198	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011732	Approved		Approved	"Nuclear bodies,Vesicles,Cell Junctions"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Cell Junctions"	"Nuclear bodies, Vesicles"	"HPA011732: AB_2668526"	"unprognostic (1.57e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.00e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (5.93e-4)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.95e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-1)"	29.0	46.5	22.7	12.9	51.4	4.7	21.7	15.1	30.3	27.5	2.7	18.8	12.2	32.2	15.2	15.1	22.2	19.3	23.7	29.4	42.7	14.8	29.3	19.0	8.4	15.4	13.4	39.9	19.4	35.1	27.2	81.1	19.8	36.2	20.3	28.0	15.8	19.8	17.5	16.9	15.8	30.6	11.5	11.7	21.7	9.4	31.0	17.1	26.8	55.7	9.0	14.8	13.4	20.1	47.2	29.0	90.1	93.7	57.9	55.7	55.1	54.3	64.9	42.4	56.3	60.5	33.0	0.2	25.2	63.3	54.5	29.7	34.8	35.7	46.5	25.7	26.0	25.7	15.7	54.0	39.7	0.3	16.2	58.2	31.5	50.0	18.4	66.8	53.4	32.2	43.2	4.5	83.2	70.7	42.3	15.9	27.6	52.0	17.4	26.0	60.7	6.2	33.7	37.5	25.6	153.1	55.5	34.2	25.7	63.7	51.5	4.0	48.8	44.6	28.5	42.2	32.7	14.0	19.2	0.4	81.9	7.6	62.3	0.4	1.5	0.9	4.7	1.8	3.3	1.6	2.8	3.1	2.9	1.6	2.4	3.0	0.4	4.4	3.1	1.4	2.3	2.5	22.7	51.4	15.1	30.3	29.4	42.7	15.4	13.4	19.8	11.5	31.0	20.1	36.3	44.8	37.1	30.3	7.3	0.0	15.0	0.0	16.5	47.7	29.4	38.6	43.0	31.5	14.9	3.7	25.0	251.7	15.2	18.7	0.0	30.9	2.4	27.6	62.7	35.1	19.4	22.1	71.2	35.6	43.7	54.6	20.9	40.5	7.6	167.5	34.6	83.6	32.9	30.3	63.1	29.3	0.0	10.5	0.0	3.5	53.1	12.2	0.0	29.0	10.8	27.5	20.6	57.3	43.7	49.9	15.4	56.4	8.4	27.3	20.1	8.9	8.0	26.7	13.1	72.1	53.3	13.3	11.7	14.1	0.0	521.5	10.4	377.5	23.5	24.3
TERB1	"CCDC79, FLJ35894"	ENSG00000249961	"Telomere repeat binding bouquet formation protein 1"	Q8NA31	16	66754640-66801620	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA079436			Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	"Cell Junctions, Cytosol"	"HPA079436: "	"unprognostic (2.15e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.91e-2)"	"unprognostic (9.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.57e-5)"	"unprognostic (6.49e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.81e-6)"	"unprognostic (1.66e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.14e-3)"	0.1	0.3	0.7	0.2	0.4	1.5	0.0	1.6	1.0	0.0	1.5	0.1	0.4	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.2	0.3	1.3	0.4	0.1	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.4	0.3	0.0	0.1	0.7	0.1	0.0	0.1	0.2	0.0	12.6	0.8	0.0	0.4	0.0	0.1	0.0	0.0	1.6	0.2	0.6	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.4	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.6	0.1	0.7	0.4	0.0	0.0	0.4	0.1	0.3	0.1	0.0	0.0	0.1	0.2	0.1	0.4	0.0	0.4	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.6	0.3	0.3	0.1	0.2	0.1	0.4	0.0	0.2	0.0	0.4	0.2	0.5	0.2	0.3	0.2	0.6	0.3	0.3	0.1	1.9	0.2	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.4	0.1	0.2	0.8	0.4	0.1	1.1	0.1	0.3	0.7	0.4	1.6	1.0	0.4	0.6	1.3	0.4	0.9	0.1	0.8	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69274615	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 212.4;Rod photoreceptor cells: 267.6;Urothelial cells: 244.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 237.5"	"Low region specificity"	"Detected in all"							"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		580000	"Cluster 35: T-regs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	44.4	14.9	35.1	11.6	45.3	12.0	30.2	44.5	42.6	16.9	25.7	39.0	54.4	19.8	13.1	45.8	23.8	24.4	35.8	38.0	45.4	44.7	64.8	47.6	9.7	52.6	39.9	37.0	21.9	57.9	5.3	18.4	52.6	24.8	35.1	122.0	37.1	21.9	14.1	35.0	49.6	16.1	55.0	5.7	58.3	32.1	39.9	32.5	44.9	15.1	23.1	55.3	22.3	66.3	237.5	6.4	24.4	25.8	92.9	90.3	108.5	37.3	26.7	54.9	29.0	31.8	106.6	33.0	37.0	20.3	31.4	158.3	33.2	79.3	75.9	115.3	20.7	34.5	22.5	165.2	28.9	13.8	59.1	71.3	65.2	43.1	32.4	19.6	143.6	9.9	19.7	24.7	34.3	36.0	5.5	2.3	49.5	194.5	50.0	23.1	26.9	2.9	192.0	194.2	8.3	14.9	13.3	111.2	3.4	55.7	37.0	7.9	196.3	44.3	48.3	32.4	38.6	23.0	5.2	0.9	48.0	19.6	16.1	0.0	0.3	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.8	0.1	35.1	45.3	44.5	42.6	38.0	45.4	52.6	39.9	52.6	55.0	39.9	66.3	2.9	44.8	22.8	76.4	2.3	65.1	79.1	26.3	4.6	212.4	4.6	1.3	38.5	40.0	33.1	3.7	35.5	27.9	2.7	74.4	0.0	32.5	3.5	7.1	1.7	36.4	11.5	10.5	10.1	24.3	25.6	15.5	64.2	9.9	5.7	0.2	27.5	104.9	5.6	18.5	13.4	45.0	36.7	14.6	28.9	6.7	29.2	8.2	28.4	22.5	9.0	111.1	1.0	21.6	82.5	44.2	65.8	13.9	5.2	115.4	73.4	1.9	51.3	267.6	0.0	4.9	13.1	19.6	18.0	40.6	64.1	43.2	3.2	0.2	50.3	244.5
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 174.7;liver: 204.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	174.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.6	204.6	0.0	0.2	0.0	0.0	0.0	1.4	8.1	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007374-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	21.6	19.1	27.6	17.0	28.8	76.6	22.1	28.2	35.1	22.9	23.8	30.9	26.6	19.8	18.8	30.3	19.4	14.1	17.0	30.1	30.1	22.8	23.9	21.0	21.7	26.7	25.8	20.1	28.7	17.8	12.2	14.4	27.7	21.2	30.2	21.8	25.4	16.4	14.8	27.5	26.1	19.9	23.7	22.2	25.2	34.1	26.7	30.0	22.2	12.7	24.1	23.4	22.9	27.0	32.7	31.2	39.2	64.6	50.6	37.7	64.4	32.2	31.7	36.4	31.7	38.1	33.6	81.1	22.6	41.7	14.6	40.4	53.1	45.1	30.1	26.6	64.5	40.2	33.8	42.3	36.6	72.6	33.9	37.3	49.3	30.1	60.2	36.8	46.6	64.4	83.8	28.7	34.5	73.3	59.7	74.4	107.7	44.0	49.2	45.4	66.7	65.7	57.0	31.6	50.2	62.7	48.0	79.0	48.1	61.9	56.6	56.6	34.8	24.4	34.2	42.3	35.7	28.8	49.7	62.4	27.0	55.7	26.3	33.3	33.6	51.2	23.5	29.2	23.1	23.8	26.3	26.6	37.4	26.2	29.8	24.7	28.7	36.6	27.8	26.8	30.6	37.4	27.6	28.8	28.2	35.1	30.1	30.1	26.7	25.8	27.7	23.7	26.7	27.0	39.7	16.0	20.5	3.6	40.4	73.4	61.5	62.2	41.5	22.8	62.2	48.6	14.9	54.3	52.1	35.0	10.4	53.2	57.3	70.4	70.5	88.6	161.1	31.1	34.9	36.2	52.7	103.7	13.2	76.1	86.0	34.8	42.3	34.4	17.7	34.6	40.7	53.6	60.4	18.5	11.8	87.5	63.1	63.1	52.0	113.7	27.1	49.7	39.2	6.5	71.1	26.6	50.4	3.5	7.2	52.7	57.6	29.3	62.1	100.2	102.3	100.4	44.5	28.0	19.7	38.3	46.7	95.0	80.9	72.9	82.1	51.6	48.3	39.6	88.6	105.2
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	26.6	38.2	61.9	13.0	60.1	23.8	27.1	58.7	76.8	25.1	57.4	26.9	15.0	28.1	24.4	36.1	29.6	19.2	34.5	61.2	65.4	32.8	49.4	22.4	16.1	61.7	64.4	26.6	28.6	30.6	38.4	13.0	62.3	39.0	14.4	10.6	26.7	23.9	36.8	28.9	23.8	18.8	60.7	25.0	30.1	28.8	63.8	21.1	29.4	20.7	14.1	27.6	24.2	59.5	26.2	31.2	25.7	42.3	39.2	28.2	20.7	39.6	45.1	52.9	44.8	13.0	53.5	16.5	30.2	42.4	24.6	35.3	28.3	38.5	21.9	22.0	54.4	27.6	24.7	30.1	58.0	27.8	26.5	49.4	21.5	50.8	28.7	24.3	35.7	32.4	21.2	37.1	33.6	23.4	40.1	29.2	48.3	27.0	38.6	32.8	17.7	33.5	51.6	15.2	54.8	48.4	30.6	42.6	39.7	9.2	42.3	44.2	33.1	31.1	26.1	50.6	38.1	39.8	38.5	17.6	47.1	53.3	45.8	38.2	20.6	27.7	32.5	32.5	24.8	37.4	29.7	24.6	18.5	30.0	29.1	30.2	56.3	31.9	35.3	30.4	37.4	25.6	61.9	60.1	58.7	76.8	61.2	65.4	61.7	64.4	62.3	60.7	63.8	59.5	22.9	9.6	13.5	8.5	25.4	11.7	13.3	26.2	15.9	42.1	24.0	29.2	8.9	18.6	13.3	12.9	14.6	30.9	20.9	24.5	39.2	39.1	25.5	13.2	17.2	20.6	29.9	43.8	12.4	40.5	33.9	22.6	18.8	12.4	17.1	22.0	11.0	15.1	28.3	43.7	15.0	21.0	40.7	8.5	12.9	76.9	20.2	12.2	26.6	6.5	20.6	51.9	22.6	17.1	14.4	48.6	22.7	19.9	18.6	19.9	28.8	19.2	7.9	18.7	13.1	19.6	20.3	27.2	18.0	19.3	13.5	30.8	20.5	22.4	23.1	12.4
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991231	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	7.1	6.0	1.8	10.8	1.8	13.0	6.1	1.6	2.4	7.3	3.4	5.8	6.6	7.3	9.6	7.8	7.4	6.6	3.7	1.7	1.9	9.9	5.6	9.3	13.6	3.0	2.1	4.6	3.2	2.9	2.0	6.3	2.7	7.0	7.3	0.4	6.1	6.2	7.6	5.2	8.9	6.1	2.4	14.3	5.8	2.1	2.7	7.7	5.5	3.0	14.6	7.0	7.0	2.7	4.8	2.6	0.4	5.6	13.0	17.3	4.6	5.9	11.7	11.2	18.5	2.0	5.0	10.5	9.4	7.3	10.8	7.3	3.6	5.8	6.6	10.7	2.3	4.8	4.6	2.0	17.2	5.7	9.4	17.4	4.2	6.9	2.5	9.2	9.8	5.0	3.2	5.7	13.5	2.3	5.5	6.4	1.8	0.0	3.5	8.3	5.4	11.2	13.3	9.3	0.1	0.1	4.4	9.1	16.2	0.6	1.3	7.3	10.1	2.0	3.4	3.5	4.0	6.5	5.1	11.7	5.4	6.9	12.6	12.1	10.2	4.7	6.9	12.5	6.6	13.1	5.8	6.2	9.8	15.1	5.4	6.0	11.4	6.5	11.7	9.0	7.9	7.1	1.8	1.8	1.6	2.4	1.7	1.9	3.0	2.1	2.7	2.4	2.7	2.7	37.6	25.6	47.1	0.3	120.2	14.9	56.9	16.1	24.5	0.6	20.1	12.8	6.0	18.6	32.4	46.0	0.0	23.5	88.5	48.3	17.6	28.5	1.1	48.4	28.1	39.9	18.1	10.3	0.1	14.9	23.5	25.5	24.5	69.4	35.5	52.4	35.0	17.5	32.6	0.0	0.1	33.3	16.2	94.0	32.7	2.8	19.9	81.3	10.6	34.7	113.2	0.2	107.1	0.0	0.2	20.4	47.4	18.8	34.3	39.7	48.3	69.5	22.7	1.1	6.6	23.1	28.2	0.3	0.5	42.7	9.2	21.2	53.1	23.0	25.6	94.7
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627108-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 422.5;Granulosa cells: 684.8;Late spermatids: 1708.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 121.7;RT4: 153.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	29.6	18.2	7.2	4.9	7.5	0.6	34.2	7.2	8.9	26.9	26.8	40.0	19.7	20.5	14.8	46.8	39.5	16.7	8.6	7.4	9.0	36.5	70.2	11.3	3.0	8.7	9.3	53.4	20.2	34.7	36.9	20.0	8.2	18.9	33.1	6.2	52.6	10.3	4.6	9.7	18.5	7.2	8.9	8.7	14.8	74.9	9.6	4.2	19.3	5.3	6.8	32.2	24.1	12.0	24.8	23.0	80.6	42.2	28.7	16.6	30.4	12.9	17.3	20.3	47.6	54.9	37.7	0.0	53.3	12.2	16.9	19.9	0.3	19.7	25.8	0.1	33.3	3.8	14.9	62.0	17.1	0.1	2.5	30.2	9.3	19.5	6.6	34.4	49.3	0.0	0.0	0.1	21.7	19.8	0.1	0.3	121.7	35.4	18.4	0.0	35.5	0.0	33.0	153.5	4.7	20.3	11.6	10.0	18.5	61.9	16.6	3.3	12.7	16.0	24.4	24.3	8.6	0.1	0.2	0.3	13.4	0.0	11.5	0.3	0.0	0.1	0.3	0.0	1.1	0.1	0.8	0.3	0.0	0.1	2.1	1.2	0.3	0.1	0.1	0.1	0.0	0.3	7.2	7.5	7.2	8.9	7.4	9.0	8.7	9.3	8.2	8.9	9.6	12.0	147.0	3.2	10.1	14.4	2.3	7.1	41.0	75.7	29.0	0.6	72.5	46.1	8.2	50.1	89.4	93.8	0.0	28.7	1.1	94.9	23.5	80.3	422.5	54.0	21.4	37.4	33.6	4.8	0.9	12.6	40.7	25.6	21.9	19.2	0.0	684.8	47.5	104.0	4.5	0.0	0.8	47.9	193.3	10.2	3.1	1708.3	32.9	3.1	10.6	1.0	1.0	48.2	0.0	9.5	0.4	18.7	55.5	35.7	0.3	33.0	43.5	43.8	193.9	1.9	19.7	17.1	43.1	20.9	32.4	23.3	5.4	13.5	2.5	49.4	94.3	89.7
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 110.3;Late spermatids: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: AB_2685717"	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	25.5	28.4	21.7	11.1	20.0	26.2	24.6	23.9	39.5	29.9	7.4	44.3	14.2	38.6	2.6	32.8	32.0	6.2	39.8	23.3	16.4	39.2	70.6	29.9	8.7	16.2	14.2	29.2	30.1	5.1	25.0	10.6	14.5	39.6	2.3	4.8	23.7	9.5	51.1	31.4	25.5	6.8	10.6	29.3	34.9	29.1	16.8	5.5	35.4	8.6	4.4	33.5	27.5	24.2	13.5	38.2	8.9	14.2	6.0	7.6	39.4	19.7	8.2	7.6	11.0	18.6	15.5	19.8	21.6	6.3	5.7	36.5	5.7	20.4	2.1	42.4	57.4	18.7	42.8	29.6	12.1	11.8	30.8	10.8	14.9	11.6	5.7	8.7	8.3	15.0	28.7	20.4	3.0	66.0	19.5	63.6	33.3	12.0	33.4	27.9	11.1	65.6	6.7	19.0	25.7	23.7	23.5	35.9	33.1	5.1	23.2	18.9	24.4	15.2	17.2	61.5	13.0	38.8	34.2	22.9	6.2	15.8	8.1	0.9	1.6	8.7	1.6	2.5	1.0	1.3	1.3	1.7	1.9	1.2	1.3	1.4	2.7	1.1	3.3	1.2	1.7	1.3	21.7	20.0	23.9	39.5	23.3	16.4	16.2	14.2	14.5	10.6	16.8	24.2	12.0	9.6	8.2	3.3	14.3	110.3	55.8	32.7	29.6	9.7	23.7	20.6	4.2	15.7	17.9	18.4	4.2	65.8	15.1	26.4	31.3	21.1	37.6	29.1	16.2	16.8	84.6	26.1	6.2	23.6	60.1	16.2	43.3	28.7	10.8	13.6	16.1	32.4	23.6	10.1	6.1	34.4	28.5	14.7	25.9	129.1	16.1	14.5	21.4	1.9	19.4	13.0	23.7	3.5	8.1	22.4	19.0	19.9	22.2	37.6	24.4	57.0	7.3	11.5	46.0	15.2	25.1	18.6	14.6	20.2	102.9	107.8	15.9	14.0	22.0	33.1
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 443.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 52.7"	"Group enriched"	"Detected in all"	7	"granulocytes: 52.7;monocytes: 22.7"	"Cell line enhanced"	"Detected in all"		"HMC-1: 270.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		32000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 15: RT4 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	54.5	24.6	9.3	75.2	8.3	94.0	42.5	9.2	12.6	37.7	11.0	88.9	61.9	89.1	6.0	37.5	54.4	27.0	36.4	8.1	9.4	39.1	27.3	58.2	48.7	13.0	10.9	22.5	20.6	10.7	17.1	31.5	13.8	43.8	20.4	1.9	30.7	39.1	12.5	32.8	63.6	36.5	11.7	107.0	70.5	14.7	15.0	24.9	27.6	8.5	32.0	71.6	39.0	12.0	68.9	66.3	20.6	35.6	10.2	17.4	50.5	70.2	52.8	47.4	40.9	30.1	142.0	31.2	55.7	56.4	31.3	60.6	6.2	69.5	15.9	87.0	14.8	183.7	32.3	55.4	56.6	68.1	270.1	26.8	38.2	44.5	28.5	38.3	71.1	25.8	112.1	67.5	29.4	53.7	30.3	58.7	36.0	65.1	44.5	21.6	12.6	12.2	40.9	216.2	23.0	16.3	83.6	41.7	48.2	13.0	45.7	115.2	107.0	74.7	74.4	24.7	112.4	32.8	43.3	54.7	52.4	82.3	92.3	13.3	8.5	52.7	4.1	13.9	2.8	3.4	3.3	3.9	5.5	3.3	2.1	2.5	34.5	4.0	22.7	2.1	2.6	5.8	9.3	8.3	9.2	12.6	8.1	9.4	13.0	10.9	13.8	11.7	15.0	12.0	80.9	16.0	19.5	2.9	99.4	98.3	95.6	48.8	37.0	6.9	53.5	57.0	19.0	48.6	41.5	33.1	27.1	67.1	85.9	202.3	17.6	138.6	3.2	33.9	30.5	77.0	114.7	20.0	2.6	98.2	443.6	26.7	81.6	58.1	83.1	17.4	48.5	15.8	160.1	6.7	3.4	159.3	44.7	132.5	232.0	3.8	26.1	192.9	49.8	10.3	162.9	13.2	185.3	2.0	2.3	212.5	245.5	49.2	38.2	73.4	134.6	20.4	18.6	14.7	131.5	46.5	89.4	18.9	15.5	38.7	77.7	140.9	95.7	21.0	129.5	144.8
VTCN1	"B7-H4, B7H4, B7S1, B7x, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 100.9;fallopian tube: 32.7;pancreas: 30.1"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 62.3;Collecting duct cells: 55.2;Ductal cells: 83.6;Endometrial ciliated cells: 42.7;Exocrine glandular cells: 34.2;Glandular and luminal cells: 79.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 244.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA				"Cluster 5: Breast - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	100.9	0.0	0.0	15.3	0.0	0.0	0.4	4.5	5.0	0.4	32.7	5.0	0.2	0.0	0.0	17.3	1.1	0.7	0.0	0.0	0.0	0.1	30.1	0.0	0.1	0.8	0.0	3.0	0.0	0.0	22.1	7.8	0.2	2.8	0.0	0.1	0.0	0.0	3.6	1.1	0.1	0.1	0.0	0.0	0.0	3.2	0.1	0.0	1.0	0.1	1.7	0.0	0.0	0.0	44.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	7.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	4.2	0.1	1.2	0.0	0.0	244.8	0.1	29.9	14.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.5	6.9	0.0	0.0	62.3	18.4	1.1	0.0	22.6	55.2	0.0	3.4	1.1	0.0	0.0	83.6	2.5	42.7	4.4	0.6	0.0	0.0	0.8	34.2	1.4	0.4	0.0	79.1	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	6.1	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.3	11.3	0.0	0.0	0.0	1.6	0.0	0.3	8.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	3.0	0.5	0.0	0.0	4.8
YAP1	YAP65	ENSG00000137693	"Yes1 associated transcriptional regulator"	P46937	11	102110447-102233424	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 145.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009370, HPA038884, HPA038885, CAB069915, HPA070359"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB009370: AB_2273277, CAB069915: AB_922796, HPA038884: , HPA038885: AB_2676255, HPA070359: AB_2732154"	"unprognostic (9.56e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (9.26e-2)"	"unprognostic (4.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-2)"	57.2	27.8	19.1	25.9	19.1	0.3	42.7	18.6	17.1	62.5	44.3	41.5	27.2	78.1	45.9	74.7	65.6	49.3	48.1	15.9	22.1	39.3	33.5	45.7	13.0	31.8	30.2	93.1	22.3	37.0	9.9	83.1	21.8	59.2	30.1	12.9	40.6	83.7	48.3	44.2	27.4	100.5	27.3	14.7	31.6	15.0	27.0	13.8	85.9	58.2	22.7	60.9	52.6	20.2	56.9	52.1	141.5	69.6	151.1	143.1	118.7	130.4	147.8	124.2	101.5	130.2	134.9	0.0	105.4	171.6	92.1	98.0	71.0	186.4	130.6	16.8	25.5	0.1	67.3	89.5	115.3	0.1	2.5	115.2	119.4	136.6	220.2	138.4	39.4	6.7	0.0	0.1	142.1	27.2	2.6	0.4	66.8	135.9	49.3	0.1	79.7	0.3	90.9	99.5	0.4	4.7	153.6	57.2	43.5	129.1	103.2	0.8	43.4	175.4	68.8	89.6	55.7	0.1	0.2	0.8	51.0	0.2	130.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	19.1	18.6	17.1	15.9	22.1	31.8	30.2	21.8	27.3	27.0	20.2	28.4	35.3	69.4	145.3	1.5	113.7	47.8	43.5	71.2	0.4	48.1	43.8	39.2	62.9	37.2	92.0	0.0	91.4	0.4	16.2	11.7	27.6	6.7	61.8	53.3	28.9	7.3	0.0	1.5	18.3	20.3	49.0	23.9	85.1	0.0	127.2	26.0	45.2	10.6	0.0	1.6	13.1	14.2	1.6	21.5	4.6	37.9	2.2	44.4	60.0	1.0	27.6	0.0	5.0	0.7	25.2	16.3	40.6	0.1	66.0	27.2	26.1	41.6	1.2	39.5	21.6	62.0	2.5	5.3	59.5	123.2	61.6	2.1	15.9	27.8	65.6
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822557-76972901	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	2.5	2.2	3.2	2.2	5.3	4.9	2.4	9.2	4.4	3.0	0.0	2.8	1.9	3.2	2.8	2.5	2.9	2.0	2.3	3.4	4.3	2.0	2.1	2.1	2.6	2.3	3.5	4.3	2.8	3.1	3.6	2.2	2.6	2.6	1.5	2.4	2.7	2.3	2.5	4.1	2.5	2.1	1.4	2.3	2.8	6.8	3.5	4.1	2.6	3.1	2.4	2.6	2.9	5.7	2.5	2.4	4.7	3.4	3.7	3.4	1.9	1.8	2.6	2.9	2.4	2.3	2.3	3.6	0.9	2.5	3.2	4.6	3.0	2.8	2.5	3.8	3.1	3.4	3.9	2.8	2.1	5.7	3.7	3.4	3.1	2.8	4.4	3.4	3.0	5.5	3.3	2.9	3.1	2.2	6.9	3.2	2.5	0.6	2.6	4.3	4.9	2.4	2.4	3.8	2.6	2.8	3.6	2.2	2.5	2.2	2.5	3.9	3.2	5.3	2.0	1.3	2.9	2.0	3.0	4.4	3.6	3.0	3.9	0.7	2.0	3.9	3.1	1.9	3.0	5.9	2.3	2.1	1.4	4.4	2.6	2.7	2.1	1.9	1.8	2.8	2.7	0.9	3.2	5.3	9.2	4.4	3.4	4.3	2.3	3.5	2.6	1.4	3.5	5.7	9.3	9.6	7.9	39.5	11.9	7.1	8.5	5.4	10.8	15.3	8.0	7.6	9.5	12.8	6.7	7.3	10.4	8.4	12.9	5.6	1.9	5.4	6.9	10.8	12.6	9.3	6.0	12.8	37.7	3.9	7.2	8.8	9.2	10.5	1.3	15.8	10.0	6.8	6.0	25.2	25.3	5.0	6.1	7.2	7.2	6.0	10.5	8.7	7.2	16.9	8.4	9.7	9.2	41.7	39.7	4.7	3.1	7.2	9.1	6.8	5.9	3.0	10.9	15.9	6.6	14.2	10.4	26.7	26.2	8.8	8.4	6.0	12.4	7.8	5.7	6.3
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569672-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 180.3;Late spermatids: 576.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	8.7	8.4	17.6	9.8	17.5	11.4	5.1	20.5	19.1	6.7	16.4	9.7	14.6	7.8	5.6	5.6	10.4	4.2	7.0	16.5	15.8	8.2	8.3	7.5	9.5	17.5	16.9	9.1	12.3	9.7	8.4	3.3	17.2	7.5	6.4	5.6	10.1	6.9	25.6	9.0	11.6	5.8	16.2	12.0	10.1	13.6	18.1	8.2	5.1	9.7	5.4	6.6	5.7	20.2	10.4	9.5	7.3	8.1	13.3	5.2	3.1	6.7	8.2	5.0	4.0	2.5	15.1	6.2	12.8	6.9	6.0	8.6	2.2	3.6	4.7	16.7	6.4	3.8	3.7	2.7	6.3	4.3	17.9	8.7	8.2	5.3	6.0	7.7	4.7	7.7	3.9	12.0	5.3	13.5	14.9	9.9	3.3	8.6	4.9	13.3	3.8	9.2	8.2	3.2	12.1	13.2	2.4	14.1	15.3	2.0	15.6	7.8	5.4	5.5	4.0	5.2	4.7	20.5	13.2	5.7	12.2	4.3	9.7	12.0	4.6	11.0	6.2	4.2	5.4	6.5	6.6	6.8	4.2	7.6	5.7	5.0	5.3	20.4	6.5	7.4	11.2	3.3	17.6	17.5	20.5	19.1	16.5	15.8	17.5	16.9	17.2	16.2	18.1	20.2	16.3	6.4	3.1	5.9	22.8	6.4	10.5	12.6	16.5	19.8	20.3	22.7	11.2	22.8	10.2	16.5	18.8	7.5	26.0	38.6	49.0	24.8	180.3	25.4	9.5	14.0	20.4	11.2	5.1	31.2	9.6	15.6	17.9	9.0	5.1	12.1	20.7	22.6	24.4	21.9	5.1	27.7	12.2	33.1	12.0	576.6	19.9	17.4	17.8	1.9	28.3	31.2	30.9	9.0	10.3	21.8	37.2	19.9	16.7	10.1	59.2	54.1	38.4	27.4	6.6	17.2	20.2	34.5	8.5	11.2	7.1	4.7	23.2	15.1	23.6	8.5